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1Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia [1]. It is mostly an
age-related disease and thus patient numbers are constantly increasing in the de-
veloped world. Although AF itself is not lethal, it accounts for several secondary
diseases and death-causes, e.g. formation of thrombi causing stroke. AF can be
managed with anti-arrhythmic and anti-coagulation drugs, but the curative abla-
tion therapy becomes more popular. Especially for younger patients, this therapy
may be a better choice. However, the success rates reported for ablation interven-
tions are still moderate and a major portion of patients need to undergo several
interventions before the arrhythmia is cured [1]. Personalized computational mod-
els of the atria may contribute to understand the reasons for the moderate therapy
success and improve the treatment in the future.
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Fig. 1.1. Overview of the fields of usage of atrial models. Atrial models are currently exploited to under-
stand pathologies in basic research. Atrial modeling is also in a transition phase to the application of atrial
models in the clinical practice. This requires a personalization of the models to the specific patient. For
examples to the fields of usage of atrial models see Figure 16.1 in the conclusions chapter.
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Computational cardiac modeling started with modeling single cell ventricular elec-
trophysiology over half a century ago. The interest in modeling the atria was com-
parable low for a long time, but atrial modeling has provided valuable insights into
physiological and pathological mechanisms in basic science over the last decade or
two. The studies most often focused on providing insights into mechanisms lead-
ing to AF [2]. As cardiac imaging and electrical measurements as well as compu-
tational resources refined to a great extent over the last decade, the use of cardiac
modeling in clinical practice moved into the focus of interest [3, 4]. Application
of cardiac modeling in the clinic requires a personalization of the models to reflect
the patients anatomy and electrophysiology as well as to suit the clinicians needs
and expectations. This is not an easy task to solve, especially for the atria, as their
anatomy is more complex compared to the ventricles and atrial electrophysiology
was studied in less detail in the past.
Atrial modeling is currently in a transition phase between the exploitation of sim-
ulations with well-established complex models to aid basic science and the in-
troduction of simplified atrial models into the clinical practice [5] (Fig. 1.1). Both
fields of applications, although often requiring contrary technical approaches, may
contribute to the understanding of atrial diseases and therapy possibilities. Even
more, knowledge gained from detailed simulations joined with insights from per-
sonalized macroscopic simulations may provide a more complete understanding
of complex relationships between microscopic changes and macroscopic observa-
tions.
To generate a more complete picture of the multi-scale relationships, both detailed
models of atrial tissue as well as personalized models of atrial anatomy, electro-
physiology and excitation propagation are required [6]. For the detailed modeling
of atrial anatomy and physiology it is important to understand and reproduce re-
gional electrophysiology, tension development and myofiber orientation to e.g. aid
the understanding of the impact of incomplete ablation lesions. Personalized atrial
models on the other hand require the segmentation of atrial and thorax anatomy
from patient image data and the adaptation of atrial conduction velocity and in-
teratrial conduction sequence to fit electrophysiological measurements from the
patient. Thereby, the fusion of electrical and anatomical data may benefit the per-
sonalization in both regards. Additionally, parameters of the complex cell electro-
physiology models need to be identified which could allow a stable personaliza-
tion. These methods need to be automated as much as possible and should require
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only minimal additional measurements to allow for an acceptance of the methods
by the clinical personnel in the future. Otherwise the potential benefits in the dis-
ease diagnosis and therapy evaluation will be outruled by the prolongation of the
patient treatment.
Once developed, detailed and personalized atrial models can be applied to var-
ious fields from basic science, clinical research and clinical practice. This will
provide new insights to understand pathological and therapeutical mechanisms,
ranging from AF initiation to moderate success rates of ablation therapy. In the
long-run, personalized computational multi-scale atrial modeling can improve the
outcome of ablation therapy, decrease actual treatment time through in-silico treat-
ment planning and thus reduce both socioeconomic costs and patient burden.
Aims of the Thesis
The euHeart project, as part of the European Commisions seventh framework pro-
gram, aims at creating integrated multi-scale patient-specific cardiac models for
treatment planning and evaluation [7, 8]. Within the work of the seventeen Eu-
ropean partners from industry, academia and clinical practice, the major goal of
this thesis is the creation of personalized atrial models and the use of these for the
model-based evaluation and planning of radio-frequency ablation. This aim is bro-
ken down into several tasks reaching from cellular modeling to ECG computation.
In particular the following milestones are covered:
• Design of a new body surface potential mapping (BSPM) layout and establish-
ment of an acquisition and post-processing workflow of BSPM and intracardiac
data.
• Investigation of heterogeneous atrial electrophysiology and tension develop-
ment. Adjustment of models of the atrial electrophysiology and tension devel-
opment to the experimental findings. Study and realistic simulation of the atrial
repolarization sequence regarding a realistic ECG.
• Development of methods and a framework for the personalization of models of
atrial anatomy, electrophysiology and excitation conduction.
• Model-based examination of radio-frequency ablation from microscopic obser-
vations to multi-physics therapy evaluation.
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• Understanding of the influence of hemodialysis therapy for renal disease pa-
tients on the increased incidence of AF in these patients.
Structure of Thesis
Part I provides an overview of the medical and modeling fundamentals underlying
the work in this thesis.
• Chapter 2 explains the general cardiac anatomy and electrophysiology and
discusses AF and the measurement of cardiac electrical activity. The topics are
covered only briefly, as these are part of the focus of the thesis and thus de-
scribed in more detail in Chapter 3 and Part II. radio-frequency ablation as a
curative therapy for AF is also introduced in this chapter.
• Chapter 3 gives a comprehensive overview of the atrial anatomy and electro-
physiology and introduces the basic methods of cardiac modeling in this regard.
Part II covers the description of the data acquisition and processing techniques as
well as the atrial modeling methods.
• Chapter 4 explains data acquisition and signal processing methods established
as part of this thesis. In the end, section 4.5 summarizes the acquired clinical
data.
• Chapter 5 introduces and evaluates new techniques of atrial modeling. A
method to augment geometrical atrial models with rule-based fiber orienta-
tion, tissue labels and generic ablation lesion patterns is presented. A well-
established model of atrial electrophysiology is enhanced to reproduce electro-
physiological properties from different regions in the atria. This model is also
coupled with a model of atrial tension development which allows the realistic
simulation of local atrial tension. Furthermore, a fast method to simulate atrial
excitation is described.
Part III presents and evaluates techniques for the personalization of atrial models.
• Chapter 6 introduces a framework for the personalization of multi-scale atrial
models.
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• Chapter 7 describes the methods and results of the efforts of anatomical per-
sonalization. In the end of the chapter, an overview of the models created in this
thesis and their use for projects related to this thesis and undertaken by external
project partners is given.
• Chapter 8 presents techniques to personalize atrial electrophysiological mod-
els.
• Chapter 9 demonstrates methods to personalize the electrical excitation se-
quence in the atria. This spans from the individualization of interatrial conduc-
tion pathways to the estimation of global conduction velocity from ECG data.
Part IV gives examples of applications of atrial models spanning from basic re-
search to clinical tasks.
• Chapter 10 investigates the atrial repolarization sequence in a cohort of anatom-
ical models.
• Chapter 11 shows an example for the simulation of AF in a 3D personalized
atrial model.
• Chapter 12 examines the behavior of gaps in ablation lesions under different
physiological environments.
• Chapter 13 covers the results of patient-specific model-based evaluation of
outcome prediction of radio-frequency ablation procedures based on late en-
hancement MRI data.
• Chapter 14 displays the impact of ablation lesions on the cardiac function from
electrical excitation to mechanical contraction and relaxation in a four chamber
model.
• Chapter 15 covers a study examining the impact of hemodialysis therapy on
the atria from cell electrophysiology to ECG and relates the outcome to the
increased incidence of AF in renal-disease patients.
At the end a summarizing conclusion for the thesis is drawn and an outlook for
fields of further investigation is given.

Part I
Fundamentals

2Clinical Fundamentals
2.1 Atrial Anatomy and Physiology
The heart is located posterior to the sternum between the left and right lung lobes.
It is a hollow muscular organ of size comparable to a closed human fist. The heart
is made up of four chambers. The right atrium collects venous blood from the main
circulatory system via the inferior and superior vena cava (IVC/SVC) and also
from the coronary sinus (CS). It passes the blood to the right ventricle through
the triscuspid valve. From there, the blood is subsequently pumped to the lung.
The left atrium (LA) collects oxygenated blood from the lung circulatory system,
usually through four pulmonary veins. The LA passes the blood through the mitral
valve into the left ventricle, which then pumps the blood into the body circulatory
system. The heart itself is perfused by the coronary arteries which originate from
the ascending part of the aortic arch. Blood from the coronary veins is collected
in the CS, which runs posterior between the left ventricle and LA into the right
atrium. The atria are electrically isolated from the ventricles by fibro-fatty tissues
at the valve plane [9].
2.1.1 Anatomy
The right atrium can be divided into four components: The right atrial appendage
(RAA) , the smooth venous part of the posterior free wall, the rough part of the free
wall and the septum [10]. The structure of the right atrium is mainly determined by
its large muscle bundles: Crista terminalis (CT) [11, 12], 15-20 pectinate muscles
(PM) [13], the intercaval bundle [14], tricuspid valve ring musculature and Bach-
mann’s bundle [10]. The CT is the right atriums most prominent structure [11] and
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separates the smooth venous part and the rough free wall [10]. The CT leads from
the right side of the orifice of the SVC on the posterior wall towards the right side
of the IVC, encircling its orifice and smoothing out between the CS and IVC in
the atrial septum. It diminishes in size between SVC and IVC [11]. The PMs lead
from the posterior side over the right lateral and anterior portion of the right atrium
towards the ring muscle around the orifice of the triscuspid valve. The first supe-
rior PM is called septum spurium and is thicker (4.2mm vs. 1-3mm) and less long
than the other PMs [11]. The septum spurium forms the onset of the musculature
of the RAA. The most inferior PM encircles the orifice of the CS. The sinus node
(SN) is located at the superior beginning of the CT near the ostium of the SVC
and the onset of the RAA [15]. The RAA is triangular-shaped and clasps the aortic
arch [11].
The left atrium lies with its posterior wall next to the oesophagus and has a smooth
endocardial surface [16]. The wall thickness of the smooth left atrial free wall re-
duces from the roof to the low posterior aspect (Fig. 2.1). The left atrial appendage
(LAA) is located supero-anterior of the left superior pulmonary vein (LSPV). It is
clearly delineated from the left atrial myocardium and has a rough endocardial
surface. Its outer shape is tubular with multiple finger-like branches [17]. Under
physiological conditions, the left atrium has a volume of 42ml [18] and a diameter
of 3.7 cm [18, 19]. Structural remodeling caused by AF commonly increases left
atrial volume [20].
The region of the right atrium enclosed by the tricuspid valve and the orifice of the
IVC forms an isthmus [9, 21]. In patients with atrial flutter, this region has a slower
conduction velocity [22] and is therefore a substrate for macro-reentries and target
of RFA [21]. In the left atrium, the region enclosed by the left inferior pulmonary
vein (LIPV) and the mitral valve annulus is also an isthmus (mitral-isthmus) and
may also be targeted by RFA in AF patients [23].
2.1.1.1 Septum and Interatrial Connections
The atria are separated by the atrial septum. The plane of the atrial septum is
orientated posteriorly rightward oblique [9]. The septum contains an electrically
isolating layer [25–28], but both sides of the septum are covered with regular my-
ocardium from the right atrium and left atrium, respectively. The atria are elec-
trically connected by various interatrial bridges and the limbus of the fossa ovalis
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Fig. 2.1. Interatrial connections (green stars, with likelihood) and atrial wall thickness in the healthy popu-
lation. Data from [10] and [24].
(FO) [29–33] (Fig. 2.1). The most prominent interatrial bridge is Bachmann’s bun-
dle (BB) on the supero-anterior side. BB extends between the two appendages,
splitting at the beginning of the appendages and encircling these partly [10]. The
inferior part of Bachmann’s bundle connects with the atrio-ventricular valve ring
musculature. Along its extent, BB bridges the interatrial grove [34, 35] and has
a width of approximately 4.6mm [36]. The CS is also covered with myocardium
and therefore builds another electrical connection. The other interatrial connec-
tions can either bridge or tunnel the epicardial fat closely to the myocardium
(bridge-type vs. path-type connection) [37]. The location and number of intera-
trial connections is highly variable between individuals [28, 37–39]. Figure 2.1
schematically shows the locations of the interatrial bridges and the probability of
existence in the population.
2.1.1.2 Pulmonary Veins
Typically two left and two right pulmonary veins (PVs) drain blood from the five
lung lobes into the left atrium [41]. The vessel of the right middle lung lobe joins
the vessel of the right upper lobe prior to connecting to the left atrium [42]. The
drainage patterns of the PVs vary between individuals. A multitude of anatomical
studies addressed this issue [40–48]. The findings vary across studies, as neither
the definition of the PV drainage pattern nor the focus of the studies are uniform.
Marom et al. defined four different patterns of left PV ostia (1-2 PVs) and ten
different patterns of right PV ostia (2-5 PVs) [40]. Figure 2.2 depicts schematically
the observed patterns. The most common variations to the normal four PV pattern
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Fig. 2.2. Drainage patterns of right and left pulmonary veins as reported by [40]. Figure adapted from [40].
are a third middle right PV [42] and a joint trunk of the left PVs (common left
trunk) [43, 45]. A common trunk is present, if the distance between the bifurcation
of the PVs to the left atrial body is greater than 1.5 cm [45] or just outside the
atrial body [43]. A short common left trunk may be present in more than half of
all individuals [47] and a third right middle PV in up to 86% of individuals [42].
The wall of the PVs is approximately 0.5mm thick [49]. The diameter of the
PV ostia is larger in the upper PVs than in the lower PVs (11 vs. 8mm) [50].
AF patients often show an increased diameter [50]. The PV onsets are covered
with myocardial cells near their ostia [9, 51, 52]. The extent of these muscu-
lar sleeves are longer in the upper PVs than in the lower PVs [38, 49, 53–55]:
LSPV 41mm, RSPV 30mm, LIPV 21mm, RIPV 13mm [53], 10.9-7.2mm [49]
and 14.8-6.0mm [54]. This might concur with a higher rate of ectopic activity in
the upper PVs [56]. Contradicting results were found whether the length of the
sleeves varies between healthy and AF-patients [49, 54]. The fiber direction at
the junction of the PV sleeves and the left atrial myocardium can show abrupt
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Fig. 2.3. Schematic representation of the major atrial fiber bundles and layers. Blue: septo-atrial bundle
(subendocardium), red: septo-pulmonary bundle (subepicardium), light blue: Bachmann’s bundle, green:
crista terminalis, green: intercaval bundle, pink: pectinate muscles, black: circular fiber orientation around
vessel orifices and valves as well in the appendages.
changes [57, 58]. Fibers are oriented circumferentially symmetric in the muscular
sleeves of the PVs [52].
2.1.1.3 Fiber Architecture
The myofiber architecture in the human atria is characterized by non-transmural
fiber layers and a number of prominent muscular bundles. Figure 2.3 schemati-
cally shows the major fiber bundles and layers in the right and left atrium. In the
right atrium, myofibers encircle the tricuspid valve ring and SVC [59]. Fiber ori-
entation is aligned along the longitudinal extension of the CT, PMs and BB. PM
fibers end perpendicular in the CT and tricuspid ring muscle fibers (Fig. 2.4b).
The myocardium between the pectinate muscles shows a fiber orientation similar
to the pectinate muscles. The intracaval bundle is the main muscular structure of
the venous component of the right atrium (Fig. 2.4e). It encircles the orifice of the
SVC. One muscle bundle leaves this circular structure left lateral of the orifice and
extends towards the right lateral side of the orifice of the IVC [14]. It connects
with the CT on the posterior wall. There are no muscular extensions and thus no
fiber orientation in the IVC [52].
The left atrium is comprised of two layers of myocardial fibers overlapping each
other (Fig. 2.3). In contrast to ventricular fiber architecture, the transmural change
in fiber orientation between those layers is abrupt. Fiber orientation is organized
in two rather continuous layers compared to the right atrium with its multiple of
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Fig. 2.4. Local fiber orientation (dashed lines) in various dissections of human atria. Black and red stars
denote interatrial muscle bridges. Photographs provided by Damien Sanchez-Quintana and reproduced
with permission. The photographs were partly also used in [26].
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independent bundles. We find the septo-atrial bundle in the subendocardium and a
septo-pulmonary bundle subepicardially [10] (Fig. 2.4c–e). The septo-atrial bun-
dle circles the orifice of the mitral valve [59] and proceeds broad over the anterior
wall towards the superior PVs [10] (Fig. 2.4f). It thereby incorporates the left atrial
appendage (LAA) in its structure and continues to spread over the left atrial roof to
encircle the orifices of the inferior pulmonary veins (Fig. 2.4f). Fibers encircle the
sleeves of the PVs symmetrically from the ostium to the end of the sleeves [52, 59].
The fiber orientation in the atrial appendages may either be circularly organized or
appear rather chaotic depending on the individual patient [10].
2.1.1.4 Wall Thickness
The myocardial wall of the atria is non-uniformly thick with values ranging be-
tween 1mm and 3mm [13, 16, 24, 60–65]. In the right atrium, the wall thick-
ness is mainly determined by the thickness of the dominant muscular bundles (CT,
PMs) [13], whereas in the left atrium also the smooth wall shows variation in thick-
ness. The left atrial wall is thicker on the posterior and inferior side compared to
the roof (2.9±1.3mm vs. 2.3±1.0mm) [24, 62]. Neher et al. reported that the left
atrial wall is thinner than the right atriumwall (2.1 vs. 3.3mm) [60], whereasWang
et al. found the opposite [13]. Females have a slightly thinner atrial wall compared
to males [62]. AF patients usually have a thinner wall than the healthy population
(2.1-2.5mm vs. 2.3-2.9mm) [24]. The regional wall thickness determines the RF
energy needed to create transmural RFA lesions and is thus important to know for
the individual patient [38, 61, 63, 66]. Table 2.1 summarizes the findings of the
atrial wall thickness.
2.1.1.5 Implications for Modeling the Atrial Anatomy
Models of the human atrial anatomy need to be build purpose specific. In some
cases it is suitable to create highly detailed models with a very fine resolution
of specific parts of the atria, in order to understand regional conduction behav-
ior [67–69]. In majority of cases however, especially if the model is to be applied
in the field of clinical research or clinical practice, macroscopic bi-atrial models
are needed. Such models should respect the specific anatomy of a patient, e. g. spe-
cial attention should be laid on the PV drainage pattern. Additionally, the models
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Table 2.1. Atrial wall thickness reported in literature.
study species condition location wall thickness
Neher et al. 2011 [60] human (7) control RA (11 regions) 3.3 mm
LA 2.1 mm
Otomo et al. 2010 [61] porcine (13) both atria 3.2 - 4.2 mm
Platonov et al. 2008 [24] human (298) control LA SPV 2.3 mm
LA CPV 2.5 mm
LV IPV 2.9 mm
AF LA SPV 2.1 mm
LA CPV 2.2 mm
LV IPV 2.5 mm
Hall et al. 2006 [62] human (34) control LA anterior 1.86 mm
LA roof 1.06 mm
LA posterior 1.4 mm
LA isthmus 1.6 mm
LA septum 2.2 mm
Deneke et al. 2005 [63] human (7) AF LA isthmus 4-10 mm
LA PV ostium 1-3 mm
LA posterior 2-5 mm
RA1 3-5 mm
RA2 2-10 mm
Hassink et al. 2003 [49] human (20) AF & control LA anterior 1.6 mm
LA posterior 1.7 mm
Wang et al. 1995 [13] human (9) control RA terminal grove 5-8 mm
RA posterior vestibule 2 mm
LA anterior 4-5 mm
LA post/ant vestibule 3 mm
Coffey et al. 1981 [64] human (n/a) n/a atrium 0.5 - 3.5 mm
atrium 2 - 3 mm
Sunderman 1949 [65] human (n/a) n/a atrium 2 mm
should include regionally varying atrial wall thickness to incorporate the multi-
layer fiber architecture of the atria. Within the atrial wall, fast conducting bundles
should be annotated and also other structures with altered electrophysiology or ex-
citation behavior should be marked. Furthermore, the atrial septum should contain
an isolating layer and several discrete interatrial bridges. If the computation of the
atrial ECG signal is desired, also a thorax model needs to be created from image
data of the same individual. In the thorax model, skeletal muscle, lungs, blood,
intestine, fat and liver should be distinguished for simulations of the atrial ECG
signal [70, 71].
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Fig. 2.5. Action potential and tension development in an healthy and a AF-remodeled (Sec. 3.2.2) human
right atrial cell. Ionic currents mentioned above the action potential indicate the ionic currents most re-
sponsible for the different phases of the healthy action potential. Action potentials simulated with the CRN
model [72, 73]. Tension data from [74].
2.1.2 Electrophysiology
The atrial electrophysiology is introduced in this section. Atrial electrophysiology
and pathology is reviewed in more detail by Schotten et al. [75]. The myocardium
consists of different cells. Cardiac myocytes form the main portion of these, fi-
broblasts a significantly smaller one. Myocytes are excitable and contracting cells.
The cell membrane is selectively permeable for certain types of ions (mainly Na+,
K+,Ca2+) through ionic channels, pump and exchangers. Each pore is permeable
for one or multiple ions. The channels may open and close depending on various
factors, e.g. transmembrane voltage, ion concentrations or other transmitters. At
rest, ionic concentrations inside and outside of the myocytes are in an equilibrium
state and a transmembrane voltage of -80 to -90mV forms.
If an external stimulus raises the potential difference between the extracellular
and intracellular space above a certain threshold (approximately -50 to -60mV),
sodium channels open, allowing a fast influx of Na+ ions. This is the so-called
depolarization phase of the cardiac action potential (Fig. 2.5). After several mil-
liseconds, the fast sodium channels are inactivated and calcium channels open. The
slowCa2+ influx prolongs the depolarization state of the cell, which is the plateau
phase of the action potential. After 200 to 400ms, repolarizing potassium chan-
nels open and the K+ outflow begins. The sodium channels leave the inactivation
state at the end of the repolarization phase. Thus, a new action potential cannot
be triggered unless the previous one is nearly completed. This so-called refrac-
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tory period prevents arrhythmias. Figure 2.5 depicts typical action potentials from
the healthy and AF-remodeled human right atrium. AF remodeling is explained in
section 3.2.2.
The intracellular spaces of adjacent myocytes are coupled via gap junctions. These
are non-selective ion channels formed by two connexons, one in each cell mem-
brane. A depolarization therefore spreads via intracellular currents through these
gap junctions. So, the myocardium forms a syncytium: If the myocardium is acti-
vated at one place, a depolarization wave will spread over the whole myocardium.
The conduction velocity of this wave is determined mainly by the gap junction
density and the upstroke velocity of the action potential.
Some regions in the atria show a specialized electrophysiology. The sinus node
(SN) and the atrio-ventricular (AV) node do not have a stable resting membrane
potential, but constantly slowly depolarize through open sodium and / or calcium
channels. As the SN depolarizes more quickly than the AV node, the frequency of
induced action potentials is greater and the SN is thus overruling the pacemaker
activity of the AV node.
Excitation Contraction Coupling
The Ca2+ influx during the plateau phase of the action potential triggers Ca2+ re-
lease from the junctional sarcoplasmic reticulum through the ryanodin-2-receptor-
channels (Ca2+-induced Ca2+ release, positive feedback loop). The cytosolic
Ca2+ binds to troponin C. This removes the troponin complex from the myosin
binding sites of actin. ATp attaches to the myosin and the myosin heads bind to
the actin filaments [76]. Under ATP hydrolysis, the myosin heads pull the actin fil-
aments towards the sarcomere center, which shortens the sarcomere. Afterwards,
new ATP replaces the ADP at the myosin heads, which subsequently relax and
can bind to a new position on the actin filament. The so-called cross bridge cy-
cle is repeated until cytosolic Ca2+ concentration decreases again. The sarco-
endoplasmic reticulum calcium-ATPase (SERCA) pumps calcium back into the
sarcoplasmic reticulum and further ATPases pump Ca2+ out of the intracellular
space into the extracellular matrix. Figure 2.5 shows the tension development mea-
sured in healthy and AF-remodeled atrial cells.
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2.1.3 Sinus Rhythm Activity
The atrial excitation sequence starts in the SN. The SN is located in the right
atrium between the orifice of the SVC and the onset of the RAA. The excitation
wave travels faster along the CT, BB and within the PMs [85–87]. These structures
have a higher conduction velocity and also an increased anisotropy compared to
the common atrial myocardium (CAM) [88]. Bachmann’s bundle usually activates
the left atrium on the supero-anterior side [89]. A second wavefront activates the
left atrium from the inferior right side. The latter wave is caused by fast down-
ward activation of the right atrium via the CT and is carried over the septum
with the musculature of the CS. The two waves merge below the LIPV approx-
imately 100ms after the depolarization of the SN. The conduction velocity in the
atrium lies between 51 and 120 cm/s under physiological conditions (Tab. 2.2).
Under pathological influences, the measured variation in conduction velocity in-
creases [5]. The conduction velocity reduces with age [90]. Anisotropy ratios in
fast conducting structures may lie between 4.76:1 and 8:1 [79, 88]. Ratios between
2:1 and 3:1 are commonly used for regular myocardium in simulation studies [91–
93]. For AF conditions, this ratio is often increased in the simulations to 10:1 and
12:1 [94–96].
2.2 Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia [97]. It
is characterized by chaotic excitation waves and fast, chaotic contraction of the
atria [1]. Normally, the atria maintain a heart rate of 60–80 bpm in rest. The heart
rate is controlled by the cardiac pacemaker function of the SN, which can adapt to
the metabolic needs of the body. During AF, the rate is increased to 400-600 bpm.
AF is not directly mortal but favors the formation of thrombi in the atria which can
cause ischemic stroke. AF-caused strokes thereby form a significant portion of all
ischemic strokes [98].
Mechanisms
AF is a self-begetting disease [99]. Paroxysmal AF (recurrent AF, spontaneous
termination within 7 days) is most commonly caused by ectopic activity in the
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Table 2.2. Conduction velocities measured in human atria. FW: free wall, H: healthy, SR: sinus rhythm,
CAB: coronary artery bypass, Aflut: atrial flutter, OSA: obstructive sleep apnea, FAT: focal atrial tachycar-
dia. Table adapted from [5].
study subjects region long BCL condition
(cm/s) (ms)
Feld et al. 1997 [22] 9 septum 58-61 300-600 H
RA FW 58-64
isthmus 51-55
Hansson et al. 1998 [77] 12 RA FW 88 SR H
Lin et al. 1999 [78] 21 RA septum 96-98 200-500 H
RA FW 94-100
Spach et al. 1988 [79] 49 PM 70 800 H
Dimitri et al. 2011 [80] 20 RA 120 SR H
20 LA 120 SR H
Kanagaratnam et al. 2002 [81] 16 RA FW 83 1006 CAB
77 500
Feld et al. 1997 [22] 9 septum 50-54 300-600 Aflut
RA FW 53-57
isthmus 37-42
Lin et al. 1999 [78] 25 RA septum 86-91 200-500 Aflut
RA FW 91-98
Schilling et al. 2001 [82] 8 isthmus 77 240 Aflut
RA smooth 108
PM 133
Shah et al. 1997 [83] 9 isthmus 70 243 Aflut
RA sup 120 Aflut
RA lat 110 Aflut
RA septum 110
Dimitri et al. 2011 [80] 20 RA 80 SR OSA
LA 90
Weber et al. 2011 [84] 5 RA, LA post&roof 108 SR AF / FAT
RA, LA post&roof 86 500
RA, LA post&roof 77 300
PVs [100] and develops to persistent AF (sustained AF > 7 days) upon non-
treatment. Paroxysmal AF may then further progress to long-term persistent AF
(continuous AF for > 12 month) and permanent AF (sinus rhythm cannot be re-
stored by any means), when AF is not interrupted by regular sinus activity anymore
(Fig. 2.6).
Epidemiology
In the European Union about 4.5 million patients suffer from AF [101]. Men are
thereby slightly more prone to AF than women [101] and the prevalence of beget-
ting AF is increasing with age (8% for individuals over 80 years) [102]. Caused
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Fig. 2.6. Example for a natural time course of AF. Episodes of AF (black) and sinus rhythm (gray) alter-
nate over time (x-axis) as the disease progresses from the undiagnosed state to paroxysmal, persistent to
permanent AF. Flashes indicate cardioversions. Figure from [75].
by the aging of the western society and probably also because of environmental
influences, the absolute number of AF patients will rise significantly in the fu-
ture [103].
Treatment
The mechanisms leading to and sustaining AF are to-date not completely under-
stood [1]. In patients with paroxysmal and persistent AF, the PVs are a common
target for therapies, as ectopic triggers arising from the muscular sleeves of the
PVs were shown to initiate AF [100]. Besides such triggers, pathological substrate
in the atria is needed to sustain the arrhythmia. Both, the triggers and the substrate
are altered under the presence of AF [104]. This so-called remodeling causes the
cell electrophysiology and tissue properties to change in such way, that AF is eas-
ier initiated and/or perpetuated. Also, the left atrial autonomic ganglionic plexi are
believed to play a role in the initiation and perpetuation of AF [1].
Therapies targeting AF can either manage the symptoms of the disease using drugs
(palliative therapy) or try to eliminate the substrate and triggers causing AF (cura-
tive therapy). Catheter ablation of AF has been shown to result in better long-term
success rates than antiarrhythmic drug therapy [105]. Nevertheless, the kind of
treatment strongly depends on the state of AF of the individual patient, the ex-
pected improvement in quality of life and thirdly also in the health economical
cost. The major cardiologist associations provide guidelines on how to treat the
different atrial arrhythmias [1, 97].
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Fig. 2.7. Pulmonary vein isolation lesions (blue), linear lesions (red), circumferential SVC isolation (yel-
low) and additional local lesions (green). Figure based on figures from [1].
Economic Factors
Treatment of AF is very costly and the number of patients is constantly increasing.
In the European Union, the overall economic burden caused by AF is estimated to
about 13.5 billion EUR annually [97]. Pharmacological treatment of AF caused an-
nual costs of about 780 to 1.500 EUR per patient (Germany, 2009) [106], although
the clear delineation of costs between AF treatment and accompanying diseases is
difficult [107]. Costs of curative catheter ablation treatment of AF vary between
years of treatment. The initial ablation procedure causes costs around 40.000 EUR
per patient [107] or at least 50.000 USD [1], but the annual follow-up costs are
substantially lower. The time for equalization of costs between pharmacological
treatment and curative ablation therapy strongly depends on the first-pass success
rate of the catheter ablation and lies anywhere between 3 to 8 years [107].
2.3 Radio-Frequency Ablation
Radio-frequencey ablation (RFA) is a curative minimal-invasive therapy for parox-
ysmal and persistent AF. In Germany approximately 12.000 AF catheter ablations
are performed annually (2011) [108]. A comprehensive review about the state-of-
art in ablation of atrial fibrillation can be found in [1].
2.3. RADIO-FREQUENCY ABLATION 23
Role of PV
Role of 
Muscle & Scar
Ablation: Isolation,     Substrate & Hybrid
AF Type: Paroxysmal Persistent Permanent
Fig. 2.8. Substrate evolution leads to changes in ablation technique. Figure from [109].
During RFA intervention, various catheters are introduced into the right heart via
the femoral veins (Sec. 2.4.2). Transseptal puncture in the atria allows access to
the left heart. Besides the ablation catheter, mapping catheters and a coronary sinus
catheter may be introduced (Fig. 2.11). By applying radio-frequency currents via
the ablation catheter, the clinician tries to electrically isolate tissue regions, mostly
in the left atrium, which are thought to be cause and/or substrate of the abnormal
activation. The myocardium is thereby heated with the radio-frequency current un-
til it is necrotic and thus electrically isolating. In a first step, the PVs are usually
isolated circumferentially from the left atrial myocardium to isolate ectopic trig-
gers in the PV sleeves (pulmonary vein isolation, PVI) [1, 100]. Afterwards, linear
lesions may be added to form a second barrier for abnormal excitation (Fig. 2.7).
Ablation lines are realized as a set of point lesion. Regions in which complex
fractionated electrograms (CFAEs) were measured or regions with pathological
dominant frequency may also be target of ablation (electrogram-guided ablation).
These are believed to act as a substrate for the maintenance of AF. From an en-
gineering perspective, the process of RF-ablation of AF can be simplified as a
three-step approach (Fig. 2.7):
1. Isolation of the pulmonary veins, to isolate ectopic foci as initiators of AF
2. Ablation of regions with strong fractionation in electrograms or abnormal dom-
inant frequency, to eliminate substrate for maintenance of AF
3. Placement of additional linear lesions, to reduce anatomical substrate for exci-
tation of rotors, which maintain AF or atrial flutter
Depending on the type of AF, not all of these steps will be conducted [1] (Fig. 2.8).
Ablation of paroxysmal AF will only include step 1 and sometimes additionally
step 2. For the treatment of persistent or long-term persistent AF all steps might
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be performed. Common linear ablation lesions include a roof-line and a mitral-
isthmus line (Fig. 2.7). In patients suffering from atrial flutter, atrial isthmuses
need to be ablated to eliminate the substrate for flutter. This may also be done
prospectively in AF patients to reduce the risk of development of atrial flutter after
RFA therapy. As the AF mechanisms are not fully understood, it is not yet possible
to find the most appropriate ablation strategy for each individual AF cause and
each individual patient [1].
The success rates of RFA of AF reported in literature show a large variation [1].
This is mainly due to variations in the definition of the success of therapies. Quite
commonly, patients need to undergo a second RFA procedure after atrial arrhyth-
mias reoccurred, which is or is not accounted for in the success rates. For the
termination of paroxysmal AF, circumferential PVI has been reported to have the
best success rates compared to other ablation approaches [109], but it leaves room
for improvement [110]. A 3-month cure rate of 65% was reported by Fisher et
al. [109], but 24% of the patients needed a redo-procedure to achieve this number.
During redo-procedures, gaps in ablation lesions are targeted. In circumferential
PVI, these can occur nearly anywhere along the lesion although lesions around
the left PVs seems to be slightly more prone to gaps than lesions around the right
PVs [111]. The isthmus area between the LIPV and mitral valve is especially prone
to gaps [111].
2.3.1 Process of Scar Formation
In RFA procedures, RF alternating current is administered via a catheter to the
atrial myocardium with a continuous sinusoidal unmodulated waveform of 300
- 1000 kHz. The most important mechanism of myocardial necrosis induction is
based on the conversion of electrical energy into heat within the myocardial tis-
sue (hyperthermia). The myocardium needs to be heated above 50 C in order
to become necrotic [112, 113]. Recently Wood et al. found this threshold to be
60 C [114]. If new RFA lesions are placed in areas of previous scar, an increased
impedance between catheter tip and myocardium as well as decreased tissue tem-
peratures can be observed [115]. Nevertheless, lesion formation is not affected
by underlying scar as long as electrode size, tissue contact and temperature are
controlled [116].
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These factors need to be managed in such a way that transmural lesions are formed.
As the thickness of the atrial myocardial wall varies regionally [117], the param-
eters also need to be adjusted during an intervention. Overheating may occur if
too much energy is distributed to the myocardium. Tissue overheating may lead to
coagulum formation and charring on the electrode tip. The electrical impedance
between the catheter tip and myocardium then rapidly increases, leading to a loss
in effective myocardium heating. To prevent such complications, temperature-
controlled energy application systems have been developed. A thermistor or ther-
mocouple embedded in the tip of the ablation catheter allows temperature moni-
toring at the electrode-tissue interface during energy application. Maximal RF en-
ergy (usually 50W) is delivered until the preselected target temperature has been
reached and thereafter automatically titrated down to maintain the target temper-
ature. Additionally, recent RFA systems cool the tip of the catheter with water to
prevent non-uniform heating at tissue directly exposed to the catheter tip [118] (ir-
rigated tip catheter, Fig. 2.11(c)). This approach also allows for an application of
higher RF currents [119].
The extent of the lesion formed by RFA is influenced by many parameters such as
delivered RF power, electrode length, electrode orientation, blood flow and tissue
contact [120]. In particular, the following relationships have been found experi-
mentally:
• Linear dependency of lesion depth on
– myocardial temperature [113, 118, 121].
– the applied RF current [118].
– the tip-electrode radius [119, 121].
– the applied power [118, 121, 122].
– the delivered energy [118].
• Logarithmic dependency of lesion depth & width on the application time
(steady state after approximately 45-60 seconds) [113, 122, 123].
• Linear dependency of lesion width on the contact force [123, 124].
During RFA, various heat transfer processes take place in the region of the catheter
tip and myocardium. The desired effect is that the catheter tip exchanges heat
conductively with the myocardium. Resistive heating of myocardial tissue is only
effective for distances less than 2mm from the catheter tip [119]. Additionally, a
resistive heating of blood and tissue near to the catheter tip is taking place. The
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catheter as well as the endocardial myocardium is cooled by convective heat loss
to the circulating blood pool. Additional heat loss is observed in areas with large
coronary arteries [121, 125].
The electrophysiological properties of myocardial cells change under hyperther-
mia. These effects are reversible with falling temperature and are thus not subject
to modeling of the long-term behavior of RFA scars. The processes are described
here for the matter of completeness. During the process of heating, tissue conduc-
tance is increased by 2% per degree Celsius [125]. Wood and Fuller reported an
increase in conduction velocity during hyperthermia, most likely caused by cell
shrinkage and / or changes in cell-to-cell coupling [126]. Haines reports an in-
creased automaticity in cardiac cells which are heated around 50 C in contrast to
cells at 45 C [118]. Nath et al. revealed a sigmoidal relationship between tissue
temperature and resting membrane voltage [112, 113]. They also report changes in
action potential morphology and duration [112]. Additionally, three stages of ex-
citability of myocardial cells during hyperthermia were shown in this study. The
median temperature associated with normal excitability (44.0 C) is significantly
lower than the median temperature associated with reversible loss of excitability
(48.0 C) and irreversible loss of excitability and tissue injury (50.5 C) [112, 113].
Acutely after application of RF current, a significant reduction in action poten-
tial duration APD50 (-41%), APD90 (-19%), APDmax (-16%), and conduction
time (16±3ms vs. 13±4ms) can be observed in the border zone surrounding the
necrotic core of the ablation lesion [126]. These effects seem to resolve after ap-
proximately 3 weeks. Other groups found similar effects in a radius of up to 8mm
around acute lesions [127, 128].
Necrotic regions caused by RFA show a loss of cell definition, separation of the
fibers by edema, extravascular red blood cells, and a loss of nuclei and cross-
striations [129]. In the border zone around the necrosis, the cross striations and
sarcolemma are partially preserved. Cells in this zone might recover and thus the
electric isolation might be undone. Tissue in RFA lesions loses its normal fiber
orientation [119]. In the border zone these changes are similar to peri-infarct re-
gions, but the tissue will have a texture of diffuse fibrosis instead of patchy fibro-
sis. Macroscopically seen, diffuse fibrosis has rather isotropic conduction proper-
ties [130] and is thus also reflecting a loss in myofiber orientation.
More detailed information about lesion formation and behavior can be found in
various review articles. Ndrepepa and Estner provide a comprehensive review of
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Fig. 2.9. Schematic representation of an acute radio-frequency ablation lesion in the atria.
biophysics of ablation scars with a special focus on RFA in the atria [119]. Sim-
ilar reviews are provided by Haines [118] and by Haemmerich [131]. Additional
information on the biophysics of ablation scars ca be found in [132]. The ther-
modynamical effects of RFA are summarized in reviews by Nath et al. [113] and
Berjano [133].
2.3.2 Lesion Structure
In the acute phase after RFA, lesions have two border zones (3mm radius each) [113,
132, 134]. These have a reduced blood flow due to microvascular injury [134]. In
contrast, others studies describe only two zones: A necrotic core with spots of
hemorrhage and a hemorrhagic border zone [119, 135]. The latter is caused by
disruption of endothelia cells and erythrocyte passage.
The shape of the lesions is determined by the thermal processes during RFA. Cir-
culating blood in the chamber cools the endocardial surface and thus prevents a
great endocardial extent of the hyperthermia. This cooling process has only very
limited transmural extent and thus, the lesion extent at the endocardial surface is
less than in the midmyocardial region. Epicardially, the scar is narrower than in
the center, because the resistive heating from RFA is also decreasing with dis-
tance. Additionally, coronary vessels at the epicardial surface form another heat
sink.
The acute lesion is covered endocardially with a fibrinious layer [119]. Volume
loss in ablated tissue may lead to an impressed endocardial scar surface [119].
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In excised tissue, lesions have a pale white color, due to the local denaturation
of myoglobin [119]. Overheating of tissue directly underneath the electrode tip
may lead to small areas of vaporization of tissue. There are also hints, that if the
myocardial wall is very thin, an epicardial inflammatory swelling might occur.
2.3.3 Lesion Size
Regular RFA lesions in the atria have a width of 5.3±1.4mm and a depth of
2.2±1.3mm [136]. The extent of the lesions changes post-ablation [113, 126,
136, 137]. Saul et al. found an increased lesion width one month post-ablation
(8.7±4.3mm), but a decrease in lesion depth (1.2±0.4mm) [136]. The decrease in
lesion depth may contradict findings from other groups which found post-ablation
lesion growth [113, 137] and also reported an increase in lesion transmurality over
time [137]. A more recent MRI-based study also found a change in lesion extent
within the first three month after ablation [138]. The previous study did not find
any further atrial lesion size changes between month 1 and 3 post-ablation [136].
A decrease in lesion depth may be linked to an inflammatory swelling in the atrial
tissue which resolves over time. A long-term increase in lesion transmurality is
plausible as AF may reoccur shortly after an RFA procedure, but 60% of these
patients do not have AF in the long-run [1]. Deneke et al. reported a chronic le-
sion width of 6-13mm (mean 10mm) and chronic atrial lesion depth of up to
5.5mm [63]. These results should be regarded carefully, as a lesion depth of over
5mm is greater than the thickness of the atrial myocardium (<3mm) [24].
2.3.4 Implications for Modeling Ablation lesions
To model RFA lesions it is important to distinguish between modeling the process
of scar formation and modeling the results of an RFA procedure. If a model of the
process of scar formation is desired, it is important to take acute changes in tissue
properties into account (temperature, electrophysiology). Usually, the heat transfer
processes are modeled in this regard [133]. Simulations incorporating the results
of an RFA procedure need to be separated in those investigating the acute effects
after RFA and those investigating the long-term effects of RFA. For modeling of
the acute effect, a slowed conduction and shorter APD in the border zone can be
chosen. For modeling of the chronic effects, a healthy action potential morphology
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along with a model of diffuse fibrosis can be set in the border zone, as fibrinious
layer and inflammatory swelling around a lesion can be neglected. Depending on
the complexity of the simulations, it can also be advisable to reduce the com-
plexity of the anatomical effects surrounding the RFA lesion. E. g. in simplified
models of cardiac excitation, it may not be necessary to include fibroblast-models
in the border zone, but instead reduce excitation velocity and anisotropy in this
region, as this will not change the simulation outcome significantly. The change in
fiber orientation in and around RFA lesions will also impact the active and passive
mechanical properties of the myocardium. Therefore, existing models of cardiac
elastomechanics may need to be adapted to reflect this behaviour. See Section 3.1.3
for an overview of existing models of RFA in the atria.
2.4 Measurement of Cardiac Electrical Activity
2.4.1 Electrocardiogram and Body Surface Potential Map
Electrical wavefronts in the myocardium cause an electrical field in the body and
on its surface. The electrical signals on the body surface can be measured as elec-
trocardiogram (ECG). Routinely a 12 lead (nine electrodes) ECG is recorded clin-
ically. The system contains bipolar (Einthoven I-III between the extremities) and
unipolar leads (Goldberger aVR, aVL, aVF and Wilson V1-V6). Long-term ECG
recordings and ECG recordings during interventions have a reduced lead system
using one to three channels. The vector cardiogram (VCG) is the spatial represen-
tation of the temporal changes in the field integral vector. The projection of the
field integral vector on the frontal, sagittal and transversal plane results in three
orthogonal VCG leads Vx,Vy und Vz. Compared to the standard ECG, the VCG
contains less information, as it has fewer leads. On the other hand, its interpre-
tation is sometimes easier, as events in the VCG signals can be better correlated
to geometric structures in the heart. More detailed information about the poten-
tial distribution on the body surface and thus about the cardiac activity can be
gained using a multi-electrode body surface potential mapping (BSPM) systems
(Sec. 4.2).
The electrical activity in the atria causes a distinct signal in the ECG (Fig. 2.10).
The depolarization wave can be observed in the ECG signal as the P-wave. The P-
wave lasts approximately 100ms and usually ends with the beginning of the QRS
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Fig. 2.10. Schematic drawing of the ECG from a healthy person and an AV-block patient. Beginning and
end of the P-wave are defined as the crossing with the isoelectric line. PWd: P-wave duration, TaWd:
Ta-wave duration, PTa: PTa interval.
complex. The P-wave is a smooth, monophasic positive, Gaussian-like curve in the
Einthoven II lead. The signal is usually strongest in this lead with an amplitude of
approximately 0.25mV. In lead aVR, it may be inverted and the P-wave is often
biphasic in V1 [139]. Enlargement of the atria, e.g. caused by persistent AF, may
result in a bifid P-wave (left atrial enlargement, P mitrale) or in a peaked P-wave
(right atrial enlargement, P pulmonale). Ectopic triggers or multifocal arrhythmias
can lead to inverted or variable morphologies [139].
The P-wave duration (PWd) corresponds to the time of complete atrial depolar-
ization. Paroxysmal AF patients, or persistent AF patients between AF episodes,
show a prolonged P-wave duration [140, 141]. The diagnosis of AF purely based
on the PWd is possible [142], but has only moderate specificity and sensitivity [97,
143]. Variations in the dominant interatrial conduction pathway (Sec. 2.1.1.1),
which may vary between individuals, may be detected in the ECG and VCG sig-
nals [117].
Integrated BSPM over the duration of the P-wave show a dipolar pattern on the
thorax front. The maximum lies near the left hip, the minimum near the right
shoulder [144–146]. Ectopic foci or a shift in sinus rhythm origin change this
pattern [144].
The signal of the atrial repolarization is occluded by the QRS complex in healthy
persons. In patients with third degree AV block, the so-called atrial T-wave (Ta-
wave) is observable [147–151]. Its polarity is inverted compared to the P-wave and
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its amplitude is also smaller (Fig. 2.10). The Ta-wave duration is approximately
300ms [150–152].
2.4.1.1 Calculation of the VCG from 12 lead ECG
Dower et al. [153] introduced a possibility to calculate the standard 12 lead ECG
signal from the Frank VCG leads. For this, a matrix D transforms the signals of
the VCG leads SVCG into the signals of the eight ECG electrodes (V1-V6,I,II) SECG:
SECG = DSVCG. (2.1)
D=
0BBBBBBBBBBBBB@
 0.515 0.157  0.917
0.044 0.164  1.387
0.882 0.098  1.277
1.213 0.127  0.601
1.125 0.127 0, .086
0.831 0.076 0.230
0.632  0.235 0.059
0.235 1.066  0.132
1CCCCCCCCCCCCCA
(2.2)
If the opposite operation is desired, e.g. to retrieve the VCG leads from the 12 lead
ECG, the Dower matrix would need to be inverted. As the matrix is not quadratic,
a pseudo inverse can be used. Carlson et al. suggested to use the Moore-Penrose
inverse for this purpose [154]:
D† = (DTD) 1DT . (2.3)
With this, the VCG leads can be calculated as
SˆVCG = D†SECG = D†DSVCG = (DTD) 1DTDSVCG = SVCG, (2.4)
with the inverse Dower matrix
D† =
0B@  0.172 0.074 0.122 0.231 0.239 0.194 0.156  0.0100.057 0.019  0.106  0.022 0.041 0,048  0.227 0.887
 0.229 0.310  0.246  0.063 0.055 0.108 0.022 0.102
1CA .
(2.5)
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In this work, the VCG is used in a study of the interatrial conduction (Sec. 9.1.2).
The ECG leads used for the VCG calculation were extracted from the recorded
BSPM leads (Figs. 7.7–7.14) to receive signals which are directly comparable to
signals measured and post-processed in the same way. By this, no additional error
was introduced by differently placed VCG electrodes.
2.4.2 Local Activation Time Maps
Electrophysiological studies can be performed to record local electrical activity
in the atria as intracardiac electrograms using electroanatomical mapping systems
(EAMS). Multiple catheters are introduced into the right heart via the femoral
veins (Fig. 2.11). Usually a near stationary catheter is placed in the CS and at
least one mapping catheter and one ablation catheter are put into the atria. The left
atrium is accessed by puncturing the fossa ovalis. The endocardial surface of the
atria is determined by moving a localized catheter along the atrial wall.
The electrodes on the catheters record the extracellular potential in the proximity to
the catheter. Signals can be recorded in two ways. During bipolar measurements,
the potential difference between two (adjacent) electrodes is recorded. Unipolar
recordings measure the potential difference between one intracardiac electrode
and a reference electrode, e.g. on the body surface. A regular, single wavefront
passing the electrode results in a biphasic signal. In AF patients, fractionated sig-
nals (complex fractionated atrial electrograms, CFAEs) can be observed [1]. The
cause for the appearance of CFAEs is under debate.
Regular intracardiac signals in roving catheters from the endocardial wall can be
analyzed by the eletrophysiologist and the time of activation per electrode can
be manually marked for each measurement. The local activation times (LAT) are
thereby determined as the difference to a reference signal, most commonly mea-
sured in one of the CS catheter electrode pairs. A collection of activation times
over the whole atria and over several sinus rhythm or pacing cycles produces data
for a LAT map. Depending on the density of the data collection, the recording of
a complete right or left atrial LAT map takes at least five minutes. Afterwards, the
LATs are interpolated by the EAMS in regions with no or sparse data.
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(a) coronary sinus (b) circular mapping
(c) irrigated tip ablation
Fig. 2.11. Distal tips of various catheters. a) Example of a coronary sinus catheter (LivewireTM, St. Jude
Medical, St. Paul, MN, USA). b) Circular mapping catheter with ten electrode pairs (InquiryTMOptimaTM,
St. Jude Medical). c) Irrigated tip ablation catheter (St. Jude Medical).
2.4.3 Conduction Velocity Vector Estimation
The spread of excitation conduction can be determined from LATs [84, 155–160].
If no interpolation has been performed before, sparse activation time data, e.g.
frommapping catheters, can be interpolated using radial basis functions [158, 159]
or by fitting a cosine function to circularly distributed data [84, 160].
LATs at discrete locations in a 3D object can be expressed in 3D+t Cartesian coor-
dinates xi,yi,zi, ti. To estimate the conduction velocity, a smooth polynomial sur-
face can be fitted to the active site and its neighboring sites. Barnette et al. intro-
duced this method and chose a quadratic polynomial to account for the wavefront
curvature [156]:
t f it = ax2+by2+ cz2+dxy+ exz+ f yz+gx+hy+ iz+ j (2.6)
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To solve the fit, the ten coefficients need to be determined. In the ideal case,
ten coordinate–time nodes need to be involved in the fit. As linear dependen-
cies between nodes in the fit were commonly observed for activation time data,
more nodes needed to be considered for the determination of the coefficients. The
overdetermined system of equations could then be solved using a singular value
decomposition least squares approach [156].
To determine the direction of the propagation of the excitation wavefront, the gra-
dient can be calculated in closed form from the polynomial fit. Thereby, the par-
tial derivatives of t with respect to x,y,z cannot be directly inverted to obtain the
conduction velocity vector, as x,y,z change simultaneously. Barnette et al. [156]
provide a solution to calculate the conduction velocity vector components from
the gradient in activation times:
dx
dt
=
∂x
∂ t
+
✓
∂x
∂y
◆✓
dy
dt
◆
+
✓
∂x
∂ z
◆✓
dz
dt
◆
,
dy
dt
=
∂y
∂ t
+
✓
∂y
∂x
◆✓
dx
dt
◆
+
✓
∂y
∂ z
◆✓
dz
dt
◆
,
dz
dt
=
∂ z
∂ t
+
✓
∂ z
∂x
◆✓
dx
dt
◆
+
✓
∂ z
∂y
◆✓
dy
dt
◆
. (2.7)
The excitation propagation direction is assumed to be normal to the wavefront
to solve equation 2.7. The partial differentiation of t with respect to x,y,z were
defined as
tx =
∂ t
∂x
,
ty =
∂ t
∂y
,
tz =
∂ t
∂ z
. (2.8)
For equation 2.6, these were
tx = 2ax+dy+ ez+g,
ty = 2by+dx+ f z+h,
tz = 2cz+ ex+ f y+ i. (2.9)
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Due to the orthogonality of the wavefront surface and the propagation direction
CVy =
ty
tx
CVx,
CVz =
tz
tx
CVx (2.10)
held true. The combination of equations 2.7 and 2.10 then led to the formulation
of the conduction velocity vector components for the fit.
CVx =
dx
dt
=
tx
t2x + t2y + t2z
CVy =
dy
dt
=
ty
t2x + t2y + t2z
CVz =
dz
dt
=
tz
t2x + t2y + t2z
(2.11)
Each node i was used in a number of fits Ni. Each of these fits was centered around
a reference point j. To achieve a spatial smoothing of the velocity vectors, the
weighted sum of velocity vectors calculated per discrete node xi,yi,zi, ti could be
calculated from all fits in which the node i was involved [156].
CVix =
Ni
Â
j=1
CV jx ⇤wji
CV iy =
Ni
Â
j=1
CV jy ⇤wji
CV iz =
Ni
Â
j=1
CV jz ⇤wji
CV i =
q
(CV ix)2+(CV iy)2+(CV iz )2 (2.12)
The weight is given as
wji =
1
LRMSE ⇤Dji +
3
RMSEj
. (2.13)
RMSE is the root mean squared error of the fit, LRMSE the RMSE of the linear
part of the fit and Dji is the distance between active sites of the fit which also takes
the spatio-temporal window size (xwin,ywin,zwin, twin) of fit j into account
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Dji =
q
(xi  x j)2+(yi  y j)2+(zi  z j)2+(ti  t j)2
+0.5⇤
q
x2win+ y
2
win+ z
2
win+ t
2
win. (2.14)
The RMSE and LRMSE provided a measure between the measured time t ji,meas
and the calculated times t ji,calc, t ji,calc,lin. The latter is the time calculated using
only the linear part of the fit equation 2.6.
t ji,calc = ax2+by2+ cz2+dxy+ exz+ f yz+gx+hy+ iz+ j
t ji,calc,lin = gx+hy+ iz+ j
RMSE =
q
mean((t ji,meas  t ji,calc)2)
LRMSE =
q
mean((t ji,meas  t ji,calc,lin)2) (2.15)
Figure 2.12 provides an example of conduction velocity vectors calculated from
a LAT map recorded with an EAMS. The vectors help to identify the direction of
wave propagation and may help to identify zones of altered conduction or conduc-
tion block.
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(a) anterior aspect
(b) posterior aspect
Fig. 2.12. Example of a left atrial LAT map with overlay of conduction velocity vectors. The LAT was
collected after successful pulmonary vein isolation in a patient suffering from paroxysmal AF (subject 12,
Tab. 4.1). Therefore there’s no activation in the PVs (constant activation time).

3Introduction to Modeling of the Atria
3.1 Fundamentals of Anatomical Modeling
3.1.1 Existing Models of Atrial Anatomy
The first models of human atrial anatomy have been established in the 1990s
(Tab. 3.1). Models with different complexity were used for the simulations. Ei-
ther rather simplistic shapes (peanut) and surface models were used with complex
propagation models, or larger datasets, e. g. 4 chamber anatomies, were simulated
with rule-based propagation models (cellular automata). As computational power
increased, detailed anatomical models could also be used with complex electro-
physiology and propagation models (monodomain). The creation of the anatomi-
cal models was generally a manual process. Thereby, image data from volunteers
was manually segmented and further post-processed to build the detailed anatom-
ical models. These models were then often used over a long period of time for
various in-silico studies. Annotations of different atrial structures allowed the in-
corporation of few heterogeneities of conduction velocity, anisotropy and action
potential. Some models were also extended with generic ablation lesions. Only
few groups extended their models to be able to compute the body surface ECG. In
most such cases, the body model was not derived from the same volunteer, from
whom the atrial anatomy was acquired from. A significant number of the published
atrial models, especially models with a finite wall thickness, did not incorporate
an isolating layer in the atrial septum. In geometries which only represent the en-
docardial surfaces, both atria are naturally separated and needed to be connected
manually. Table 3.1 provides an overview of published 3D atrial models.
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3.1.2 Fiber Architecture in Atrial Models
Almost from the beginning of the use 3D atrial anatomy models, the impor-
tance of fast conducting structures and atrial fiber orientation for the atrial ex-
citation sequence was recognized. Already the first complex models of human
atrial anatomy [91, 161, 162] incorporated parts of the atrial fiber architecture.
Over the last decade, a significant number of new models of atrial anatomy were
presented [5]. Some of these models included atrial fiber architecture [92–94, 163–
165]. All of these models represented singular anatomies derived from volunteer
image data which was manually segmented and annotated. The majority of these
models were 3D surface models [93, 163–165] which cannot reflect the complex,
multi-layer fiber architecture of the human atria (Sec. 2.1.1.3). Existing volumetric
models [92, 94] took fiber architecture to be transmurally constant, thus neglect-
ing intersecting and overlaying bundles and layers. In contrast to this, myofiber
architecture is commonly set automatically in ventricular model utilizing statis-
tical [166] or rule-based (data from [167]) methods. For the atria, such methods
were not available but initial, incomplete approaches were presented in 2008 and
2009 [94, 168, 169]. Most recently, a high resolution model of sheep atria contain-
ing detailed information about the sheep fiber architecture has been presented [96].
Table 3.1 lists the fiber orientation properties of atrial models described in the lit-
erature.
3.1.3 Models of Radio-Frequency Ablation
Computational studies of RFA split in three different types of physics. Thereby,
the majority of studies focused on modeling the thermodynamical effects of
RFA to gain a deeper understanding of the processes leading to the scar forma-
tion [115, 125, 170–182]. The main achievements are summarized in a review by
Berjano [133].
Electrophysiological modeling of the atria focused for a long time on aiding the
understanding and prevention of AF [2]. Only very few groups have tried to model
the electrophysiological effects of RFA on cardiac tissue. Some groups tried to ex-
amine the temporal electrical behavior of ablation lesions [125, 179, 183]. None of
these investigated or included changes in atrial electrophysiology after RFA. Two
recent studies model the effects of RFA on intracardiac electrograms to examine
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the role of late-potentials around lesions [183] and to evaluate the transmurality of
lesions from electrograms [61].
Whole atria simulation studies concentrated on investigating the effects of differ-
ent ablation lesion and Maze procedure patterns on the atrial activation sequence
and the success to terminate AF. In all of these studies lesion tissue conductivity
was set to zero [93, 184–187]. In a first approach, Ellis et al. modeled ablation
lesions in a bi-atrial model in 1997 [184]. The Lausanne Heart Group compared
several years later, as computational resources had increased, different catheter ab-
lation patterns to the former state-of-the-art treatment, the Maze procedure [185].
Within this study, they also evaluated the impact of gaps (1.3, 1.7, 2.4, 3.0mm) in
the ablation lines on the outcome of the procedure. As did Rotter et al. (also from
the Lausanne group) two years later to evaluate the feasible use of biophysical
models to develop new ablation patterns and anticipate RFA success rates [186].
Reumann et al. modeled different ablation patterns in a computer model based on
an adaptive cellular automaton [187]. They tested various ablation lesion patterns
reported in the clinical literature for the ability to prevent AF onset from ectopic
firing in the pulmonary veins. Additionally, the effects of non-transmural lesions
were evaluated.
3.1.4 Thorax Models
From the beginning of atrial modeling only few group investigated the simu-
lation of atrial body surface ECG signals [188, 228]. For this purpose, mod-
els of the human thorax were needed besides the atrial model. These thorax
models represented either very detailed anatomy derived from the Visible Man
Project [70, 71, 162, 214] or generically generated thorax shapes including simple
models of the lungs were used [217–219, 229–231].
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Fig. 3.1. Schematic structure of the Courtemanche-Ramirez-Nattel model [72] of atrial electrophysiology.
Ionic currents which are altered during electrical remodeling are encircled in dashed red. Figure modified
from www.cellml.org.
3.2 Fundamentals of Electrophysiological Modeling
The first model of the electrophysiology of a cell was presented by A.L. Hodgkin
and A.F. Huxley in 1952 [232]. The model contained a mathematical description of
the ionic mechanisms underlying electrophysiological phenomena, e.g. the action
potential. Their model was based on voltage-clamp experiment data on the axons
of a giant squid. In 1962, D. Noble published the first mathematical model of the
electrophysiology of a cardiac cell, which also included pace-maker activity [233].
It took another 35 years, until the first models of human atrial electrophysiology
were published [72, 227].
3.2.1 Existing Models of Atrial Electrophysiology
The Courtemanche-Ramirez-Nattel (CRN) model [72] provides a mathematical
description of the action potential based on ionic current data obtained from human
44 CHAPTER 3. INTRODUCTION TO MODELING OF THE ATRIA
atrial cells (Fig. 3.1). Nonlinear-coupled ordinary differential equations describe
the electrical behavior of a human atrial myocyte by calculating ion concentra-
tions, ionic currents, bindings to intracellular structures, and the transmembrane
voltage. The change in transmembrane voltage Vm is thereby described by
dVm
dt
=
 (Iion+ Ist)
Cm
, (3.1)
where Ist is the externally applied stimulus current and Cm the cell membrane
capacitance. The net current across the cell membrane Iion is given in the CRN
model by the sum of twelve ionic currents
Iion = INa+ IK1+ Ito+ IKur+ IKr+ IKs+ ICa,L
+Ip,Ca+ INaK + INaCa+ Ib,Na+ Ib,Ca. (3.2)
Each current Ix is defined following Ohm’s law as the product of the specific ion
channel conductivity gx and an ion specific voltage weighted with a product of
gating variables gi
Ix = gx’
i
gi(Vm ENernst,x), (3.3)
where ENernst,x is the Nernst voltage of the specific ion. The conductivity gx scales
the amplitude of the current and the gating variables gi describe the kinetic behav-
ior of the ion channels permeable to ion x. More specific, they describe the open
probability of the channels. For channels which have only two states (opened,
closed) the change in the number of opened channels is described by
dgi
dt
= ai(1  gi) bigi. (3.4)
The voltage-dependent rate constants ai and bi describe the transition from opened
(gi) to closed (1  gi) state (and vice versa) of the ion channel gates.
Atrial electrophysiology shows variations in the APD and morphology as well as
in its dynamic behavior. Besides the sinus node, which depolarizes spontaneously,
also the other atrial structures (Sec. 5.2) show differences in the cell electrophysi-
ology [234, 235]. A detailed review about the atrial electrophysiology and patholo-
gies is given in [75].
Currently, five mathematical models describing human atrial electrophysiology are
available [72, 227, 236–238]. Although they are partly based on the same data,
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Fig. 3.2. Simulated single cell human atrial action potentials.
their action potential morphology and restitution behavior differs significantly
(Fig. 3.2). The electrophysiology models can be adapted to reproduce the au-
torhythmicity of the sinus node [92, 239]. Less complex phenomenological mod-
els can be parameterized to reproduce the action potential and restitution behavior
of physiological models with only few currents across the cell membrane [240].
Figure 3.1 exemplary depicts the schematic structure of the CRN model [72].
3.2.2 Electrical remodeling
Models of atrial electrophysiology can be adapted to reflect electrophysiologi-
cal changes caused by persistent AF. This so called electrical remodeling alters
ion channel behavior [241] and may also reduce the excitation conduction veloc-
ity [242, 243]. Based on data from [241, 244, 245], the maximum ion conductances
of ICa,L (-65%), Ito (-65%) and IK1 (+110%) in the CRN model were altered to re-
produce the experimental findings [73, 246]. Recently, additional alterations of the
sustained outward K+ current Isus/IKur and the slow delayed rectifier K+ current
IKs under persistent AF conditions have been reported [247]. The electrical re-
modeling has different impacts depending on the progression of AF (paroxysmal,
persistent, permanent) and eventual accompanying diseases, e.g. congestive heart
failure [241, 248–250]. Due to inconsistencies in the experimental data, various
other implementations of persistent AF electrical remodeling have been devel-
oped [68, 201, 208, 251] (Tab. 3.2). Thereby, besides changes in the maximum ion
channel conductances, also the mathematical formulations of the activation and
inactivation curves and channel kinetics may be altered [208, 251]. The general
effects (shorter APD, slower conduction velocity) are similar in all remodeling
models (Fig. 3.3).
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Table 3.2. Different implementations of persistent AF electrical remodeling. Simulated action potentials
are shown in Figure 3.3. Zhang et al. [251] and Tobon et al. [208] additionally altered the mathematical
formulation of channel kinetics.
Study EP Model IK1 ICa,L Ito IKr IIKur
Zhang et al. 2005 [95, 251] [72, 227] +235% -74% -85% - -
+90% -64% -65% - -
Zhao et al. 2009 [68] - -45% -63% -68% -
Seemann et al. 2010 [73] [72] +110% -65% -65% - -
Tobon et al. 2010 [208] [227] +250% -74% -85% - -
Uldry et al. 2012 [201] [72] - -30% -80% +50% -90%
3.3 Fundamentals of Modeling the Excitation Propagation
The atrial muscle mainly contains myocyte cells within the extracellular matrix.
The intracellular spaces of the myocytes are electrically interconnected via gap
junctions. A change in cell current or transmembrane voltage in one cell is there-
fore distributed to the neighboring cells. So, a depolarization wave can spread over
the myocardium. The conduction behaviors in the extracellular and intracellular
space are anisptropic, having greater conductivity along the myocyte orientation.
The anisotropy is caused by the cylindrical cell shape and because the majority of
gap junctions is located at the short sides of the myocytes.
3.3.1 Mono-/Bidomain
Excitation propagation in atrial models is commonly modeled with a macroscopic
approach, in which the atrial tissue is described as a continuum [5]. One node in
the model represents several hundred myocytes. Depending on the problem, the
resolution of such models varies between 50 µm and several millimeters.
The excitation sequence can be described mathematically by detailed reaction-
diffusion models. The bidomain model computes the electrical currents in the ex-
tracellular and intracellular space using two Poisson equations [252, 253]
— · (se—Fe) = b Im  Ise, (3.5)
— · (si—Fi) = b Im  Isi. (3.6)
Where Fi and Fe are the intracellular and extracellular potentials, si, se are the
conductivity tensors and b is the cell surface-to-volume ratio. Isi,e are externally
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Fig. 3.3. Simulated single cell human atrial action potentials with different implementations of AF remod-
eling in the CRN model [72]. Maximum ion channel conductances were implemented as listed in Tab. 3.2.
Modifications of the mathematical formulations of the current kinetics as described by [208, 251] were
neglected.
applied current sources in both domains. The transmembrane current density Im is
the sum of all membrane currents
Im =Cm
dVm
dt
+ Iion. (3.7)
Cm is the cell membrane capacitance and Iion is the sum of the ionic currents across
the cell membrane (Eqn. 3.2). The bidomain model can handle differences in con-
ductivity tensors between the two domains. Further domains can be added to the
formulations to represent other myocardial spaces [254]. If the anisotropy ratio
(longitudinal/transversal) is considered to be equal in both domains, the bidomain
model can be reduced to one domain. The monodomain model calculates the cur-
rent in the intracellular space and through gap junctions
— · (s—Vm) = b
✓
Cm
dVm
dt
+ Iion
◆
, (3.8)
with
s = se ·si
se+si
. (3.9)
The monodomain and bidomain models are coupled with models of the car-
diac electrophysiology (Sec. 3.2) and can therefore reflect the complex reaction-
diffusion processes in the human heart. A more detailed description of the bido-
main model and the simplification to the monodomain model can be found
in [253]. With regard to atrial modeling, the monodomain model is commonly
used (Tab. 3.1). The bidomain model plays only a minor role.
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3.3.2 Cellular Automaton
The detailed reaction-diffusion models are computationally very expensive. Rule-
based simulation systems were therefore also commonly used to compute the elec-
trical activation in the atria. Such automata enabled atrial simulations as early as
1964 [255]. The electrical excitation is modeled by a rule-based extension of the
activated region. Thereby, tissue anisotropy [162, 256], wavefront curvature [256]
and rate-adaptive APD and conduction velocity can be included in the rules. Au-
tomata are not suitable to reflect the diffusion processes in the atria, although they
may imitate the cells action potential morphology [257].
3.3.3 Eikonal / Fast-Marching
Cardiac excitation propagation can also be computed by adapting shortest paths al-
gorithms, which are commonly used in image processing [258]. The fast-marching
method is based on the Eikonal equation [259]
|| —T || F(x) = 1, (3.10)
where T is the arrival time at point x and F is the speed of the wavefront expansion.
For the implementation of the fast-marching level set method, nodes in a model
are divided into three sets: 1) active nodes, 2) nodes on the border of the activation
wave front and 3) inactive nodes. Each node i can initially be assigned to one of
these groups and has an initial arrival time Ti. Let s be the given seed points.
Winactive = {i | i 6= s}
Wactivated = {i | i = s}
Wtrial = {i | i neighbor of s}
Ti = inf 8 i 2 Winactive
Ti = 0 8 i 2 Wactivated
Ti = distance(i,s) 8 i 2 Wtrial
The state of each node can then be updated iteratively until the set of inactive
nodes is empty.
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while (Winactive 6= /0) do
find {x | x 2 Wtrial | Tx = min(T)}
Wactivated  x
for all (n neighbor of x) do
if (n /2 Wactivated) then
Wtrial  n
if (Tn > distance(n,x)) then
Tn = distance(n,x)
end if
end if
end for
end while
The distance function corresponds to the speed of the wavefront F and may be
given as the Euclidean distance between two neighboring nodes. Other distance
functions can also be used, as well as weighted distances (see Sec. 5.7).
The fast-marching level set approach can be extended to reflect diffusion [260,
261] and can also be coupled with models of the cell electrophysiology to repro-
duce the behavior of the detailed reaction-diffusion models [262]. Such systems0
become computationally more intensive again (yet remaining faster than detailed
reaction-diffusion systems), but can be used to reliably model reentries and other
arrhythmic patterns [263, 264]. Recently, a graph-based method to model cardiac
excitation was presented [265] which might allow a further increase in computa-
tional speed in trade-off of further detail.
3.4 Forward Calculation of the ECG
The electrical signals at the body surface which are caused by the excitation of
cardiac tissue can be measured in the ECG (Sec. 2.4.1). To compute the ECG
signals from simulated transmembrane voltages, the forward problem needs to the
solved. In a first step, the impressed current sources Iimp can be calculated from
the transmembrane voltages
Iimp = — · (si—Vm). (3.11)
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In a second step, the parabolic part of the bidomain formulation [252, 266], a
Poisson equation, is solved
— · [(si+se)—Fe] = Iimp. (3.12)
For the reference potential and the thorax-air boundary, Dirichlet and Neumann
boundary conditions are set. Equation 3.12 can then be discretized to a linear
system of equations using either finite elements or boundary elements [5]. The
finite element method, although computationally more expensive, has the advan-
tage that it can handle conductivity anisotropy within the tissue. The forward-
calculated potentials form body surface potential maps (BSPM) at each time in-
stance. The integration of the surface node potentials over time results in a static
integral BSPM [144].


Part II
Developed Methods
We actually made a map of the country,
on the scale of a mile to the mile.
Lewis Carroll
Sylvie and Bruno Vol. II

4Clinical Data Acquisition and Processing
Clinical data were acquired at three medical centers:
1. Guy’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
2. Pädiatrische Radiologie, Heidelberg University Hospital / Radiologie, German
Cancer Research Center (DKFZ), Heidelberg, Germany
3. Städtisches Klinikum Karlsruhe, Germany
Some datasets were collected as part of the PhDwork of Dr.-Ing. David Keller [267],
Dr.-Ing. Frank Weber [268] and Dipl.-Phys. Thomas Fritz. Table 4.1 on page 75
summarizes the data collection.
4.1 Image Data Acquisition
Image data were acquired for two purposes. First, cardiac images were needed
to create patient specific atrial models. Second, thorax image data were needed
for those patients from whom BSPM data were recorded. Image acquisition in
London was performed using a 1.5 T Achieva MRI scanner (Philips Healthcare,
Best, The Netherlands), in Heidelberg using a 1.5 T Magnetom Avanto MRI scan-
ner (Siemens AG, Munich, Germany) and in Karlsruhe using a Sensation 64 CT
scanner (Siemens AG, Munich, Germany).
To image the heart, a respiratory-navigated and ECG-gated steady-state free pre-
cession cardiac MRI sequence was run. The resolution varied between
1.0⇥ 1.0⇥ 1.0mm3 (Heidelberg) and 1.25⇥ 1.25⇥ 1.37mm3 (London). CT im-
ages had a resolution of 0.4⇥ 0.4⇥ 3mm3 (Karlsruhe).
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(a) thorax MRI (b) cardiac MRI
(c) LGE MRI
Fig. 4.1. Example images acquired at Guy’s Hospital London, UK, with a Philips Achieva 1.5 T MRI
scanner (subject 8 in Tab. 4.1). a) Coronal slice of thorax MRI. b) Sagittal slice of SSFPMRI. c) Transverse
slice of LGE-MRI of the left atrium.
Thorax images were only acquired on MR scanners. A breath-hold ultra fast
gradient echo sequence was run using the same receiver coils as for the car-
diac scans. This way the patient did not need to be moved between the scans
and the image stacks were co-registered in the MRI scanner coordinate system.
Thorax images had a resolution between 0.98⇥ 0.98⇥ 2.0mm3 (Heidelberg) and
1.48⇥ 1.48⇥ 2.0mm3 (London).
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In AF patients, also late Gadolinium enhancement (LGE) MRI was performed.
Myocardial regions with reduced perfusion have a slower contrast agent wash-out
than regular myocardium. An image acquisition 15–30 minutes after infusion of
a contrast agent has strong image intensity in these regions. Thereby, scar tissue
from RFA [269–271] and fibrotic tissue [272] can be imaged. Imaging of RFA scar
tissue acutely after the intervention (imaged < 24 h after RFA) may not provide
a reliable prediction of the chronic scar delineation. Within the first three to six
months after an RF intervention, damaged tissue can regenerate and scar outline
will change [138, 273]. For three patients, chronic LGE-MRI scans were acquired.
4.1.1 Discussion
Cardiac CT images had a resolution and image quality superior to the MRI data.
Nevertheless, CT acquisition is based on ionizing radiation. For patients awaiting
RF intervention, the additional radiation dose caused by the CT scan might be neg-
ligible low compared to the radiation dose from fluoroscopy. Nevertheless, MRI
provided additional functional information of the myocardium and could also be
performed on volunteers. The latter was useful to test and establish imaging and
post-processing workflows, which then provided more reliability when working
with patient data.
MRI data collected at the Heidelberg centers had better resolution compared to the
data collected in London. The resolution and image quality from the data collected
in London was sufficient to segment and post-process the images for the model
generation. None of the MR images could show the atrial wall. MRI resolution was
in the range of half the atrial wall thickness (Sec. 2.1.1.4). Thus, partial volume
effects overlap at the border between the endocardial blood pool, myocardium and
surrounding tissue. Additionally, MRI does not provide a good contrast between
myocardium and surrounding tissue anyway.
During the first image acquisition sessions in London, no MRI sequence to im-
age the thorax using the cardiac coils with sufficient image quality was avail-
able. Therefore, a number of datasets were not selected for post-processing (see
Sec. 4.5.1). Philips Research provided later on a thorax MRI sequence which was
then used for the subsequent data acquisition sessions.
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Care needed to be taken to image the heart and the thorax in the same breathing
state. This allowed a good alignment of both image stacks. If similar breathing
states cannot be achieved during the acquisition, the heart position might need to
be manually corrected along the sagittal axis.
Image intensity in LGE-MR images cannot be used as a quantitative measure. The
image intensity depends on various factors, such as the amount of contrast-agent
given, time after contrast-agent injection and accumulation of contrast-agent in
tissue surrounding the myocardium. This also contributes to difficulties during the
segmentation of scar of fibrotic tissue from LGE data [274].
4.2 BSPM Acquisition
Several companies offer body surface potential mapping (BSPM) systems. The
products most commonly cover not only the ECG recording system, but also solve
the inverse of problem of ECG (ECG imaging, ECGI). Among the offered products
are Prime ECG R (80 leads, Heartscape Technologies Inc., Bothell, WA, USA),
AMYCARD-01C (256 leads, Amycard, Moscow, Russia) and ECVUETM(252
leads, CardioInsightTMTechnologies Inc., Cleveland, OH, USA). These products
have in common, that the raw ECG data cannot be accessed directly, as the system
setup is proprietary. Additionally, all but the Amycard system use (expensive) dis-
posable electrode vests and do not allow a flexible adjustment of the electrodes to
new schemes (see below). BioSemi (Amsterdam, The Netherlands) offers a multi-
purpose biosignal recording system which allows for flexible electrode setups,
multi-channel ECG recordings and full data access (Active Two). Furthermore,
the modular setup of the hardware allows the storage and transport of the system
in a regular hand baggage case. The system could therefore be used in different
hospitals in Europe. The other systems mentioned above a more integrated and
designed for use in a single clinical site, as they cannot be transported between
hospitals due to the size of the overall casing.
4.2.1 BioSemi System
The Active Two system is comprised of different hardware modules, as well as
a signal recording software (Fig. 4.2(a)). The active electrodes are organized in
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(a) Setup of the Active Two system.
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(b) Preparation of active electrodes.
Fig. 4.2. Hardware setup of the BioSemi Active Two system.
flexible strips of eight or twelve electrodes and connected to the analog/digital
(A/D) converter with flat cables. The A/D converter is powered by a battery pack
and includes a 50Hz hardware realized band-stop filter. The digital signals are
sampled with 2048Hz and transmitted via a fiber optical cable to the USB receiver
(galvanic separation). This connects to a laptop computer, which visualizes the
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signals on the display in real time by a software (ActiView). The software also
provides a low and high pass filter, which were turned off for the ECG recordings.
Before sticking the electrodes on the skin, the electrodes need to be cleaned and
disinfected (1), adhesive rings need to be applied (2), electrode gel needs to be
filled in the gel cavity (3) and at last the protection needs to be removed from the
adhesive rings (4). The preparation for all electrodes is usually undertaken prior to
the actual use of the system to not lengthen procedure time. Figure 4.2(b) depicts
the electrode preparation.
4.2.1.1 80 Leads Electrode Setup
The 16 single electrodes of the first IBT Active Two system proved to be imprac-
tical in clinical environments for several reasons. i) Preparation of multiple single
electrodes for application to the patient often led to electrodes sticking together
and gel covering the adhesive rings. ii) Localization of the electrodes was more
complicated, as the electrodes did not underlie a fixed interelectrode distance. iii)
Single electrodes were very light and often did not stick as well to the skin as the
strips. iv) Cables connecting to the distal end of the single electrodes often broke,
as these were rather thin and not flexible enough. Altogether this caused a greater
time consumption in the setup of the system and the application to the patients.
This led to delays in the clinical workflow. Therefore, a new electrode setup was
designed. The major requirements were to create a setup which could more easily
and timely be used in clinical environments and which would be more robust for
electrode tracking (Sec. 4.2.2). These requirements were realized by using only
electrode strips. A combination of four strips of twelve electrodes and four strips
of eight electrodes increased the electrode count to 80 (Figs. 4.4(a) and 4.4(b)).
The new setup additionally offered the optional use of three single electrodes to
record a standard Einthoven ECG if desired and the workflow allowed.
Due to a constant electrode spacing within each strips, the electrode localization
was more robust. The strips themselves could be easily prepared prior to a mea-
surement in the clinical environment, as the strips could be laid out next to each
other on a tray without moving. Nevertheless, the strips with two different elec-
trode spacings allowed a flexible adjustment of the electrode placement on the
body surface, e.g. if additional ECG leads or navigation system reference elec-
trodes needed to be placed on the chest (Fig. 4.5). The strips also allowed for a
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(a) Schematic drawing of 64 electrode BSPM setup. Figure from [275].
(b) Photography of 64 electrode BSPM setup (subject 3,
Tab. 4.1).
(c) Model of 64 electrode BSPM setup (model of
subject 3).
Fig. 4.3. BSPM electrode setups. Classic 64 channel setup.
better electrode to chest contact, as they weighed more than the single electrodes
and thus the elastic forces of the cable did not counteract the adhesive connection.
Overall the preparation time for the hardware setup for a patient was reduced from
15–30 minutes to 5–10 minutes. Figures 4.3 and 4.4 show both setups as schemata,
applied to volunteers and as electrode positions mapped to thorax models of the
volunteers.
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(a) Schematic drawing of 80 electrode BSPM setup.
(b) Photography of 80 electrode BSPM setup (subject 1,
Tab. 4.1).
(c) Model of 80 electrode BSPM setup (model of sub-
ject 1).
Fig. 4.4. BSPM electrode setups. Newly developed 80 channel setup.
4.2.2 Electrode Tracking
The positions of the electrodes on the patients’ thorax need to be precisely located
and registered to the thorax MRI data, to allow for a reliable comparison of simu-
lated and measured ECG signals in these positions. Tracking of electrodes can be
performed with various systems. In this section, two systems used during the data
acquisition in this work are presented. Additionally, a localization approach using
X-ray images is presented.
4.2. BSPM ACQUISITION 63
Fig. 4.5. Photography of 80 electrode BSPM setup on patient in cath lab during a VT stim procedure.
Photography provided by Walther H. W. Schulze, Institute of Biomedical Engineering, Karlsruhe Institute
of Technology (KIT).
Electrode locations were tracked either magnetically using Fastrak R (Polhemus
Inc., Colchester, Vermont, USA) or optically using Optotrak (Northern Digital
Inc., Waterloo, Ontario, Canada). Both systems had in common that each electrode
position needed to be tracked individually with a pen marker. The Fastrak R system
registers the positions to a local coordinate system. Later on, this coordinate sys-
tems was manually fitted to the MRI coordinate system. One of the X-MRI EP
laboratories at Guy’s Hospital, London, UK, in which some of the measurements
were conducted, had an Optotrak system installed. This system registers a marker
pen using three fixed infrared cameras. The system was coupled to the MRI and
X-ray systems and thus the captured electrode positions were tracked within the
MRI coordinate system [276].
In cases where both information could not be acquired, electrode positions were
manually marked on the thorax model surface of the patient following a detailed
protocol. This was only done for the 80 channel setup using electrode strips. The
electrode strips were placed along the median line on the thorax front begin-
ning with their distal electrode on the clavicle bone. The strips were horizontally
equally spaced on the clavicle bones. Additionally, the constant electrode spacing
within the electrode strips could be used to ensure a best possible match between
model and measurement.
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(a) phantom in cath-lab
(b) active electrode strips on phantom (c) example x-ray image of phantom with
electrodes
Fig. 4.6. Test setup of acquisition of electrode positions using an X-ray system. For this test a
RANDO R Man phantom (The Phantom Laboratory, NY, USA) was used.
To further reduce the clinical procedural time of acquiring BSPMs, BSPM elec-
trode locations might also be tracked using conventional low radiation dose X-
ray images. As AF patients are admitted to RFA, and all BSPM measurements
and tracking was done prior to the EP intervention, this approach promises sig-
nificant time reduction as well as a direct registration of the electrode loca-
tions to the coordinate system of an appended electroanatomical mapping system
(Sec. 2.4.2) and thus the atrial geometry. In an initial experiment, a thorax dummy
(RANDO R Man, The Phantom Laboratory, NY, USA) was placed on the patient
table in an EP laboratory (Fig. 4.6(a)). The BSPM electrodes were placed on the
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dummy according to the regular 80 channel BSPM scheme (Fig. 4.6(b)). 44 pairs
of biplane X-ray images were acquired. The collaborators at KCL reconstructed
the electrode positions from these data with an accuracy of 2.0±1.3mm [277] us-
ing the epipolar constraint [278] and also found that 12 pairs of X-ray images were
sufficient for the reconstruction of the electrode positions.
4.2.3 Discussion
The new 80 electrode BioSemi BSPM system enabled a smoother clinical work-
flow with less preparation time with the patient compared to the previous 64 elec-
trode setup. Additionally, the electrode tracking became more robust and the signal
quality was better overall, as the single electrodes tended to loose contact during
the measurement. Having less cables around the patients while still being able to
flexibly position the electrode strips also allowed for a use of the system during EP
interventions [277]. Using an electrode vest, as done by some ECGI system manu-
facturers, would further ease the handling of the system in the clinical environment
but would also restrict the use of the system to ECGI purposes.
The optical tracking system installed in the London XMR suites was easier to use
and more robust in the tracking process. With the magnetic tracking system, field
distortions due to metal in the patient bench may result in unusable tracking re-
sults. No problems were observed while using the magnetic tracking system in the
same room as the MRI system outside the five Gauss line. Recent developments in
the localization of BSPM electrodes during the RF intervention may in the future
provide a precise localization of the electrodes while decreasing procedural time
for the trade-off of negligible additional radiation dose.
Using the optical tracking system, traced electrode positions were directly regis-
tered with the MRI scanner coordinate system. The electrode positions from the
magnetic tracking system needed to be manually registered with the thorax model.
Other systems with passive electrodes allow the imaging and registration of elec-
trode positions directly with the acquisition of the thorax geometry [279, 280].
This is, to this point, only possible using CT and not MRI for the acquisition of
the thorax geometry. Thus, if also functional information about the cardiac muscle
is desired (Sec. 4.1), two expensive and time consuming image acquisition ses-
sions (CT &MRI) need to be carried out [279]. This is usually not feasible neither
for the hospital nor for the patient.
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4.3 ECG Signal Processing
In the course of this work, ECG signals from different modalities were recorded
and processed. This comprises ECG signals from multi-channel ECG systems,
electroanatomical mapping systems and VCG signals calculated from standard 12
leads ECG. The ECG signal processing workflow is shown in Figure 4.7.
4.3.1 ECG Signal Processing
ECG signals were post-processed to retrieve a representative average ECG signal
of the atria (P-wave). The complete signal processing workflow was realized in
Matlab (The MathWork Inc., Natick, MA, USA). For this purpose an I/O interface
for the BioSemi file format (BDF) was created in Matlab based on the BioSig
toolbox (http://biosig.sourceforge.net).
In a first step, a signal of at least 60 seconds length with least motion artifacts, was
manually chosen from the complete ECG data which was usually several min-
utes long. Then baseline wander was removed using the wavelet-based technique
presented in [281]. Subsequently, high frequency noise was removed in a similar
manner. A further increase in signal-to-noise ratio could be achieved through com-
mon noise removal as described in [282]. As a consequence, one signal channel
was removed from the data. This work step was optional. Afterwards remaining
50Hz noise was removed by a 3rd order FIR Notch filter.
A template heart beat was created from the data by channel-wise signal averaging.
This eliminated singular events (e. g. extra systoles), uncorrelated noise was sup-
pressed and thus SNR was increased by a factor of
p
N, where N is the number
of superimposed cycles. The template heart beat represented the mean ECG mor-
phology and amplitude of the subject. This was especially important for the use
of the data for model personalization, as the models behave deterministically. The
modeling error could therefore increase if the model was fitted to a single ECG
complex, instead of an averaged signal.
For the creation of the template heart beat, first the R-peaks in one low-noise,
high amplitude channel were delineated using a Hilbert-transform approach [283].
ECG signals in all channels were cut 350ms before and 650ms after the detected
R-peak times. ECG complexes belonging to RR-intervals which were shorter than
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Fig. 4.7. ECG signal processing workflow.
0.1 times the average RR interval or greater than 1.9 times the average RR in-
terval were considered to be falsely detected and thus removed from the data.
As small differences in P-R time may be present in the signals, the averaged P-
wave might be broadened during the averaging process. To remove this artifact
while preserving the signal-to-noise ratio improvement, the P-waves preceding
the R-peaks were shifted to have the greatest possible cross-correlation. Thus, the
R-peaks were not precisely aligned, but the averaged signal of the P-wave was
best-possibly aligned.
The P-wave duration was determined as the difference of P-onset and P-offset. The
fiducial points were defined as the crossing of the P-wave with the isoelectric line
68 CHAPTER 4. CLINICAL DATA ACQUISITION AND PROCESSING
in the Einthoven II signal [284] (Fig. 2.10). The points were marked manually in
each template heart beat.
4.3.2 Spatial BSPM Interpolation
To visualize the measured multi-lead ECG signals as BSPMs on the patient thorax,
the averaged ECG signal was interpolated on the surface of the finite element tho-
rax model using a variant of the Laplacian interpolation [285]. As the size of the
problem was small (typically about 5000 unknowns), the interpolation could be
performed fast. Simulation results were written do disk every every millisecond.
Thus, prior to the ECG signal interpolation, the signals were sampled down from
2048Hz to 1000Hz. ECG signals usually contain frequencies of up to 120Hz in
the QRS complex. The atrial parts of the ECG signal contain frequencies much
lower. The down sampling to 1000Hz does therefore not result in a loss of infor-
mation.
To create integral BSPM maps, the ECG signals were normalized and integrated
over the P-wave duration using a trapezoidal function. Afterwards the integral val-
ues were interpolated on the thorax surface. For simulated BSPMs, signals at the
electrode locations were virtually recorded and treated in the same manner to cre-
ate integral maps (integration, interpolation). This reduced uncertainty between the
simulated and measured integral maps, as potential errors from the interpolation
process were common to both measured and simulated integral maps.
4.3.3 Discussion
The ECG signal processing pipeline described above was set up to create a repre-
sentative template ECG signal of the electrical activity of the atria for each patient.
There could be variations in morphology and duration between subsequent P-wave
in a patient. Multi-scale cardiac and thorax models are not able to recreate such
behavior as they are deterministic. Thus, simulation results should be compared to
an average ECG signal from the patient. ECG signals will need to be adapted to
other investigations. E.g. the inverse problem of ECG might be better solved using
continuous ECG signals instead of the averaged signal.
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The signal averaging techniques were originally engineered to create a ventricular
template ECG complex. The techniques were refined and further adapted to the
atria by aligning the P-waves through signal cross correlation. The heart rate was
assumed to be constant (60–80 bpm) over the averaging interval. There seems to
be no relationship between PWd and heart rate [150] and thus no broadening of
the P-wave is to be expected even if the heart rate would change over the averaging
interval.
The spatial interpolation of BSPM signals between electrodes on the thorax sur-
face can provide a visual impression of the potential distribution on the body sur-
face. Nevertheless, the information content remains the same as in the ECG sig-
nals. In areas with few electrodes, e.g. the thorax back or the right side of the
thorax when using the 64 channel setup, the interpolation may produce unrealistic
potential distributions. On the other hand, the visual impression of the potential
distribution might highlight regions of interest better than the signals could do.
The vector cardiogram is calculated from the standard ECG lead signals (Sec. 2.4.1.1).
This describes a reduction of information content. Nevertheless, the three VCG
signals may provide an easier understanding of electrical processes in the atria.
For the future, BSPMs could be used to find another reduced number of electrode
positions, which may under certain pathologies provide better insights into the
electrical dysfunction of the heart, e.g. ECG-silent cardiac ischemia [286].
4.4 Adaptation of the Conduction Velocity Vector Estimation
For five patients (8–12, Tab. 4.1), LAT maps (Sec. 2.4.2) from the left atrium were
collected using electroanatomical mapping systems (CARTO, BiosenseWebster,
Haifa, Israel and NavX, St. Jude Medical, St. Paul, MN, USA). From the LAT
maps, local conduction velocity was estimated based on the algorithm from Bar-
nette et al. [156], which is described in Section 2.4.3. In this section, two extension
to the algorithm are described. The algorithm is evaluated for the use with LAT
map data and the results are discussed.
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4.4.1 Adaptation to Measured and Simulated LAT maps
The original algorithm proposed to fit a second order polynomial to the LAT data.
Under certain conditions it could be useful to apply a linear fit instead of a second
order polynomial. This could e.g. be the case if a planar wavefront is propagat-
ing over a patch of tissue. For such linear fit, only four parameters are needed to
solve the system of equations. This allows to retrieve a higher spatial resolution of
conduction vectors. The linear fit was realized by exchanging equation 2.6 with
T = ax+by+ cz+d, (4.1)
and equation 2.9 with
tx = a,
ty = b,
tz = c. (4.2)
It is worthwhile to note that in the linear case the linear RMSE (LRMSE) and
RMSE are the same.
On the other hand, complex activation patterns in the atria with a low spatial res-
olution, e.g. as observed in clinically measured LATs (Sec. 2.4.2), may require
higher order polynomials to depict the wavefront curvature. Equation 2.6 could
therefore be replaced by a third order polynomial with 20 unknowns
T = ax3 + by3+ cz3+dx2y+ ex2z+ f y2x+gy2z+hz2x+ iz2y
+ jxyz+ kx2+ ly2+mz2+nxy+oxz+ pyz
+ qx+ ry+ sz+u, (4.3)
with its corresponding derivatives (Eqn. 2.9)
tx = 3ax2+ f y2+hz2+2dxy+2exz+ jyz+2kx+ny+oz+q,
ty = 3by2+dx2+ iz2+2 f yx+2gyz+ jxz+2ly+nx+ pz+ r,
tz = 3cx2+ ex2+gy2+2hzx+2izy+ jxy+2mz+ox+ py+ s. (4.4)
Activation times retrieved from electrophysiological simulations usually had a
very high spatial resolution (e.g. 0.33mm). Using all computational nodes M
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for the calculation of local conduction velocity vectors would outrun computer’s
memory capacity in most cases, as an M⇥M distance matrix needed to be cal-
culated. A spatial sampling of 1.32–2.00mm was sufficient to ensure a good con-
duction velocity estimation in most cases, especially in whole atria simulations.
The introduction of randomized variation for the spatial sampling of the nodes on
the regular simulation grid reduced linear dependencies between adjacent nodes
involved per fit.
For the visualization of the conduction velocity vectors in the 3D geometry, fewer
vectors than calculated were visualized to avoid an overlay of adjacent vectors.
Additionally, the endocardial surface of the atria was included in the visualization
to avoid an overlay of vectors from overlapping tissue regions (e.g. anterior and
posterior side). If only surface data were used in the calculation of the conduction
velocity vectors (e.g. using clinically measured LAT maps), the conduction veloc-
ity vectors were geometrically projected into the plane orthogonal to the surface
normals. This constraint corrected vectors pointing inside or outside the endocar-
dial surface.
4.4.2 Evaluation of Artificial Setups
The algorithm was tested on two artificial environments (Fig. 4.8). Activation
times were computed with an adaptive cellular automaton [162, 187, 223]. First,
a patch with heterogeneous conduction velocity and second an arc with homoge-
neous conduction velocity was simulated and analyzed. Additionally, the arc setup
was recreated in Matlab using an analytical calculation of the activation times.
t = 0 . . .p
x = r · cos t
y= r · sin t
z= constant
AT = r · t · 1
CV
(4.5)
where r was the (constant) radius of the arc (geometry and activation times not
shown). The simulated activation time distributions are shown in Figures 4.8a,c.
Figures 4.8b,d show histogram plots of conduction velocity magnitude calculated
using the cubic fit. The conduction velocity in the flat patch was determined pre-
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Fig. 4.8. Conduction velocity values calculated from simulated activation times in two test environments.
Conduction velocity histogram plots were generated using the cubic fit method. Dashed red vertical lines
indicate the conduction velocities which were used as input for the cellular automaton.
cisely with all three fit methods (linear, quadratic, cubic). Using the linear fit re-
sulted in more detailed conduction velocity vector directions at the borders of
conduction velocity regions, but also produced erroneous conduction velocity vec-
tors within the regions. There was little difference between the solution using the
quadratic and cubic fit. The conduction velocity which was set in the automaton
for the curved geometry seemed to be underestimated by all fit methods (peak at
0.68m/s instead of 0.75m/s). The linear fit also calculated a variation in conduc-
tion velocity magnitudes. For the analytically determined activation times in the
arc, the conduction velocity was determined precisely with all methods and for
all tested input conduction velocities. Histogram plots are not shown for these re-
4.4. ADAPTATION OF THE CONDUCTION VELOCITY VECTOR ESTIMATION 73
sults, as the calculated conduction velocity did not show a variation and thus the
histograms were single vertical lines overlaying another.
4.4.3 Discussion
In this section a method to calculate local conduction velocity magnitude and
direction from simulated and measured activation time data was presented. The
method was originally designed to analyze data from in-vitro experiments in ca-
nine ventricles. It was extended by a linear and cubic fit option and adapted to
clinical data collected in-vivo in human atria.
The algorithm produced exact results for the flat test environment. The conduc-
tion velocity was determined precisely from the analytical arc setup realized in
Matlab with all fit methods. The conduction velocity set in the automaton was
not the resulting conduction velocity observed in the automaton arc simulation.
This was most likely caused by a longer pathway for the excitation wavefront in
the discretized arc geometry. This is the explanation for the discrepancy between
the conduction velocity which was input into the automaton and the conduction
velocity determined with the fit.
The linear fit method showed better performance at edges of regions with different
conduction velocity but also produced more errors. This was due to the smaller
number of neighboring coordinate–time tuples needed for the linear fit compared
to the quadratic or cubic fit. The cubic fit produced more realistic conduction ve-
locity vectors at wavefront positions with multiple bends in the wavefront curva-
ture but required more neighbor nodes than the quadratic fit. Depending on the
given activation wavefront curvature, the most suitable fit method should be used.
The method to determine local conduction velocity used LATs as input. From sim-
ulations such data may be easily accessed in high quality. Intracardially measured
LAT maps on the other hand are prone to several errors. First, the endocardial
surface acquired with the electroanatomical mapping systems (EAMS) may not
correlate to the real atrial morphology, as e.g. derived from MRI or CT scans.
This will influence the localization of the activation time measurements and will
thus impact on the calculated conduction velocity. Second, the time of activation
is determined by the electrophysiologist manually from the catheter signals, which
may introduce a user-specific error. Third, if the LAT measurements are not dense,
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the activation times are interpolated between the measurement positions by the
EAMS. This could occlude activation pattern variations between the measurement
positions. Fourth, catheter signals recorded at the left atrial septal wall may overlay
with the far field signals from the right atrial septal wall. This could lead to misin-
terpretation of the earliest activation there. Nevertheless, the method may provide
a visual impression of the local excitation direction and an approximation for the
local conduction velocity.
Methods which directly access the catheter signals for analysis and conduction ve-
locity determination [158, 160] rule out the user specific error in determination in
activation time. On the other hand, the presented method works on existing LAT
maps and can provide a picture of the complete atrial activation at once. A coupling
of the automatic determination of the LAT from the catheter signals and the poly-
nomial fitting procedure to determine the excitation direction and velocity could
bring the advantages of both approaches together in the future. The present con-
duction velocity calculation method may also support methods to solve the inverse
problem of ECG by providing boundary conditions for the solution space [287].
4.5 Patient & Volunteer Data
In the course of this work, the following datasets were acquired in different studies:
• one dataset with heart and thorax image data, BSPM data and intracardiac data,
• ten datasets comprising image data and BSPM data,
• three datasets containing image data from the atria and intracardiac data, and
• one dataset only of intracardiac data
Table 4.1 summarizes the acquired data. A number of datasets were not chosen
for further processing due to low data quality (Sec. 4.5.1). For the remaining
datasets, image data were segmented and anatomical models for the simulation
of atrial electrophysiology and ECG computation were created (Sec. 7). ECG data
were processed where available. Volunteer datasets (controls) were used to es-
tablish data acquisition and processing workflows and to create model databases
(Sec. 7.3.1).
Table 4.1. Acquired patient and volunteer data sorted by completeness. Dataset with numbers in italics were not
further processed.
Subject Diagnosis Sex Age Weight Center Date models LGE-MRI LAT ECG
thorax / atria channels HR PWd
thorax & atria datasets
1† control male 26 79 Heidelberg 19.03.08 M / M&A – – 64 (FT) 69 107
2† control female 47 52 Heidelberg 15.08.07 M / M – – 64 (M) 81 95
3 control male 27 100 London 16.07.09 M / A – – 64 (FT) 70 103
4 control male 25 70 London 14.07.09 M / A – – 64 (OT) 53 97
5 control male 38 90 London 25.02.10 M / A – – 83 (OT) 86 99
6† LQT 2 female 17 66 Heidelberg 15.08.07 M / M – – 64 (M) 76 95
7† LQT 1 female 50 79 Heidelberg 14.05.10 M / M – – 77 (M) 62 91
8 AF male 66 100 London 14./15.07.09 M / A pre, post NavX 78 (OT) 62 176
atria datasets with LAT maps
9 AF male n/a 68 London 25.11.09 – / A/M pre, post NavX 3 n/a 107
9c 02.12.09 – / A chronic – – – –
10 AF n/a n/a 105 London 27.07.11 – / A chronic Carto 3 n/a 118
11 AF n/a n/a 75 London 29.06.11 – / A chronic Carto 3 n/a 127
12 AF n/a n/a n/a Karlsruhe 02.11.11 – / – – NavX – – –
atria datasets
13‡ pAF female 50 n/a Karlsruhe n/a – / A – – – – –
14‡ pAF female 73 n/a Karlsruhe n/a – / A – – – – –
15‡ pAF male 58 n/a Karlsruhe n/a – / A – – – – –
16‡ pAF male 75 n/a Karlsruhe n/a – / A – – – – –
17⇤ n/a n/a n/a n/a n/a n/a – / A – – – –
18⇤ n/a n/a n/a n/a n/a n/a – / A – – – –
19⇧ control male 33 86 Heidelberg n/a – / M – – –
Visible Human datasets
20 (VM) control male 38 n/a – 11.1994 M / M – – – – –
21 (VF) control female 59 n/a – 11.1995 M / M – – – – –
discarded datasets
23 VT male n/a 70 London 27.04.09 – / – – – – – –
24 control male 32 75 London 28.04.09 – / – – – 64 (FT) – –
25 control male 43 80 London 28.04.09 – / – – – – – –
26 control male 27 100 London 29.04.09 – / – – – 64 (FT) – –
27 AFlut male n/a 88 London 13.07.09 – / – – – 64 (FT) – –
28 AF female n/a 90 London 15.07.09 – / – – – 64 (OT) – –
29 AF male n/a 118 London 24.02.10 – / – – – 80 (OT) – –
†: Data which has been collected as part of the PhD thesis of Dr.-Ing. David Keller [267]. ‡: Data which has been collected as part of the PhD thesis of Dr.-Ing.
Frank Weber [268]. ⇤: Data provided by Philips Research, Hamburg. ⇧: Data provided by Thomas Fritz, IBT, KIT. ECG processing, cardiac segmentation and
parts of the thorax segmentation were performed as part of this dissertation. M: manual segmentation, A: automatic segmentation, LQT: long QT syndrome,
FT: Fastrak, OP: Optotrak, –: not available, x: available.
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4.5.1 Data Selection
Seven datasets were excluded from post-processing (23–29). Dataset 23 was dis-
carded because no thorax MRI could be acquired for this patient. Datasets 24 –
26 had low thorax MRI quality. In datasets 27 and 28, the BSPM recording failed.
A very low signal to noise ratio made the data unusable. For the data acquisi-
tion of these datasets, the initial version of the BioSemi BSPM system was used
(Sec. 4.2). Patient 29 was in constant AF during the MRI scans, BSPM acquisition
and the EP procedure. The data was thus not selected for further use, as relevant
mophological and ECG information could not be extracted from the data.
4.5.2 Discussion
The aim of the data acquisition was to acquire complete datasets comprising car-
diac MRI/CT, thorax MRI, BSPM data and LAT maps. Seven datasets could not
be used for further processing as some of the data were corrupted. Among these
were mainly datasets from the time, in which the collaboration between King’s
College London and IBT started. During this phase, data acquisition protocols and
workflows were tested.
5Modeling of the Atria
5.1 Adaptations of the Courtemanche-Ramirez-Nattel Model
5.1.1 Adaptation to Variable Extracellular K+ Concentrations
In contrast to other models of cardiac electrophysiology (e. g. [288]), the CRN
model in its original formulation is not able to cope with variable extracellu-
lar potassium concentrations [K+]o. To allow for variable [K+]o concentrations,
the mathematical formulations of two potassium currents were changed to reflect
such behavior by utilizing correction terms commonly used in models of ventric-
ular electrophysiology. A square root term was added to the formulation of the
time-independent K+ current IK1 and to the formulation of the rapid delayed out-
ward rectifier K+ current IKr (highlighted in gray in equations 5.1 and 5.2). The
correction term was formulated as in the Luo-Rudy model [195] and bases on
experimental data [289].
IK1 =
gK1 · (Vm EK)
1+ e(0.07(Vm+80))
·
r
[K+]o
5.4
(5.1)
IKr =
gKr ·Xr · (Vm EK)
1+ e(
Vm+15
22.4 )
·
r
[K+]o
5.4
(5.2)
gK1 and gKr are the maximum channel conductances for IK1 and IKr, respectively.
Vm is the transmembrane voltage and EK is the K+ Nernst potential. The denom-
inator in the new square root term (5.4) is the physiological value of [K+]o in the
CRN model, the unit of [K+]o is mmol.
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Table 5.1. Implementation of electrical remodeling due to persistent AF into the CRN model by adaptation
of model parameters. Maximum ion channel conductances were changed [73, 246] based on measurements
of [241, 244, 245]. Initialization values for Ca2+ and Vm needed to be adapted afterwards, as the CRN
model was not in steady state due to the altered channel conductances. The effects are negligible for the
simulation of the action potential, but significantly influence Ca2+ concentrations in the simulations.
Parameter Healthy Model Persistent AF
g_to 0.16520 0.05782
g_CaL 0.12375 0.04330
g_K1 0.090000 0.194625
Init_f_Ca 0.75607 0.81388
Init_Ca_i 0.000112836 0.000079981
Init_Ca_up 1.52919 0.96431
Init_Ca_rel 1.10817 0.55740
Init_Vm -0.0808887 -0.0844802
5.1.2 Steady State Remodeling Conditions
As described in Section 3.2.2, ongoing AF alters the atrial electrophysiology. The
CRN model has been adapted to reflect electrical remodeling in patients with per-
sistent AF by changing three maximum ion channel conductances (Tab. 5.1) [73,
246]. With these changes, the CRN model is able to reproduce the action potential
morphology previously described in the literature for AF patients. Action poten-
tial morphology changes only marginally during the course of multiple beats but
calcium concentrations in the different model compartments change significantly
(Fig. 5.1b). In combination with a tension development model, this can cause un-
steady results (Fig. 5.1c). Adaptation of the calcium initialization parameters of
the remodeling CRN model (Tab. 5.1) compensated for this transient behavior
(Fig. 5.1).
5.2 Model of Heterogeneous Atrial Electrophysiology
In-silicomodels of the human atrial electrophysiology have been used for decades
to investigate the role of atrial electrophysiology in the context of atrial arrhyth-
mias and other cardiac pathologies [2, 5]. Besides pathological changes of the
atrial electrophysiology, e.g. electrical remodeling (Sec. 3.2.2), the human atria
show regional variations in action potential morphology and dynamics [75, 290–
292]. In 3D atrial models, electrophysiological heterogeneities, mostly in the RA
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Fig. 5.1. Transient behavior into steady-state of the remodeling CRN model. Red curves show the transient
behavior of the remodeling model presented in [73]. Blue curves display the transient behavior of of the
model with altered initialization values. Normalized tension was computed using the Hybrid model adapted
to the tension development of AF patients (Sec. 5.3).
(CT, PM, TVR), have been recognized (Tab. 3.1). In simple patch simulations with
electrophysiological models of non-human mammals, also other regional differ-
ences in atrial electrophysiology have been investigated for their pro-arrhythmic
character [68, 69, 239, 293]. More recently, Aslanidi et al. presented a 3D atria
model, which also covered differences between right and left atrial electrophysiol-
80 CHAPTER 5. MODELING OF THE ATRIA
Table 5.2. Overview of experimental studies of heterogeneous atrial electrophysiology. MC: multi-cell,
SC: single-cell, n/a: information not available, RK: also measurements of recovery kinetics. Table adapted
from [295].
Study Species Location MC/SC BCL (ms) Channels
Burashnikov et al. 2004 [296] canine (n/a) RA MC 700 Ito
Caballero et al. 2010 [247] human (22) RAA, LAA n/a n/a Ito, IKs
Cha et al. 2005 [297] canine (37) PV, LA MC 500–2000 Ito, ICaL, IK1,
IKr, IKs
Ehrlich et al. 2003 [298] canine (n/a) PV, LA MC 1000 Ito, ICaL, IK1,
IKr, IKs
Feng et al. 1998 [234] canine (19) RA MC 500, 1000,
10000
ICaL, Ito, IKr
Gong et al. 2008 [299] human (16) Sep, RAA MC 10000 INa, ICaL, IKur,
INa (RK)
Melnyk et al. 2005 [300] canine (n/a) PV, LA n/a n/a IK
Li et al. 2001 [235] canine (33) LA, RA SC, MC 167-1000 IKr
Qi et al. 1994 [301] rabbit (n/a) LA, RA SC 1000 Ito (RK)
Voigt et al. 2010 [249] human (43) RAA, LAA n/a n/a IK1
Wand et al. 1999 [302] human (26),
rabbit (n/a)
RA n/a n/a Ito (RK)
ogy [218] and Ridler et al. showed that gradients in APDmay protect the atria from
arrhythmia [221]. None of these studies investigated the tissue properties of the re-
gional variations in atrial electrophysiology in detail or presented more extensive
heterogeneities. Especially, the regional differences in the LA electrophysiology
are often neglected. For example, no specific electrophysiological model of the
area of the PVs exists, although this region plays a crucial role in the initiation of
AF.
Up to now, five models of human atrial electrophysiology have been published [72,
227, 237, 238, 294]. All models use similar measurement data from human atrial
cells, or mammal cells where human data was unavailable. The form and dynamics
of the simulated action potentials varies quite significantly underneath the models
(Sec. 3.2). This could be interpreted as additional evidence for regional differences
in atrial electrophysiology. In the models as well as in the previously modeled
heterogeneities in right atrial electrophysiology, mainly the repolarization phase
of the action potential varies.
In this section a model of heterogeneous atrial electrophysiology in healthy and
AF-remodeled state is presented. The electrophysiology in the different parts of
the atria is examined for its pro-arrhythmic properties and an approach how to
smoothly include electrophysiological heterogeneities into patient-specific atrial
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Table 5.3. Relative values of ion channel conductivities of all implemented heterogeneities with respect to
the original model of [72]. *: derived heterogeneity as a combination of LA conductivity and heterogeneous
RA conductivity.
Heterogeneity Source gNa gto gCaL gKr gKs gKur2 gK1
RA / PM original model 1.0 1.0 1.0 1.0 1.0 1.0 1.0
CT upper endo [234] 1.0 1.0 1.67 1.0 1.0 1.0 1.0
CT upper epi [296] 1.0 0.50 1.67 1.0 1.0 1.0 1.0
CT lower endo [296] 1.0 0.68 1.67 1.0 1.0 1.0 1.0
CT lower epi [296] 1.0 0.34 1.67 1.0 1.0 1.0 1.0
BB (RA part) [234, 296] 1.0 1.0 1.67 1.0 1.0 1.0 1.0
TVR [234] 1.0 1.0 0.67 1.53 1.0 1.0 1.0
MVR⇤ [234, 235] 1.0 1.0 0.67 2.44 1.0 1.0 1.0
RAA [234] 1.0 0.68 1.06 1.0 1.0 1.0 1.0
LAA⇤ [234, 235] 1.0 0.68 1.06 1.60 1.0 1.0 1.0
LA [235] 1.0 1.0 1.0 1.60 1.0 1.0 1.0
PV [297, 298, 300] 1.0 0.75 0.75 2.40 1.87 1.0 0.67
Sep [299] 1.5 1.0 0.25 1.0 1.0 0.67 1.0
geometries is proposed. The simulations are validated against in-vitro cell mea-
surements. Conclusions are drawn for a better understanding of the repolarization
sequence in the ECG under persistent AF remodeling.
In models of cardiac electrophysiology, ionic currents across the cell membrane
are described by the ion channel conductivity gx and a product of gating variables
gi (Sec. 3.2). The conductivity scales the amplitude of the ionic current and the
gating variables describe the open probability of the channels and thus the kinet-
ics of the ionic current. Most of the experimental data presented in the literature
(Tab. 5.2) show that the ionic currents differ across the atria only in the ampli-
tude of current density and not in current kinetics. In other cases it can also be
necessary to change the mathematical formulations of the ion channels, e.g. to
reproduce certain pathologies [93]. Although a number of models of the human
atrial electrophysiology exist, the models of Courtemanche et al. and Nygren et
al. are the most established ones and the majority of the newer models base upon
their mathematical formulations [5].
Measurement data of human atrial electrophysiology are sparse, especially regard-
ing action potential variations. Few studies investigated the ionic mechanisms un-
derlying regional action potential variations in human due to ethical considera-
tions. More studies investigated such effects in other mammals, mainly canine
(Tab. 5.2). Canine cardiac electrophysiology is similar to human cardiac electro-
physiology and therefore often used if human data is not available.
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Fig. 5.2. Derivation of parameters sets from known electrophysiological parameters to model the electro-
physiology of various atrial regions.
From the experimental data (Tab. 5.2), relative changes in maximum ion channel
conductivities were extracted (Tab. 5.3). The current densities of the modeled cur-
rents are directly related to the value of the corresponding maximum channel con-
ductance. Most experiments were conducted on mammal cells and all experiments
were done in-vitro in different experimental settings. Relative changes in ion chan-
nel expressions between two preparations from different atrial cell types provided
the most reliable data on how atrial electrophysiology might change regionally in
the in-vivo human atria. Figure 5.2 provides an overview how the parameter sets
for the various atrial regions were created.
Experimental data from the left mitral valve annulus musculature as well as from
the left atrial appendage were not found. It was assumed that the relative difference
between the left atrial myocardium and these structures is the same as the relative
difference in ion channel conductances between respective structures in the right
atrium. It was also assumed that the two basic models reproduce action potentials
from the right atrial free wall (CAM and RA cells). The parameters for the upper
part of the CT were also used for the right part of BB, as AP morphology and APD
was shown to be similar in both structures [296, 303].
Three experimental studies were found describing the relative difference between
LA and PV canine electrophysiology [297, 298, 300]. They found differences in
four potassium currents (Ito, IK1, IKr, IKs) and one calcium current (ICaL). The
tendency of change in all current densities was similar in all studies, but absolute
values differed slightly. Melnyk et al. did not measure Ito and ICaL current densities.
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Fig. 5.3. Current density (channel conductance) – transmembrane voltage (TMV) relationship as observed
between cells from the human right atrium (RA) and the septumby Gong et al. [299] and during simulation
with the heterogeneous CRN model. In both cases curves split at voltages above -20mV and the curve of
the septal tissue runs flatter compared to the right atrial curve. Left figure adapted from [299].
To model the electrophysiology of the PVs, the measured relative differences to
the LA electrophysiology were averaged.
The relative changes in ion current densities were introduced into the models of
Courtemanche et al. and Nygren et al.. Measurements from human atrial septum
cells revealed a decreased current density of the ultrarapid delayed rectifier K+
current IKur for TMVs greater than -20mV [299] (Fig. 5.3). In the CRN model,
this was considered by adaptation of the parameter gKur2 in the formulation of the
maximum IKur conductance:
gKur = gKur1+
gKur2
1+ e
Vm 15mV 13mV
(5.3)
This parameter determines the slope of the curve, if the channel conductance is
plotted against the TMV (Fig. 5.3). The model of Nygren et al. does not include
a similar formulation. It was therefore not possible to generate a parameter set for
the septal region with this model.
Persistent AF alters atrial electrophysiology (Sec. 3.2.2). The parameter sets for
the different atrial regions were coupled with a model of electrical remodeling due
to persistent AF [73] to create a model of heterogeneous AF-remodeled atrial elec-
trophysiology. The remodeling conditions were created by scaling two potassium
and one calcium current (IK1·2.1, ICaL·0.35, Ito·0.35) as described in [73]. These
scaling factors were multiplied with the scaling factors of the various atrial regions
(Tab. 5.3) for this purpose. Single-cell action potentials simulated with the CRN
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Fig. 5.4. Regional distribution of physiological (blue) and AF-remodeled (red) single-cell action potentials.
model and the different parameter setups in healthy and AF-remodeled state are
shown in Fig. 5.4.
Simulation of action potentials with the model of Nygren et al. and the parameter
sets for CT and PVs led to model instabilities. While a CT action potential could be
simulated in a single-cell setup, simulation of coupled Nygren CT cells resulted
in a drift of resting membrane potential. The drift was so strong, that after few
stimulations no AP could be initiated. For Nygren PV cells, a similar behavior
was also observed in single-cell and coupled cell simulations.
Atrial electrophysiology does not change abruptly, but shows transition gradients
between adjacent regions [296, 303]. These gradients could ensure smooth transi-
tions in ion channel expression or gradual mixture of cells with different channel
expressions. No data were found to quantify these smooth changes. Smooth transi-
tion between neighboring regions with different channel expression was achieved
in the geometrical atria models by applying Gaussian distance maps at region bor-
ders. The width were set depending on the region borders. The CT is known to
have a rather isolated electrophysiological behavior. Therefore the width of the CT
to other structures was set smaller than the gradient width between large structures,
e.g. the valve rings and the atrial body. The widths of the transition gradients were
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Fig. 5.5. Gradients of maximum ion channel conductances in model number 8 (Tab. 7.1). Figure adapted
from [295].
set to LA-PV: 16.5mm, RA-Septum: 3.3mm, CT-RA: 6.6mm, TVR-RA: 26.4mm
and MVR-LA: 26.4mm. Figure 5.5 shows the gradients in a representative model
of the model cohort.
5.2.1 Reproduction of in-vitro Experiments
In the majority of the experiments (Tab. 5.2), both a change in ion channel expres-
sions and a change in APD were measured. The changes in ion channel expression
were used to parameterize the model for different atrial regions. The relative APD
difference between two regions was used to evaluate the simulation. For this, the
experimental settings of the in-vitro studies (BCL, single-cell / multi-cell) were
reproduced in-silico and the simulated APD change was compared to the experi-
mental findings. Table 5.4 summarizes the results of the evaluation process. The
tendency of APD variation could be reproduced in the simulations in nearly all
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Fig. 5.6. Comparison of simulated and measured action potentials in the right atrium and the right atrial
septum. Measurement data from [299]. Figure adapted from [295].
cases with the CRN model. In the majority of the simulations, the APD variations
were less pronounced compared to the experimental findings. Measured differ-
ences in APD from human cells were met precisely. Figure 5.6 shows an example
for such well correlating measured and simulated action potentials in the human
right atrium and septum.
Simulations with the model of Nygren et al. did not produce results as good as
those achieved with the CRN model. E.g. the tendency of APD variation in the
RAA was not met and the difference between simulated and measured APD vari-
ation between left and right atrium was greater than by using the CRN model. A
comparison of PV and septal cell could not be performed, as no parameter setup
for the septum was available and simulations of PV action potential failed.
5.2.2 Detailed Analysis of Heterogeneous Electrophysiology
The electrophysiological behavior of atrial myocytes in different atrial regions
were explored using a cable model. The cable consisted of 300 voxels (Dx=0.1mm)
and was stimulated at one side with different cycle lengths and stimulation proto-
cols. Using this setup, APD, effective refractory period (ERP) and CV were de-
termined depending on the preceding stimulation cycle length. The wave length
was calculated as the product of the ERP and CV. The wavelength is a quantita-
tive measure for the minimal length of a pathway in which a reentrant circuit can
sustain. Simulations were carried out with the heterogeneous models of Courte-
manche et al. and Nygren et al.. Furthermore, simulations were performed for the
AF-remodeled heterogeneous CRN model.
The comparison of the models of Courtemanche et al. and Nygren et al. revealed
that i) the action potential shape is triangular in the Nygren model and the CRN
model has a more pronounced plateau phase. ii) The morphology of the APD and
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Fig. 5.7. Simulated electrophysiological properties in various regions of the atria. Action potentials were
simulated in single-cell simulations and other properties were determined using a cable setup. The y-axes
are differently scaled in all three columns to highlight the regional differences in electrophysiological
properties. Figure adapted from [295].
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Table 5.4. Relative changes of APD between two atrial regions in simulations compared to measurements.
Compared were APD95 for measurements of Feng et al. [234] and APD90 for all other measurements, as
measurements were quantified by the authors this way. Table adapted from [295].
Heterogeneity D APD (%) BCL (ms) Setting Source
Measurement CRN Nyg.
CT (w.r.t. PM) 44 17 14 500 SC [234]
42 23 4 1 000 SC
34 3 22 10 000 SC
RAA (w.r.t. PM) 2 2 2 500 SC
-5 0 4 1 000 SC
-14 -3 7 10 000 SC
TVR (w.r.t. PM) -8 -20 1 500 SC
-16 -22 -7 1 000 SC
-26 -8 -14 10 000 SC
LA (w.r.t. PM) -14 -9 -13 250 SC [235]
-14 -14 -3 330 SC
-12 -13 -3 500 SC
-11 -13 -3 1 000 SC
-19 -11 -5 400 MC
-19 -12 -3 1 000 MC
PV (w.r.t. LA) -16 -11 n/a 500 MC [297]
-11 -6 n/a 1 000 MC
-5 2 n/a 2 000 MC
Sep (w.r.t. PM) -29 -30 n/a 10 000 MC [299]
ERP restitution curves differed between the CRN and Nygren model. At pacing in-
tervals shorter than approximately 500ms, APD and ERP increased in the Nygren
model, whereas they further decreased in the CRN model. iii) APD and ERP were
significantly shorter in the Nygren model than in the CRN model in all cell types.
iv) CV was in the same range in both models, but the steep part of the restitution
curve covered a wider range of pacing cycle length in the Nygren model.
Inter-regional differences were found in all measures. i) In the model of Nygren
et al., the triangular morphology of the action potential is present in all cell types,
whereas the morphology of the action potentials generated with the CRN model
shows different morphologies ranging from spike-and-dome (CT) to triangular
(septum). ii) The variation in APD, ERP and wavelength was greater within the
CRN model. iii) APD, ERP, CV and wavelength were smaller in the LA regions
compared to the respective regions in the RA. iv) APD and ERP were shortest
in the septum (CRN) and MVR (Nygren). v) The CV was similar in all regions,
except for the septum setup. This was the only setup in which the maximum ion
channel conductance of a depolarizing sodium current was altered. vi) The slope
of the wavelength restitution curves produced with the Nygren model are steeper
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Fig. 5.8. a) Time of start of depolarization, APD and time of start of repolarization. Representative example
(Model 5). BCL of 800ms. b) Representative histogram plots of the distribution of APD and repolarisation
time (model 5). In the homogeneous simulations (solid), a normal distribution of APDs around the general
APD of the CRN model could be observed. Introduction of heterogeneities (dashed) led to a bi-maximum
distribution of APDs centered around the APD of the left and right atrial model. Overall, the distribution
widened as expected. Distribution of the repolarization time shifted towards shorter times. In most models
a small plateau at the right side was present (arrow). This was due to isthmus-caused late-activated cells in
the RA with a relative long APD due to their location near the CT.
than the curves produced with the CRNmodel. vii) In general, APD was decreased
with increased distance to the sinus node, with the exception of the LAA setup.
Combination of the heterogeneous CRN model and a model of electrical remod-
eling significantly reduced APD, ERP and wavelength. The differences between
atrial cell types were preserved. CV was not significantly changed. The morphol-
ogy of the action potential was triangular in all cell types. The relative difference
between APD, ERP and wavelength of the CT and the other cell types was larger
under remodeling conditions compared to the regular model.
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In eight atrial models (Tab. 7.1, 1-8), sinus node activity (BCL=800ms) was sim-
ulated to evaluate the impact of the heterogeneities on the atrial depolarization
and repolarization sequence. In the 3D atria models, depolarization time was de-
termined in each node as the time at which the TMV was greater than -6mV for
the first time. Repolarization time was determined as time at which the TMV was
to 90% repolarized again. The depolarization sequence showed no significant dif-
ferences between the homogeneous and heterogeneous simulations (Fig. 5.8(a)).
Repolarization followed the depolarization sequence in the homogeneous simula-
tions, thus beginning near the sinus node and ending in the posterior left atrium.
In the heterogeneous simulations, first repolarization occurred in the anterior left
atrium while the depolarization was still ongoing. The last region to repolarize
was in the inferior right atrium, near the area of the inferior isthmus. This region
was slowly activated due to the reduced CV in the right inferior isthmus and had a
long APD due to the proximity to the CT. The histogram of the APD and repolar-
ization time distribution (Fig. 5.8(b)) revealed that the heterogeneities flatten the
APD distribution. APD values accumulated around the APDs of the left and right
atrium. The repolarization time histogram was shifted to earlier times, as the re-
polarization started earlier in the heterogeneous simulations. A plateau at the late
end of the histogram curve was present. This was caused by the late repolarization
of the right atrial inferior isthmus area. The repolarization sequence was overall
more synchronous in the heterogeneous simulations.
5.2.3 Discussion
In this section, a model of heterogeneous healthy and AF-remodeled atrial elec-
trophysiology was presented. The CRN model was thereby more suitable for the
reproduction of the measured changes in APD between different atrial regions than
the model of Nygren et al.. The latter model also showed instabilities for the CT
and PV parameter setups. The shorter APD and ERP as well as the steeper wave-
length restitution produced by the Nygren model might explain why the Nygren
model is used more frequently to simulate atrial fibrillation in 3D atrial models [2].
The observed variety in action potential morphologies in the atria might also serve
as an explanation that the plurality of models of atrial electrophysiology base on
similar measurement data, but reproduce different action potential shapes. It could
be that each model describes the action potential from a different atrial region,
or that measurement data from different regions were mixed in the development
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process of the models. Both investigated models were identified to reproduce RA
action potentials in their original formulations. It may be arguable that the Nygren
model rather reproduces the LA action potential, as its action potential morphol-
ogy is rather triangular. It is yet to be investigated if a different parameterization
for various atrial regions beginning from the LA would result in a better outcome
for the model of Nygren et al.. As the changes in ion current densities for the RA
regions will be exaggerated in this case, the observed problems in simulating CT
action potentials using the Nygren model could then increase as well.
Only very sparse experimental data was available on regional heterogeneities of
human atrial electrophysiology. Nevertheless, experimental results not applica-
ble to humans were neglected in this study. E. g. measured differences in rabbit
Ito recovery kinetics [301] were not implemented, because no changes in APD
were expected due to much faster Ito recovery in human cells [302]. All other hu-
man and mammal data were used, although single-cell preparations may alter IKr
expression [304]. Thus, experimental data from multi-cell preparations might be
more reliable. The measurement of EP properties of atrial cells is also affected
by the method of cell isolation and cell temperature [305]. Therefore only relative
changes of ionic current densities of cells in the same experimental setup were
used. There was an uncertainty within some of the experimental studies, as not all
studies provided precise information on the region of cell extraction. E. g. some-
times the RAA was defined as the rough RA wall, and other times it was defined
as the triangular extension of the RA next to the aortic arch. If it was not clear
from the experimental data where cells were exactly extracted, parameter setups
for both anchor regions were created and simulated. The configuration with better
match to the simulation data was chosen afterwards. APs simulated with altered
channel conductances reproduced the relative changes in APD of the atrial region
in the experimental data.
For the right atrial septum, Gong et al. were able to show that besides the alter-
ation in ion channel expression, also the channel kinetics were different [299].
The CRN model was adapted to reflect these changes using the Powell-algorithm.
The optimized parameters (tact,original = 0.135ms, tact,septum = 0.265ms, recovery
time constant +40%) had only little influence on the simulated action potential
and were thus neglected for the heterogeneous 3D model.
Atrial regions in the left atrium had a shorter wavelength compared to right atrial
parts. This hints that the LAmay provide a better substrate for the development and
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maintenance of atrial arrhythmia than the RA [1]. The regional variations in ion
channel conductivities resulted in a gradient of decreasing APD with increasing
distance to the sinus node in the models. This finding supports the hypothesis of
the presence of such gradients from Ridler et al. [221]. It is also in agreement with
experimental studies [291, 306] and in-vivo intracardiac measurements from the
RA [307], which showed decreasing APD along the CT and other RA parts. The
repolarization sequence in heterogeneous bi-atrial sinus rhythm simulations was
more synchronous than in the respective homogeneous simulations.
Although the repolarization sequence in the heterogeneous models was more syn-
chronous, repolarization did not start in all atrial regions at the same time, e.g. the
LA started to repolarize before the RA in most models. Changes in interatrial CV,
e.g. via Bachmann’s bundle, could compensate for this difference and thus produce
a smoother repolarization sequence. An additional gradient in APD in the LA from
between the anterior and posterior region, similar to the gradient along the CT in
the RA, could further synchronize the LA repolarization. No experimental data
were found to approve or disprove this hypothesis.
The effect of the electrical remodeling on APD, ERP and wavelength was much
larger than the effects of regional variations in electrophysiological properties,
although these were also present under electrical remodeling. This finding is in
agreement with canine experimental results from Cha et al. [297]. Cha et al. found
an APD difference between LA and PV cells, which was decreased under remod-
eling conditions, although the remodeling acted in the same way on both tissue
regions.
As described in Section 3.2.2, electrical remodeling due to persistent AF has been
implemented in electrophysiological models in various ways. The described model
used the remodeling implementation proposed by Seemann et al. [73], which al-
tered ICaL, Ito and IK1. Other implementations might vary the model behavior. Nev-
ertheless, the major impact of electrical remodeling (short APD, ERP and wave-
length) is similar in all remodeling model variants. The tendency of the present
simulation outcome is therefore not likely to change with a different remodeling
implementation. The reduction in CV due to a reduced gap junction density under
AF remodeling [242, 243] was neglected in the present simulations, as the aim
was to investigate the influence of changes in membrane electrophysiology only.
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5.3 Model of Atrial Tension Development
The electrical excitation of cardiomyocytes causes the development of an active
force in the cells (Sec. 2.1.2). The electro-mechanical coupling depends on the
intracellular calcium concentration. For ventricular cells, various models of the
tension development have been used to study ventricular tension and subsequently
deformation [308]. These models neglected the atrial compartments of the heart
so far, as neither a tension model was available to compute the local tension in the
atria, nor sufficiently detailed geometrical models of the atria were available for
the simulation of the atrial deformation. Some groups proposed to use a prescribed
low blood pressure as boundary condition for the AV junction or to model atrial
contraction by using a 0D model (a time-dependent ODE) [309]. Although such
approach might be sufficient for ventricular deformation simulations, the influ-
ence of pathological alterations of atrial electrophysiology or anatomy on the car-
diac function cannot be investigated. In this section, a methodology to model the
atrial tension development under healthy and persistent AF remodeled conditions
is proposed. The model is named atrial hybrid tension development (aHTD) model
following the naming of the hybrid tension development (HTD) model which was
used for a basis.
Schotten et al. measured the tension development in atrial muscle preparations [74,
310] and showed that the tension development is faster in the atria than in the ven-
tricles. They also revealed a decrease in tension in chronic AF patients [74]. To
model the atrial tension development, the HTD model, which had been proposed
to simulate ventricular tension [308, 311], was adapted to the atrial experimen-
tal data. The HTD model consists of three coupled Markov chain models with 14
state variables (Fig. 5.9). These describe the three components involved in the ten-
sion development process: troponin, tropomyosin, and actin-myosin interaction.
The model computes a tension normalized to the maximum tension during resting
stretch. The HTD model was coupled to a model of the atrial electrophysiology
via the intracellular calcium concentration [Ca2+]i.
In a first step, the experimentally determined maximum amplitude of atrial ten-
sion Fmax,healthy = 11.27mN/mm2 was normalized to the maximum of the tension
Fmax,HTD,CRN = 0.86N/N produced by the HTD model coupled to the CRN model.
This yielded the following relationship:
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Fig. 5.9. Schematic structure of the hybrid tension development (HTD) model. Figure from [308].
Fmeas =
Fmax,healthy
Fmax,HTD
·FHTD = 13.10
mN
mm2
N
N
·FHTD (5.4)
The AF remodeled curve was then adjusted by the same factor
Fmax,AF = 2.74
mN
mm2
=ˆ 0.21
N
N
. (5.5)
The adjustment preserved the same relative difference between amplitudes of the
healthy and the AF curve
Fmax,AF
Fmax,healthy
=
2.74 mNmm2
11.27 mNmm2
=
0.21NN
0.86NN
= 0.24. (5.6)
The HTD model was adapted to the experimental data iteratively using the Powell
algorithm [312]. As the duration of the optimization process largely depends on the
number of free parameters, it is desirable to only include those parameters having
a reasonable influence on the model output. To determine these parameters, ten-
sion curves were simulated with variation of all model parameters independently
by a factor of two initially. Those parameters which showed a significant influence
on the tension curve morphology were selected for the adaptation process. Param-
eters contributing to the cross-bridge cycle were included into the optimization
process independently from the sensitivity analysis. The parameter for the max-
imum tension during resting stretch was left constant. Altogether, 16 parameters
were considered for the optimization process (Tab. 5.5).
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Table 5.5. Parameters of the HTD model which were chosen for variation to adapt the model to measure-
ment data from the atria. Original parameter values as well as adapted values to fit the tension development
in the healthy and AF remodeled atria are listed.
Parameter HTD aHTD aHTD AF
kon 40 26.6 46.4
ko f f 40 55.1 74.2
tmon 12 28.9 26.2
tmo f f 35 56.9 45.8
TMoncoop 2 5.31 9.63
TMonpow 4 1.66 1.61
k5 25 9.4 13.6
km5 8 2.6·104 292
k5stretch 1 3.37 1.33
k5xb 1.5 4.65 5.35
k6 50 9.8·104 2.1·103
km6 20 585 3.2·103
k7 30 13.2 56.3
k7base 2.25 2.18 2.88
k7stretch 1 1.41 5.91
k7 f orce 1 6.0·10 7 22.3
For the optimization process, [Ca2+]i was computed in an isolated atrial myocyte
using the CRN model. Subsequently, beginning with the standard parameters of
the HTD model (Tab. 5.5), tension curves were computed. A fitness value was
calculated as the mean squared error between the measured and simulated tension
curves and the aHTD parameters were altered following the Powell algorithm to
iteratively find the minimum in the multi-dimensional parameter space.
The same procedure was afterwards applied to fit the HTDmodel to the AF remod-
eled tension curves reported in [74]. The initial implementation of the persistent-
AF remodeling [73] did not produce stable [Ca2+]i. This did not influence the
action potential significantly, but lead to false results in the computation of the ten-
sion based on the calcium concentration. Therefore, the steady-state persistent-AF
remodeling CRN implementation introduced in Section 5.1.2 was used to calcu-
late [Ca2+]i for the adaptation of the HTD model to the measured AF remodeled
tension curve.
The aHTDmodel parameters for healthy and AF remodeled atrial tension are given
in Table 5.5. The final root mean squared error (RMSE) was 1.68·10 2 for the
healthy case and 2.80·10 3 for the AF case. The RMSE is unitless, as the tension
curves were normalized for the HTD model. Figure 5.10(a) shows the measured
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Fig. 5.10. Tension development in the atria. a) Simulated normalized tension with the Hybrid model [311]
which was iteratevily adapted to measurement data from [74]. b) Comparison of normalized tension simu-
lated with the original and the adapted Hybrid model.
atrial tension development curves and the curves simulated with the two aHTD
model parameter sets. Figure 5.10(b) shows an overlay of the tension curves simu-
lated with the original HTD model coupled to the healthy and AF-remodeled CRN
model. The tension development was notably shorter compared to the ventricular
setting. The amplitude of the AF-remodeled tension curve was approximately 25%
of the amplitude of the healthy curve.
In a further step, the aHTD model was coupled to the heterogeneous model of
atrial electrophysiology introduced in Section 5.2 to evaluate eventual spatial gra-
dients in atrial tension development. Figure 5.11(b) shows the normalized courses
of the sinus rhythm action potential, [Ca2+]i and tension in the different atrial re-
gions. Only minor variations in tension between the RA, LA and appendages were
observed. However, the amplitude of the tension curve is increased by 25% in the
CT and BB. Maximum tension in the region of the openings of the atria to the
ventricles and connecting veins (PVs) is reduced by -75% compared to the regular
myocardium.
At last, sinus rhythm excitation was simulated in a 3D bi-atrial model (model 19,
Tab. 7.1) using the heterogeneous CRN model (Sec. 5.2) coupled with the aHTD
model. Gradients between adjacent atrial regions were created to ensure a smooth
transition between region with different electrophysiological properties. Tension
curves were extracted from simulation results at 50 site equally distributed over the
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Fig. 5.11. a) Curves for healthy and persistent AF remodeled right atrial tissue (Sec. 5.1.2). b) Simulated
(single-cell) transmembrane voltage (dashed red), [Ca2+]i (dash-dotted blue) and tension (solid green) in
various atrial cell types (Sec. 5.2). Curves are normalized to curves in healthy right atrial myocytes. The
regional curves for electrical remodeling are not shown, as these did not show a relevant difference to the
RA remodeling data.
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Fig. 5.12. Superimposed tension curves from measurements and a 3D gradual heterogeneous simulation
(model 19, Tab. 7.1). Tension curves were extracted in 50 equally distributed locations in the right atrial
part of the 3D model. Time scale of the simulated curves is the same as for the measured curves. The
relationship between the normalized tension and the measured tension is given in Equation 5.4. Left figure
adapted from [75] based on data from [310].
right atrium. The curves were aligned at their onset (F = 0.01). A broad spectrum
of tension curves was observed (Fig. 5.12, right).
5.3.1 Discussion
The adaptation of the HTD model to experimental data from the human atria un-
der healthy and AF remodeled conditions using a standard optimization algorithm
provided a model for the atrial tension development. The workflow can be applied
to other tension model / electrophysiological model combinations, once desired,
as the relevant subset of model parameter was identified and a framework for the
adaptation of the HTD model was established. This could be also used to couple
other implementations of electrical remodeling to the HTD model.
The adapted model parameters km5, k6 and km6 showed significant variation from
the initial parameter value after the adaptation process. Parameter km5 adds to the
inhibition of cross-bridge enabled cross-bridge development in the HTD model.
The parameters k6 and km6 describe the transition between a state contributing to
the final tension magnitude and a non-contributing state within the cross-bridge cy-
cle. k6 and km6 are out of the range of ventricular measurement values [313–315].
It is not clear whether the cross-bridge cycle in the atria differs from the ventricu-
lar one and thus the Markov chain formulation needs to be changed or if measure-
ments in atrial myocytes would reveal a different data range. The other adapted
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parameters are within the measurement ranges [308] or in reasonable proximity to
the original values if no measurement data were available.
The Powell algorithm may lead to a local minimum instead of the global min-
imum. Other optimization approaches, e.g. the particle swarm algorithm [316],
might provide more reliability in this respect. In the present case, the assumption
was made that the atrial tension development should be closely related to the ven-
tricular tension development. Therefore, the minimum was expected to be in close
proximity to the ventricular HTD model parameters and thus the use of the Powell
algorithm should be valid.
The aHTD model was coupled to the heterogeneous CRN model and additionally
also reflected AF remodeling. The effects of AF-remodeling outruled the effects
of regional variations in atrial electrophysiology when both influences were cou-
pled. This was to be expected, as electrical remodeling also outruled the effects of
heterogeneous ion channel expression (Sec. 5.2). Eventual regional variations in
the electro-mechanical coupling were not included into the heterogeneous model,
as respective experimental data were not available.
The use of the aHTD model parameters for healthy atrial tension coupled with
the AF-remodeled CRN model and thus reduced [Ca2+]i did not produce senseful
tension results (not shown). This indicates that the remodeling of the tension devel-
opment, as observed in the measurements, is not solely caused from electrical re-
modeling processes. AF tension curves rather result at least from the combination
of remodeling of the electrophysiology and remodeling of the electro-mechanical
coupling.
In agreement with the combined cause of the AF tension curves, the duration of
the tension development curve was not reduced in the measurements (and thus also
not in the aHTD model), in contrast to a significantly reduced APD and refractory
period. Under AF-remodeling conditions, the duration of the tension development
was almost twice as long as the ERP. This implies that myocytes can depolarize
again while still developing tension during AF. A more detailed analysis of the
electro-mechanical coupling under such extreme conditions is needed to under-
stand effects resulting or influencing such behavior.
Coupling of adapted HTD model with the heterogeneous model of atrial electro-
physiology (Sec. 5.2) led to differences in maximum tension output, but did not
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significantly alter the tension development onset or duration. Schotten et al. pro-
vided an averaged tension curve for human right atrial tissue in [74] which was
used to fit the HTD model parameters. The initial measurements on the other hand
showed a broader variance in tension amplitude [310]. The simulated regional
variations in tension amplitude suggest that the variance of measured curves were
caused by using tissue samples from different right atrial locations in addition to
using samples from different individuals. Figure 5.12 shows the measured data and
the simulated curves side-by-side.
Maximum tension in regions close to the orifices of the PVs and the valve an-
nuli was strongly decreased. Although regional measurement data of the human
atrial tension development are missing, these results make sense, as the atrial my-
ocardium is not contracting significantly in these regions, as can be seen e.g. in
cine-MRI data. The heart skeleton (AV plane) and the attachment of the PV to the
left atrium do not allow for a great deformation in these regions. A regular contrac-
tion of the surrounding atrial myocytes would work against the static properties of
these structures. It is therefore reasonable to assume, that over the human evolu-
tion, tension development in myocytes near valve opening is markedly reduced.
Notably, the morphology of the tension curve in the CT differs from the other
regional curve morphologies and could not be recognized in the experimental data.
Further region specific variations in the electro-mechanical coupling process could
be responsible for additional changes in the tension curve.
Up to date, elastomechanical simulations of the human atria were restricted to
the investigation of passive atrial deformation and stress without a link to the
atrial electrophysiology [317–319]. The atrial hybrid tension development model
(aHTD) now allows for the simulation of the electro-mechanical coupling in the
human atria. The aHTD model enables in-silico investigations of active atrial elas-
tomechanics and subsequently atrial blood flow. Among others, the risk of blood
clot formation during AF could be estimated or the effects of atrial fibrosis on the
ejection fraction could be examined model-based. In a future step, the mechano-
electrical coupling in the atria [320–322] could be included into the modeling
workflow to better understand atrial arrhythmia caused by hypertension or atrial
dilation. First attempts have been undertaken to use atrial models to investigate the
role of stretch-sensitive channels in the initiation and maintenance of AF [323–
325]. These investigations were limited to the simulation of the atrial electrical
activation under pre-defined conditions for the stretch-activated effects.
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The aHTD model together with volumetric anisotropic atrial models (Sec. 5.4)
now provide all prerequisites for the simulation of both the passive and active atrial
deformation resulting from electrical excitation of the atria and ventricles. A first
application of such an 3D atrial elastomechanical model with electro-mechanical
coupling is presented in Chapter 14.
The adaptation process which has been established to fit the HTD model to atrial
measurement data by altering a subset of model parameters can in the future be
used to adapt the HTD model to other situations. The use of other atrial or ven-
tricular cell models, different implementation of electrical remodeling or new ex-
perimental data of the cardiac tension development may require such parameter
adaptation and may now be done in a reasonable time as the essential parameters
and a suitable parameter fitting framework are available.
5.4 Modeling Fiber Architecture in Patient-Specific Models
Atrial fiber architecture (Sec. 2.1.1.3) determines the atrial activation pattern [10,
26, 89] and plays a crucial role in the development and maintenance of AF [32]. It
therefore also influences ablation strategies for different atrial
arrhythmias [38, 66].
Various in-silico studies have investigated the impact of local fiber architecture
on the excitation pattern in patch preparations (e. g. [67, 68]). In these studies,
fiber orientation was transferred from image data directly into the model. Detailed
3D data about fiber architecture in the whole human atria is sparse (Sec. 2.1.1.3)
and volumetric data, e.g. diffusion tensor MRI (DTI), is not available for the
atria in contrast to the ventricles [166, 326–330]. This is mainly due to the
DTI resolution, which is in the order of magnitude of the atrial wall thickness
(Sec. 2.1.1.4) and thus partial volume effects outrule the real image information.
Additionally, the thin wall makes it difficult to fixate the atria with a physiologi-
cal filling. Fiber orientation in patient-specific ventricle models, can be included
rule-based (rules from Streeter et al. [167, 331]), based on the adaptation of at-
lases [330, 332] and recently also from in-vivo interpolated DTI [328]. In human
atrial models, fiber architecture was commonly included based on anatomical stud-
ies (Sec. 2.1.1.3). Thereby, fiber orientation was placed manually in each computa-
tional node [92, 93, 163–165]. In some cases simple interpolation approaches were
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Fig. 5.13. Workflow for the generation of rule-based fiber architecture in atrial geometries. Green: input
/ output, pink: eventual user interaction needed, yellow: pre-processing, red: fiber-placement, blue: post-
processing.
also utilized [94, 168]. As the majority of these models represent only a monolayer
3D surface [93, 163–165], the complex multi-layer atrial fiber architecture could
not be reproduced realistically. Volumetric models [92, 94] also assumed a con-
stant transmural fiber orientation in the atrial wall and covered only parts of the
atria with fiber orientation (e.g. only LA or CT/PM/BB, Figs. 5.14(a), 5.14(b)).
Fiber orientation in the heart of the Visible Human datasets was previously de-
termined using techniques similar to those which were used to extract ventricular
and skeletal muscle fibers [161, 162] (Figs. 5.14(c) & 5.14(d)). The quality of the
extracted fiber orientation is questionable, as the approach was created for ventric-
ular fiber orientation and the atrial results were not validated.
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(a) VF left atrium (b) VF right atrium
(c) VM left atrium (d) VM right atrium
Fig. 5.14. Fiber in models of the Visible Human datasets. Local fiber orientation is shown as colored
cylinder. The color corresponds to the orientation of the fiber. a) Left atrial fiber orientation as modeled
by Plank et al. [94]. b) Right atrial fiber orientation as modeled by Seemann et al. [92]. c,d) Left and right
atrial fiber architecture as extracted from image data [161, 162].
5.4.1 Semi-Automatic Rule-Based Placement of Fibers
It is necessary to incorporate human fiber architecture into patient-specific atrial
models with minimal user interaction. As no atlas data was available, a rule-based
approach was chosen to model human atrial fiber architecture in patient geome-
tries. Rules (Fig. 2.3) were extracted from anatomical literature (Sec. 2.1.1.3),
photographic images of atrial specimen (Fig. 2.4) and previously described fiber
orientation (Fig. 2.3).
The transfer of the fiber rules into geometric models was realized by identifying 22
landmarks in the atrial anatomy. These were used as seed points for an augmented
fast-marching level set shortest path method for 3D lattices based on [259]. With
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Table 5.6. Description of the locations of the 22 atrial landmarks required for the creation of rule-based
fiber orientation in the atria.
Right Atrium
R1 orifice of SVC, posterior wall, border of LA and RA
R2 orifice of SVC, anterior wall, border of LA and RA
R3 orifice of SVC, right lateral posterior, border of SVC and RAA
R4 orifice of IVC, right lateral
R5 orifice of IVC, left lateral at anterior wall
R6 tip of RAA, if multiple, tip with greatest distance to R3
R7 orifice of TV, inferior of RAA
R8 orifice of TV, right lateral
R9 orifice of TV, minimal distance to LA
Left Atrium
L1 orifice of MV, left lateral at anterior wall, inferior of LAA
L2 orifice of MV, posterior wall, centered between L1 and L3
L3 orifice of MV, right lateral at anterior wall, minimal distance to RA
L4 onset of RSPV, left lateral superior on anterior wall
L5 onset of LSPV, anterior wall between LAA and LSPV
L6 right lateral between RPVs
L7 left lateral between LPVs
L8 right lateral inferior of RIPV
L9 left lateral inferior of LIPV
L10 left lateral on anterior wall at onset of LAA
L11 tip of LAA
L12 left of LPVs, inferior of L7, onset of LAA
L13 right inferior of RIPV near septum
this, a skeleton was constructed and fiber orientation was interpolated along and
between the borders of the skeleton. Fig. 5.13 summarizes the workflow.
The method required a pre-processing of the models (Fig. 5.13, yellow). The left
atrial wall was separated into two transmural regions by computing a static electri-
cal field. By solving Poinsson’s equation, a virtual steady state potential distribu-
tion between the endocardial surface (blood pool) and the epicardial surface in LA
was calculated. The wall was then separated at the mid potential into a subendo-
cardial layer and a subepicardial layer. Similarly, a 0.33 – 0.66mm thick epicardial
layer was marked in the RA. The 22 landmarks (Tab. 5.6, Fig. 5.15 blue circles)
were marked in each model manually.
From the seed points, an initial skeleton was constructed by connecting the points
with the shortest geometric path between them (Fig. 5.15). The fast-marching
shortest path approach was tuned in one aspect. If multiple shortest paths were
found, the path with the least distance to the direct line between the two connected
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Fig. 5.15. Location of seed points (blue circles) and schematic view of the skeleton created by fast-marching
shortest path between those. Dashed lines were used for auxiliary purposes only and did not contribute to
the fiber interpolation later on. Blue lines indicate interatrial connections. Figure modified from [216].
points was used. Bundles aligned along such paths were dilated at the centerline
of the path to receive a finite bundle thickness within the atrial wall. Fiber orien-
tation was set along the extent of the centerline. A spatial low pass was applied
by averaging the orientations within a radius of 1.65mm. The orientations in the
centerline were then interpolated into the dilated region.
The shortest paths algorithm was partly restricted to certain tissue classes (e.g.
right / left atrium or subendocardial / subepicardial LA layer). As a restriction
for the shortest path CT centerline (between R3 and R4, Tab. 5.6, Fig. 5.15), a
5.28mm wide corridor needed to be created around a 3D plane defined by the
points R3, R4 and the point 40% down the path between R4 and R5. The width
of the CT diminishes linearly from R3 to R4 (3.96mm at R3, 2.64mm at R4).
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The CT extended further towards R5 with a constant width. 15 pectinate muscles
started equidistantly from the CT centerline between 20% and 90% of its extent.
These connected equidistantly to the path between R7 and R8. The upper pectinate
muscle, the septum spurium, was set to be 3mm wide and 5mm long.
Circular fiber orientation around the valve annuli, the pulmonary vein orifices and
the SVCwas realized by the connection of three seed points each. Fiber orientation
in the appendages was set to be circulating around the main axis of the appendages.
The sinus node was modeled as an ellipsoid at point R3 (4⇥2⇥2mm). Its main
axis was aligned at the local CT fiber orientation at this site.
Five interatrial connections were realized. Bachmann’s bundle started from R3,
passed R2 and then extended towards L5. The main component of the BB was
set to be 4.29mm broad. A thinner right inferior branch of BB was modeled as
the path from R7 to the breakthrough of BB to the LA. A left inferior branch of
BB was modeled as path from 80% extent of BB in the LA towards L1. BB was
disconnected from the LA myocardium in the first 20% of its extent towards L5
in the LA. One posterior bridge was modeled on the path between the point 80%
from R3 to R4 and L6, and another posterior bridge lay on the path from R4 to R8.
A CS bridge was generated on the path from R7 to L10. A further lower anterior
bridge was introduced from L2 to the point 40% from R4 to R5. All bridges, except
of BB, were only marked in a range of 1.65mm from the septum and were also
marked 1.65mm thick.
Fiber orientation in voxels which had not been marked as bundles before, was
interpolated from the fiber orientation surrounding the isotropic region. These re-
gions were marked by using a symmetric region growing [333]. This was e.g. done
for the septo-atrial bundle in the subendocardial layer of the LA as the region en-
closed by L4, L6, L8, L9, L7, L5, L1 and L3. A region superior of the IVC orifice
in the RA, was excluded from the fiber placement algorithm, as fiber orientation
in this area is not clearly described in the literature. The electrical properties were
set to be isotropic in this region.
Different regions in the atrial models were also labeled during the fiber generation
process. In the models, the following tissue labels were distinguished besides the
original tissue labels RA and LA: SN, CT, PM, BB, RAA, LAA, TVR, MVR
and IS.
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The anisotropic models underwent a post-processing afterwards (Fig. 5.13, blue).
At the border of the models, fiber artifacts were observed in the form of fibers
pointing outside the atrial tissue. As such fiber alignment is not realistic, myocar-
dial sheets in the atria were defined, similar to those found in the ventricles [334].
The normal to the sheet plane was set to be in the direction of the local gradi-
ent from the endocardial surface to epicardial surface. The local fiber orientation
was then projected into the sheet plane to generate an orthonormal system of the
fiber, sheet and sheet normal vector. In a further post-processing step, the right and
left atrium were separated by a 0.66mm thick layer of isolating tissue. Interatrial
bridges were thereby not interrupted.
The method has been applied to 20 patient-specific models (Tab. 4.1). In the mod-
els, well aligned fiber orientation along the main bundles (CT, BB, PM) could be
observed. The CT was crossed epicardially by the intercaval bundle (Fig. 5.16a).
The fibers of this merged with the fibers of the PMs, which then ended perpen-
dicular in the TVR (Fig. 5.16b). Fibers encircled the orifices of the valve annuli
and the PV ostia as well as the SVC. The appendages showed circular fiber ori-
entation, with some discretization artifacts at the thin parts. Septo-pulmonary and
septo-atrial bundles overlayed another in the box between the PVs in the LA and
on the anterior side of the LA (Fig. 5.16c,d). The method was constructed to gen-
erate fiber orientations in left atrial geometries with four PV ostia, but it was able
to handle variation in the number of PVs. In such cases, two or more adjacent PVs
were circulated by the fibers, instead of each individual PVs being circulated.
Fig. 5.17 provides a comparison of rule-based fiber architecture in three represen-
tative models to fiber orientations reported in anatomical literature. The camera
view of the models was adjusted to reflect the camera view of the anatomical pho-
tographs. The modeled fiber architecture was in good agreement with the fiber
architecture of the pictured specimen.
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Fig. 5.18. Simulated transmembrane voltage and activation times in an isotropic, homogeneous and an
anisotropic, heterogeneous model 3. Figure adapted from [216].
5.4.2 Influence on the Atrial Excitation Sequence
Models 3 and 8 were chosen randomly for simulation of sinus rhythm excitation
using the CRN model for heterogeneous human atrial electrophysiology [92] and
the monodomain equation for cell coupling. The monodomain tissue conductivi-
ties were determined to reproduce heterogeneous conduction velocities of a well
established atria model [91]. The ratio of longitudinal to transversal tissue con-
ductivity was set to 3:1 in regular atrial myocardium and 1:7 to 1:20 in fast con-
ducting atrial bundles (CT, PM, BB). The right atrial inferior isthmus was set to
be isotropic.
For model 3, two simulations were performed. One isotropic simulation, neglect-
ing tissue heterogeneities and fiber orientation, and one regular anisotropic het-
erogeneous simulation. In both simulations, the isolating layer in the septum was
neglected. In the isotropic simulation, the excitation wave spread circular over both
atria centered around the sinus node (Fig. 5.18, top row). In the anisotropic simu-
lation, the atrial excitation sequence was mainly determined by a fast conduction
along BB and CT. The LA was activated by two wavefronts, one coming from the
BB the other one coming from the posterior bridge. In the heterogeneous model,
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Fig. 5.19. Comparison of the simulated activation sequences in model 8 and atrial activation sequences
reported in literature [85–87].
the prominent plateau phase of the CT was clearly visible in the RA (Fig. 5.18,
bottom row).
For model 8, only an anisotropic, heterogeneous simulation was performed. The
computed atrial excitation sequence was then compared against measurements of
the atrial excitation pattern (Fig. 5.19). In both models, the atrial excitation pattern
was determined mainly by the fast conduction along the CT and BB. This behavior
was also observed experimentally before (Fig. 5.19, bottom row). The curvature
of the wavefront was stronger in the regions of CT and BB. This highlights the
importance to include such structures in patient-specific models and also provides
evidence for the correct location of the modeled fiber bundles.
5.4.3 Comparison of Rule-Based Fibers to Existing Models
Validation of the outcome of the rule-based fiber modeling procedure is an essen-
tial task, but difficult to realize as no ground-truth 3D data was available. The rule-
based fibers were therefore evaluated against i) photographic images, ii) against
existing fiber models in the Visible Female (VF) atria model and iii) against inter-
polated fiber orientation obtained from image data in the Visible Man (VM) atria
model. Furthermore, sinus rhythm simulations were performed and the activation
patterns were compared to measured activation patterns.
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Fig. 5.20. Combined boxplot (blue, red, dashed black) and histogram (grey) of the angular errors between
rule-based fiber orientation and pre-existing fiber orientation in the atrial models of the Visible Man and
Visible Female dataset. Errors are shown for all material and certain atrial structures.
For the atrial models of the Visible Human datasets, a quantitative error between
the rule-based and pre-existing fiber orientations was calculated. The angle Ei be-
tween two fiber orientation vectors Fi,1 and Fi,2 in voxel i was calculated as
Ei = arccos
✓
Fi,1 ·Fi,2
kFi,1kkFi,2k
◆
. (5.7)
If Ei was greater than 90 , it was corrected by
Ei = 180   Ei 8 Ei > 90 . (5.8)
An error Ei = 90  then represents orthogonal fiber orientation, whereas errors Ei
45  represent fiber orientations having similar major axis.
In the VF atria model [94, 335], we observed similarities in the fiber direction
in the major atrial bundles, CT, BB and PM (accumulation of fiber errors below
45  in the histogram, Fig. 5.20(a)). The left atrial fiber architecture in the VF
dataset used in [94] had only little agreement with the rule-based fiber orientation
leading to a very broad distribution of fiber errors overall (Fig. 5.20(a)). The latter
was caused, among others, by the fact, that the fibers from Plank et al. did not
represent the two layers of fibers in the LA and that the LAA had a different fiber
orientation. Fiber orientation extracted from image data in the VM atria had a
low resolution (Dx=1.0mm). The local change in fiber orientation was therefore
coarser compared to the changes achieved by fiber placement in higher resolution
models (Dx0.33mm). This led to a wide distribution of fiber angles between the
image-based and rule-based fiber orientations overall. Better agreement of the fiber
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Table 5.7. Difference between microscopy and rule-based fiber orientation in the sheep atria model.
Original Fibers Filtered Original Fibers
Region Q45 Q22.5 RMSE MAE±STD Q45 Q22.5 RMSE MAE±STD
All 47.6 18.9 53.4 47.6±24.1 53.5 23.7 50.5 44.3±24.3
BB 73.2 36.9 40.7 34.1±22.2 78.2 42.7 38.5 31.6±22.0
CS 51.3 21.8 51.4 45.4±24.0 66.0 38.7 42.5 35.9±22.8
CT 55.2 25.2 50.1 43.5±24.9 60.0 33.2 46.7 39.3±25.2
PM 61.4 30.0 47.9 41.0±24.9 72.2 34.2 39.6 33.9±20.6
MVR 57.5 30.6 49.2 41.9±25.7 69.3 36.8 43.2 36.1±23.7
TVR 60.4 28.7 47.5 40.8±24.4 75.5 41.7 38.3 31.8±21.4
LAA 46.8 16.9 53.5 48.1±23.4 54.2 26.2 49.3 43.0±24.0
RAA 31.5 8.5 61.0 56.8±22.3 30.6 7.3 61.5 57.4±22.0
orientations were found in the region of the AVR, PM and BB. This led to an
accumulation of fiber errors below 45  in the histograms (Fig. 5.20(b)).
5.4.4 Anisotropic Model of Sheep Atria
Dr. Jichao Zhao and Prof. Dr. Bruce Smaill from the Bioengineering Institute of
the University of Auckland, New Zealand, provided a high resolution model of
sheep atria [96]. Fiber orientation was extracted from a stack of microscopic im-
ages (Dx=50 µm), which were aligned and post-processed previously. Fiber ori-
entation was extracted from the 3D data using a gradient-based structure tensor
approach [336]. The structure tensor matrix J was constructed as the tensor prod-
uct of the gradient vector components I
J =
0B@Ix · Ix Ix · Iy Ix · IzIy · Ix Iy · Iy Iy · Iz
Iz · Ix Iz · Iy Iz · Iz
1CA (5.9)
Local fiber orientation was extracted as the Eigenvector of the tensor with the
largest Eigenvalue, hence the direction which had the greatest signal variation. A
more detailed description of model generation procedure can be found in [96, 337].
The model was provided with a voxel resolution of Dx=300 µm and contained
tissue labels (RA, LA, CT, PM, BB, PVs) as well as fiber orientation in each voxel.
In a first step, the sheep atrial model was compared to the well established VF
dataset [92] with rule-based fibers [216] (see previous section for more details).
The anatomical features and gross fiber architecture showed qualitatively a good
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Fig. 5.21. Quantitative comparison between rule-based and microscopy fibers in the geometry of the Auck-
land sheep atria.
correspondence (Fig. 5.22, left & center) [337]. In the sheep model, fiber orienta-
tion was more chaotic in the appendages and less organized in the rest of the atria
as expected. This might partly also be caused by the direction extraction method
from the image data [96]. Also, simulation of sinus rhythm in both models showed
a similar atrial excitation sequence (Fig. 5.22, right) [337].
In the fiber data provided for the sheep model, artifacts and distortions in fiber
orientation at the model borders were observed. Therefore a spatial low-pass filter
was designed to smooth the fiber vector field. Fiber orientation defined by the
angles f and q in each node covered by the 3⇥3⇥3 filter kernel was transformed
into a symmetric structure tensor Ts.
Ts =
 
R ·F ·RT 
R=
0B@ cosf sinf 0 sinf cosf 0
0 0 1
1CA
0B@ cosq 0 sinq0 1 0
 sinq 0 cosq
1CA F =
0B@1 0 00 0 0
0 0 0
1CA (5.10)
These tensors were summed up and the Eigenvector which corresponds to the
largest Eigenvalue of the tensor was then used as fiber vector for the voxel at the
filter kernel center.
In a second step, the sheep model was augmented with a second fiber vector field,
by generating rule-based fiber orientation as described in Sec. 5.4.1. Notably, the
sheep atrial geometry differs significantly from the human atrial geometry. The
inferior caval vein did not connect from inferior to the right atrium but rather from
posterior. The two right pulmonary veins had a common trunk and only small ostia.
The left pulmonary veins showed a different connection pattern. The appendages
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Fig. 5.22. Comparison between Visible Female atria with rule based fibers (top row) and Auckland sheep
atria with measured fibers (bottom row). Left: material labels; Middle: fiber orientation; Right: sinus rhythm
activation times. Figures adapted from [337].
were the dominating structures in both atria. Nevertheless, the necessary landmark
locations could be identified on the sheep geometry.
The difference between both fiber vector field could be expressed by the angle
between local fiber orientation vectors Ei (Eqns. 5.7 and 5.8). The mean absolute
angle error (MAE) or the root mean squared angle error (RMSE) were not the
best suitable error measures, as the error distribution was not expected to be Gaus-
sian. Therefore, two quality measures Q were defined. They represent the relative
amount of error angles below two threshold (45  and 22.5 ).
Q45 =
| {x | 8 Ei < 45 } |
| {x | 8 Ei} | ·100
Q22.5 =
| {x | 8 Ei < 22.5 } |
| {x | 8 Ei} | ·100 (5.11)
Vectors with an angle of less than 45  between them point approximately into the
same direction and vectors with an angle error below 22.5  may be considered to
be nearly similar, as local jitter in the measured fiber orientation was present even
after application of the spatial low pass filter.
Table 5.7 sums up the RMSE, MAE and quality measures Q45 and Q22.5 between
the measured and the rule-based fiber orientation in the sheep atrial model for
various regions of the model. Histograms and box plots of the error distribution are
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Fig. 5.23. Visual comparison of microscopy fiber orientation (averaged) and rule-based fiber orientation in
the Auckland sheep atria. Fiber orientation is color encoded. Circular fiber orientation around the PVs and
linear fibers orientation between PVs as well as fiber orientation along the rim of the MVR can be observed
in both models (PVs inlay). BB is less wide in the rule-based model compared to the microscopy fiber
model, but extent and overall orientation of the bundle is similar (LAA inlay). Fibers encircle the SVC in
both cases. Fibers from microscopic images in the RAA are mainly oriented towards the tip of the RAA,
whereas fibers in the rule-based model show a rather circular pattern around the RAA (RAA inlay).
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Fig. 5.24. Photographic image of a slice of the Auckland sheep atria [96]. Figure provided by Jichao Zhao,
Auckland Bioengineering Institute.
shown in Fig. 5.21. The regions automatically created by the algorithm described
in Section 5.4.1 were used for the purpose of regional fiber comparison. Good
correspondences of fiber orientation could be observed in BB and the valve rings
as well as in the PMs. The CT was a rather prominent muscular bundle in the rule-
based model, whereas in the original model, PMs dominated the fiber orientation
in this area of the RA. Nearly no agreement of fiber orientation was present in the
region of the RAA. Measured fiber orientation in the RAA pointed towards the tip
of the RAA, whereas rule-based fibers encircled the RAA leading to angle errors
accumulation between 45  and 90  in the histogram. Fiber orientation in the LAA
was in better agreement. In other human anatomical studies, organized circular
fiber orientation and near chaotic arragement of myofibers were observed in the
atrial appendages depending on the individual patient [10]. Figure 5.23 provides a
qualitative, visual comparison of the measured and rule-based fiber orientations in
different regions of the model.
Overall, the rule-based fiber modeling approach was able to reproduce the global
fiber orientation in the sheep atria, although the sheep anatomy was significantly
different compared to the human atria.
In a third step, sinus rhythm activity was simulated in the sheep atrial model in
different setups (Tab. 5.8). Thereby, always pairs of simulations were run. In each
pair the excitation in the microscopy and rule-based fiber orientation were com-
pared. The CRN model of human atrial electrophysiology and the monodomain
equation for cell coupling were solved to simulate the atrial excitation. The ratio
of longitudinal and transversal tissue conductivity was set to 10:1 (in one case to
3:1), which results in a conduction velocity anisotropy ratio of approximately 3:1
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Fig. 5.25. Comparison of local activation times and conduction velocity vectors in simulation No. 1
(Tab. 5.8).
(1.75:1). The sinus stimulus was applied at the sinus node location of the original
Auckland sheep model.
In two pairs of simulations (Tab. 5.8, No. 1 & 2), conduction velocity variations
and electrophysiological heterogeneities were neglected to determine the influence
of the differences in fiber orientation on the sinus rhythm excitation sequence. The
anisotropy ratio was set to 10:1 in the first simulation pair and to 3:1 in the second
pair of simulations. Table 5.8 provides the quantitative differences between both
models. Figure 5.25 shows the isochronal LAT maps and the conduction velocity
vector fields extracted from the LAT data (see Sec. 4.4 for details). The simulations
with both fiber orientation setups were in good agreement, although the anisotropy
ratio was rather pronounced in the first setup. The errors in LATs and in excitation
propagation direction were smaller in the low anisotropy simulation pair.
The introduction of regional conduction velocity heterogeneity into both models
(Tab. 5.8, No. 3 & 4) led to a better correspondence of the sinus activation sequence
between both fiber orientation models. This showed that the regional variations in
conduction velocity outruled the effect of local fiber orientation variations during
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Fig. 5.26. Comparison of local activation times and conduction velocity vectors in simulation No. 5
(Tab. 5.8).
sinus rhythm activity. The error between simulations with models having different
conduction velocity regions and different fibers (Tab. 5.8, No. 5) was also smaller
compared to the homogeneous, anisotropic simulations (No. 1).
5.4.5 Discussion
In this section, a semi-automatic method to introduce local multi-layer fiber ori-
entation into patient-specific atrial models was introduced. The presented method
was partly based on user-provided data. Although the locations of the anatomical
landmarks were described in detail, it cannot be outruled that an unexperienced
user may provide false landmark locations. For twelve models, at least two experts
selected landmark locations independently. Although locations varied, the result-
ing fiber orientation fields did not differ significantly. Additional uncertainties may
be introduced if more than four PVs are present in the patient LA geometry. In this
case, two or more PVs need to be considered as one PV and landmark locations
need to be set accordingly.
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Table 5.8. Quantitative comparison between simulations with the original sheep fiber orientation and the
rule-based fiber orientation. M: taken from microscopy model, R: taken from rule-based model, H: homo-
geneous.
Microscopy Fibers Rule-Based Fibers Activation Time CV vectors
Anisotropy Tissue Anisotropy Tissue RMSE (ms) MAE ( ) Q45 (%) Q22.5 (%)
1 10:1 H 10:1 H 7.0±13.8 33.2±21.4 79.3 33.8
2 3:1 H 3:1 H 4.3±11.4 21.5±15.6 93.6 62.7
3 10:1 M 10:1 M 5.9±8.1 28.9±18.2 85.8 41.8
4 10:1 R 10:1 R 5.1±6.8 28.5±19.3 86.5 44.6
5 10:1 M 10:1 R 8.1±12.7 32.3±21.5 79.0 36.9
A further automation of the process could be achieved by implementation of the
landmark locations into mean models for the automatic segmentation of cardiac
images [338]. This would also eliminate user-introduced errors and ensure repro-
ducible results. Alternatively, the generation of fiber architecture could be per-
formed directly in volumetric mean models [60] and could then be adapted to the
patient without running the fiber algorithm again [339].
Despite the questionable reliability of the VM and VF LA data, the rule-based fiber
architecture was able to reproduce fiber orientation in the major atrial bundles, as
described by Seemann et al. [92] and as observable in the VM RA. Additionally,
fibers were arranged circularly around the valve annuli in the VM dataset. An
arrangement which was recreated by the fiber rules as well.
Other groups have presented anisotropic singular anatomy models (Tab. 3.1). Fiber
orientation was thereby placed manually into 3D surface models based on simi-
lar data as used for the presented semi-automatic method. These models usually
contain less artifacts but cannot reflect the complex transmurally differing fiber
orientation in the human atria.
Although it is not clear how sheep fiber architecture corresponds to human fiber
architecture, application of the rule-based fiber algorithm led to a good approxi-
mation of the sheep fiber orientation and also allowed realistic simulation of sinus
rhythm activity in the sheep model. The electrically isolating layer, as introduced
by the rule-based fiber algorithm, was neglected in all simulations, because in the
original sheep image data (Fig. 5.24) no such layer could be identified. It is not
clear whether sheep atria differ in this respect to human atria, or if a different
staining technique would make such layer better visible in the image data.
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Fig. 5.27. Scheme for the creation of generic ablation lesion pattern in patient specific atrial geometries
using shortest paths. Figure adapted from [340].
The applied tissue conductivity anisotropy ratio of 10:1 was rather strong for atrial
simulation. Usually, such strong anisotropy is set in fast-conducting bundles in
established atrial models (Sec. 2.1.3) or to model fibrotic tissue [94]. The effect
of the conduction velocity heterogeneities outruled the effects of the differences
in fiber orientation during sinus rhythm simulation. In contrast, fiber architecture
may play a more important role in the simulation of atrial arrhythmia [68, 94, 96],
although electrophysiological variations will also contribute to the development
and maintenance of these arrhythmia.
5.5 Modeling Generic Lesion Patterns in Patient-Specific Models
In the literature, various approaches for successful RF ablation of AF are de-
scribed. Commonly, a three step approach serves as a basis to cure patients from
AF (Sec. 2.3). Initially, the pulmonary veins are isolated, then linear lesions are
placed to prevent reentry circuits and at last, additional punctual lesions may be
placed in regions showing abnormal electrical activity [1]. Modeling studies from
various research groups have investigated the influence on different ablation le-
sions on the impact of the left atrial excitation sequence (Sec. 3.1.3). In this sec-
tion a method is presented to incorporate different ablation lesion patterns into
patient-specific atrial models semi-automatically.
Ablation lesion patterns were reconstructed based on the left atrial anatomical
landmarks also used for the semi-automatic placement of atrial fiber orientation
(Sec. 5.4). Landmarks were connected to create center lines for ablation lesions,
122 CHAPTER 5. MODELING OF THE ATRIA
Table 5.9. Overview of implemented ablation lesion patterns.
pattern PV isolation linear lesions reference
A – set of linear lesions [341]
B individual circumferential PVI – [342]
C pairwise circumferential PVI – [343]
D pairwise circumferential PVI roof line, mitral isthmus line [344]
E individual circumferential PVI posterior line [345]
F individual circumferential PVI roof line, miral isthmus line, low posterior line [346]
G single circumferential lesion mitral isthmus line [347]
H single circumferential lesion mitral isthmus line, second line to MV [348]
I Cox Maze III [349]
by using the fast-marching level set shortest path method described in the previous
section. Figure 5.27 shows schematically the skeleton created from the landmark
and the shortest paths. Table 5.6 provides distinct information about the location
of the landmarks.
To model different ablation lesion patterns, different parts of the skeleton were
used. At each point along these paths, a 5mm [136] (Sec. 2.3.3) wide ablation
lesion was applied to the atrial tissue. Ablation lesion patterns were taken from
literature descriptions [1, 187, 350] and are listed in Table 5.9.
Tissue conductivity was set to zero in the ablation scars (Sec. 2.3.1, 3.1.3). Addi-
tionally, tissue anisotropy can be removed, as observed in experiments. To model
the acute effects of RF ablation, a border zone of slow conduction or diffusive
fibrosis may be set around the ablation lesions (Sec. 2.3.1). The method was ap-
plied to 18 atrial models (1-11 & 13-19, Tab. 7.1). Figure 5.28 shows an example
of lesion patterns in a left atrial model.
5.5.1 Discussion
In this section a method to create a broad range of atrial ablation patterns in patient-
specific atrial geometries was presented. The method was derived from the fiber
placement algorithm (Sec. 5.4). It uses the same user-defined landmarks and was
thus also prone to the same user-introduced uncertainties discussed previously
(Sec. 5.4.5).
Tissue conductivity in the ablation lesions was reduced to zero. This approach is
commonly undertaken in modeling RF lesions in the atria (Sec. 3.1.3). Neverthe-
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Fig. 5.28. Generic ablation lesion patterns in a patient specific left atrial model (subject 13, Tab. 7.1).
Scar tissue is shown in pale white. Tissue which was isolated from sinus rhythm activation is shown
in brown. Atrial activation was calculated using the fast-marching level set approach (Sec. 5.7). Figure
adapted from [340].
less, the method also allows for a consideration of more details with respect to the
microstructure of the ablation scars and the border zone (Sec. 2.3.2). Conduction
velocity and electrical anisotropy could be reduced in the modeled border zone.
During bidomain simulations, different conductivity tensors for the intra and extra-
cellular space could be considered, e.g. setting only the intra-cellular conductivity
to zero in scar tissue. These factors are independent of the geometrical modeling
of the ablation lesion patterns.
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Fig. 5.29.Workflow for the determination of the monodomain tissue conductivity from only three simula-
tions in a desired simulation setup.
Punctual ablation lesions placed in regions of abnormal electrical activity or with
the aim to change the local dominant activation frequency (Sec. 2.3) were not
included in the method. The placement of such ablation points is based on elec-
trophysiological measurements and depends on the patients electrophysiology and
may also change in the course of the intervention. The number of additional lesions
and their location is therefore not predictable. The evaluation of the influence of
randomly placed ablation lesion in left atrial models on the atrial excitation may
pose an alternative approach to investigate the general influence of such ablation
lesions on the atrial function.
5.6 Calculation of Tissue Conductivity to match Conduction
Velocity
The monodomain tissue conductivity depends on various simulation parameters
(e.g. electrophysiological model, model resolution, discretization method). The
correct tissue conductivity for a desired conduction velocity in a certain simula-
tion settings is usually determined iteratively employing optimization algorithms
which vary the conductivity until the desired conduction velocity is matched. In
this section a method to fit the tissue conductivity to a given conduction velocity
with only three simulations is presented (Fig. 5.29).
The monodomain tissue conductivity and the conduction velocity can be approxi-
mated by a quadratic relationship [351, 352]:
sdiscretization,resolution = a ·CV 2+b ·CV + c. (5.12)
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Table 5.10. Resulting coefficients of equation 5.12. FD: finite difference, FE: finite elements.
discretization resolution a b c
mm s2m 3S sm 2S m 1S
FD 0.10 0.121 0.008 0.00
FD 0.20 0.119 0.018 1.63 ·10 4
FD 0.33 0.120 0.027 1.52 ·10 3
FD 0.40 0.119 0.034 2.39 ·10 3
FE 0.10 0.174 0.015 -2.63 ·10 4
FE 0.20 0.182 0.021 8.80 ·10 4
FE 0.33 0.179 0.036 3.32 ·10 3
FE 0.40 0.172 0.051 3.76 ·10 3
Figure 5.30 provides an example of this relationship. The unknown coefficients
a, b and c can be determined if at least three conductivity – velocity value pairs
are known. These can be created by choosing three tissue conductivities, running
one simulation each and measuring the resulting conduction velocity (Fig. 5.29).
The pairs can then be used to solve the linear system of equations for the three
coefficients a, b and c, which are specific to the simulation setup. If more than
three simulations were performed the over-estimated system can be solved with
a regular least-squares approach. From there on, the conductivity for any desired
conduction velocity for the same simulation setup can be calculated analytically.
To test the algorithm, 186 isotropic cable simulations using the CRN model were
performed with different spatial resolution, discretization method and tissue con-
ductivity. The procedure was done for the complete dataset and only for a subset
of three value pairs of each dataset. Figure 5.30 provides an overview of the simu-
lation results and the curve fits and Table 5.10 lists the resulting coefficients. The
RMSE of the reduced fit was slightly worse than the RMSE of the original data fit
(Tab. 5.11), but still provides a precise estimation of the actual conductivity.
To determine anisotropic tissue conductivities the following relationship can be
set up
slong
strans
=
a ·CV 2long+b ·CVlong+ c
a ·CV 2trans+b ·CVtrans+ c
. (5.13)
The coefficients a, b and c are the same for both fiber orientations, as fiber orienta-
tion is reflected in the excitation propagation models as anisotropic conductivity.
The conductivity–CV relationship is thereby not altered. The quadratic term of the
equation has a larger weighting than the linear part (Tab. 5.10). The relation can
therefore be approximated to
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Fig. 5.30. Results of quadratic fits to simulation outcome.
slong
strans
⇡
✓
CVlong
CVtrans
◆2
. (5.14)
Using this relationship, conductivities for any desired anisotropic conduction can
be calculated directly from the initially determined (longitudinal or transversal)
tissue conductivity.
5.6.1 Discussion
In this section a simple method to determine the monodomain conductivity for
desired conduction velocities was presented. Previously, if the conductivity for a
specific conduction velocity needed to be estimated, an iterative simulation ap-
proach was employed to find a conductivity which resulted in the desired conduc-
tion velocity. This approach often required a large number of simulations and only
provided an estimate of the conductivity. With the approach presented in this sec-
tion, only three simulations and a curve fit are needed for a precise determination
of the monodomain conductivity. The three initial conductivities should be cho-
sen to cover the greatest possible conduction velocity range without running into
discretization or numerical problems. A good choice was s=0.05, 0.15, 0.25. For
the future, the approach enables a regional adaptation of the conduction velocity
in whole atria monodomain simulations.
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Table 5.11. Error of quadratic fit to various sets of simulations. FD: finite difference, FE: finite elements.
number of
EP model resolution discretization simulations RMSE RMSE 3
(mm) (S/m) (S/m)
CRN 0.1 FD 3 0.000000 0.000000
CRN 0.2 FD 12 0.000300 0.000608
CRN 0.33 FD 26 0.000717 0.001225
CRN 0.4 FD 32 0.000835 0.001369
CRN 0.1 FE 17 0.000576 0.000845
CRN 0.2 FE 33 0.000799 0.001215
CRN 0.33 FE 32 0.001029 0.001481
CRN 0.4 FE 31 0.001274 0.002000
5.7 Fast-Marching Method to Compute Activation Times
Level set methods calculate arrival times at discrete points in 3D geometrical ob-
jects (Sec 3.3.3). These arrival times can be interpreted as activation times in a car-
diac model [197, 264]. Level set methods thereby reflect a monotonously expand-
ing front and are usually easier to handle than e. g. full Eikonal models [262, 263].
On the downside, level set methods neglect diffusion processes and cell electro-
physiology.
Based on an implementation of fast-marching level set method for structured
grids [259], an anisotropic, heterogeneous fast-marching method was developed [225].
The method calculated activation equivalent arrival times and also supports mul-
tiple starting points. The method was by order of magnitude faster than the mon-
odomain approach and easier to handle than e. g. the adaptive cellular automa-
ton [162]. It produced similar results for sinus rhythm excitation as the mon-
odomain approach both in the isotropic and anisotropic case. Body surface ECGs
also showed a good similarity to the ECGs computed from the monodomain solu-
tion (Sec. 9.1.2).
The distance between two points in 3D space can be expressed as the L2 norm in
Cartesian coordinates:
di =
q
(Dx)2+(Dy)2+(Dz)2. (5.15)
This distance corresponds to the arrival time in the level set approach. Anisotropy
could be introduced by weighting the isotropic distance di depending on the fiber
angle in the starting coordinate and the angle between the two points:
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da =
       
⇣ 
R ·W ·RT  1⌘ ·
0B@DxDy
Dz
1CA
        . (5.16)
W is a tensor containing the conduction velocity (CV) along and across the fiber
orientation and R is a rotation matrix (Eq. 5.20).
W =
0B@CVlong 0 00 CVtrans 0
0 0 CVtrans
1CA (5.17)
The longitudinal CV (CVlong) can be expressed as a product of the anisotropy ratio
for the tissue k and the transversal CV (CVtrans). For regular sinus rhythm simula-
tions k was set to 1:
p
3, to reflect the commonly used monodomain tissue conduc-
tivity ratio of 1:3. For fast conducting bundles, k was set to 1:3 (corresponding to
1:9 in monodomain tissue conductivity).
CVlong = k ·CVtrans (5.18)
W =
0B@k ·CVtrans 0 00 CVtrans 0
0 0 CVtrans
1CA (5.19)
Fiber orientation in the starting point can be expressed in spherical coordinates by
two angles f and q , which vary between 0 and p radians. This led to the rotation
matrix R
R=
0B@ cosf sinf 0 sinf cosf 0
0 0 1
1CA
0B@ cosq 0 sinq0 1 0
 sinq 0 cosq
1CA (5.20)
Heterogeneous CV between different tissue types was included in the distance
calculation by weighting the anisotropic distance norm between two coordinates
da with the reciprocal of the ratio between the CV in a specific tissue and the CV
in the regular myocardium.
da,t = wt ·da (5.21)
Inter-tissue CV ratios wt were set based on the monodomain tissue conductivities
used in [225]:
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wCAM = 1.000
wCT = 0.756
wPM = 0.740
wBB = 0.599
wIS = 1.940
Body surface ECG signals were forward computed in a three step process. 1) For
each time step (e.g. each millisecond), the activation time results were converted
to binary data. The threshold was chosen as the respective time step. Each com-
putational node with activation time shorter or equal to the threshold was set to
+5mV, all other nodes were set to have a value of -82mV. From this binary model,
a regular two step forward calculation was performed (Sec. 3.4).
5.7.1 Evaluation
To evaluate the correspondence of the activation times calculated from the fast-
marching method to the monodomain solution, both types of simulations were
performed on models 1-8 (Tab. 7.1). The monodomain simulation setup is de-
scribed in more detail in [225]. The mean absolute error was 11.9±13.2ms. Syn-
chronization of the latest activation times resulted in a mean RMSE of 4.25ms for
the isochrones in the models. The error between the conduction velocity vectors
(Sec. 4.4) had a mean Q22.5 of 62.6% and a Q45 of 92.4%. Figure 5.31 shows two
representative examples of the simulations.
5.7.2 Discussion
In this section, a method to calculate LATs based on the fast-marching level set
method was presented. The algorithm was able to reproduce anisotropic and het-
erogeneous conduction velocity and may thus be used to simulate the complex
atrial excitation sequence.
The method was tested on eight patient-specific atrial models and compared to
the monodomain solutions. Activation times calculated with both method showed
a good qualitative and quantitative correspondence, although the time for com-
plete atrial activation varied between the solutions. The mean RMSE error was
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Fig. 5.31. Two representative examples of monodomain and fast-marching simulation of sinus rhythm in
two patient models (Tab. 7.1). The excitation sequence and the isochrones correspond well. Local isochrone
curvature varies to some extent.
mainly caused by differences in activation times in very thin tissue areas, where
the excitation propagation was slowed down in the monodomain solution. Addi-
tionally, in the monodomain simulations a broader range of anisotropy ratios were
used compared to the fast-marching approach. Differences in anisotropy ratios and
local conduction velocity variations also account for variations in wavefront cur-
vature and thus conduction velocity vector directions. The fast-marching calcula-
tions were by magnitudes faster than the monodomain computations (minutes vs.
hours) and the method was easier to use than the adaptive cellular automaton. The
latter is an important factor to use the simulation environment for high-throughput
simulations.
The fast-marching approach was not able to account for diffusion processes. It
may therefore not be able to reproduce wavefront curvature dependent conduction
velocity alterations. The method was able to reproduce multiple wavefronts, but
could not reproduce reentries, as it does not include repolarization. Sermesant et al.
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have presented a similar method including cell repolarization [264]. The method
introduced in this section could in the future be extended accordingly.
Other groups have also shown approaches to include diffusion processes into
Eikonal models [260, 261] which may be used to model arrhythmic behav-
ior [262, 263]. Such approaches might be useful for arrhythmia simulations, but
will slow down the computation compared to the pure fast-marching approach,
which was not desirable for this study. The advantage in computational speed was
used for a high throughput simulation study with multiple models (Sec. 9.1.2). A
graph based method for a yet faster computations of the ventricular activation se-
quence was presented recently [265]. The adaptation of this method to the atrial
sinus rhythm excitation could further speed up the computations. On the other
hand, the forward-calculation of the ECG currently consumes the vast portion of
computational time.

Part III
Model Personalization
The best material model for a cat is another, or preferably the same cat.
A. Rosenblueth & N. Wiener
Role of Models in Science

6Personalization Framework
The use of atrial models in a clinical environment requires a personalization of
the existing general models. Three different types of models need to be distin-
guished in the context of modeling and simulating the cardiac electrical activity:
i) Anatomical models, ii) cellular electrophysiological models and iii) models of
the excitation propagation. The personalization of the anatomy is mostly a task
of image acquisition, segmentation and post-processing. The personalization of
the cellular electrophysiological model requires the acquisition, processing and
interpretation of electrical cardiac signals. The personalization of the excitation
propagation requires anatomical and electrophysiological data acquisition and a
personalization of both other models (Fig. 6.1).
The main task of anatomical model personalization is the segmentation of the 3D
atrial geometry from clinical image data (MRI, CT), but it also covers the extrac-
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Fig. 6.1. Hierarchical structure of the model personalization with respect to atrial anatomy, electrophysiol-
ogy and excitation propagation.
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Fig. 6.2. Personalization of atrial models can be divided into three different categories each covering levels
of detail from generic models to regional variations. Figure adapted from [340].
tion of further patient-specific information from such images, as e.g. regions of
pathological tissue. Atrial cellular electrophysiology models have various param-
eters which can be adapted to a patient or patient group. Usually a combination of
such parameters is changed to fit the model to diseases, electrophysiological in-
vitro measurements and regional differences within the atria. A personalization of
the atrial excitation sequence model covers the personalization of the conduction
velocity, specialized conduction routes and other local conduction properties.
Model personalization can be performed on different levels of detail. With this
work, a hierarchical scheme of personalization is proposed (Fig. 6.2). From a gen-
eral level, models of all types can be personalized to a patient group and, as ap-
propriate, also a patient sub-group. This first level of model personalization offers
the possibility to adjust general models to a diagnosed patient without any further
measurements and therefore might form a simple but yet effective method in future
clinical application. Such model personalization was formerly often used to inves-
tigate general effects of diseases in-silico without the direct link to the real patient
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(e.g. [2]). On a next level, the models can be adapted to the individual patient by
taking global measurements into account (e.g. [225]). The most detailed level of
model personalization covers the adaption of the models in specific regions of the
atria. This step usually requires invasive measurement data (e.g. [223]). Figure 6.2
provides examples for personalization of each of the three model types at the dif-
ferent levels of detail.
The types and levels of model personalization need to be serialized into a contin-
uous workflow, to allow for a use of the personalized models in a clinical environ-
ment. In this thesis a sequential and flexible framework of model personalization
is proposed to create, evaluate and eventually validate personalized atrial models
(Fig. 6.3). This framework couples a-priori knowledge about the atrial anatomy,
electrophysiology and excitation sequence, with measurement data from various
entities and with different level of detail to create patient-specific models for the
model-based evaluation and planning of RFA in patients with AF. The workflow
was used on seven volunteer datasets and four AF patient datasets so far (1–11,
Tab. 7.1). Not all datasets underwent the complete workflow, as some data were
not acquired for some AF patients. The steps of the personalization workflow are
described in more detail in the next three chapters.
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Fig. 6.3. Generalized framework for the creation and validation of personalized atrial models. Background
colors of the individual steps refer to the color scheme used in Fig. 6.1. Figure adapted from [225].
7Personalization of Anatomy
Over the past decades, modeling studies have used standard anatomical models
of the atria and thorax. The atrial geometry was thereby either approximated by
simple geometric shapes, e.g. a ”peanut”, or was derived from clinical image data.
Models of the segmented Visible Man [353, 354] and Visible Female [355, 356]
datasets were also frequently used, especially for whole body ECG computation
studies. For the computation of atrial ECG signals, various groups also used sim-
ple homogeneous thorax models, sometimes including lung compartments [217–
219, 229–231]. Table 3.1 provides an overview of atrial modeling studies using
generalized anatomical models or the Visible Human atrial models. The creation
process of these models often lasted months, and the models were refined over
several years and several studies.
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Fig. 7.1.Workflow of the creation of patient-specific atria and thorax models. The automatic segmentation
of the MRI data was realized by software developed by Philips Research. The LGE-intensity mapping was
performed at King’s College London, UK.
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Today, cardiac modeling is moving towards clinical applications. Methods to cre-
ate patient-specific models are needed to create new anatomical models in a rea-
sonable time with minimal user interaction. Atrial simulation studies put special
requirements on the anatomical model (Sec. 2.1.1.5). Specifically, pulmonary vein
drainage pattern, atrial wall thickness, fiber orientation, isolating septal layer and
region classifications need to be included. In this chapter, a workflow to create
patient-specific atrial and thorax models from clinical image data is proposed and
the results of the modeling process are shown. The workflow is based on meth-
ods to segment the atrial endocardium. These were developed at Philips Research
Europe, Aachen and Hamburg, in collaboration with the IBT. These segmentation
methods were not part of this PhD thesis, but received collaborative input from
the work described in this thesis. The methods are described here for the matter of
completeness. Figure 7.1 schematically summarizes the workflow. All model gen-
eration steps after the segmentations were developed as part of the present thesis.
7.1 Creation of Simulation-Ready Atrial Models from MRI
The workflow to create simulation-ready anatomical atrial models from image data
was comprised of three steps. In a first step, the endocardial surfaces of the whole
heart (4 chambers, great vessel stubs) were extracted from the image data using an
automatic approach [357–359]. Thereby, a statistical shape model was adapted to
the image stack. The location of the heart in the image was initially determined us-
ing a 3D implementation of the generalized Hough transform. Then, the complete
model was adapted by a global similarity transform. Afterwards, each compart-
ment was adjusted independently by an affine transformation and last a deformable
adaptation was performed locally. Each node in the statistical model was thereby
trained independently from the others, to account for local variations in image pa-
rameters. The framework was developed by Philips Research, Aachen and Ham-
burg, Germany, and was implemented as a plugin to GIMIAS (Graphical Interface
for Medical Image Analysis and Simulation, www.gimias.org). This segmentation
approach defined the endocardial surfaces of the four chambers, the stubs of the
major vessels and the left ventricular wall from cardiac MRI or CT data.
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Fig. 7.2. Hybrid segmentation approach as presented in [48]. Initially, the left atrial body is segmented
without PV orifices (left). Then a guided region growing is conducted in the area where PV ostia are
commonly present (right). The region growing can further split the PV segmentation into multiple branches.
Figure from [48].
Segmentation of Atrial Chambers
The segmentation algorithm has been previously adapted to better handle regional
variations in atrial anatomy. A hybrid method to detect and segment variable pul-
monary vein drainage patterns in the left atrium from CT data is used [48, 360].
The method bases on the approach of Lorenz and von Berg [357]. In this approach,
the left atrial endocardium is segmented automatically, but the PV ostia are left out.
A directed region growing in the region in which the ostia were expected are used
to segment the PVs and early branches. Models 13–16 (Tab. 7.1) were segmented
this way.
In a second effort, a method to segmented both atria from CT data was developed at
Philips Research. Wall thickness as well as myocardial structures relevant for elec-
trophysiological simulations were added to the statistical shape model [60, 361]
in collaboration with this thesis. The method also based on the model proposed
by Lorenz and von Berg [357]. Although it neglected variations in PV drainage
pattern, it solved the problems arising with the segmentation of volumetric mod-
els (e.g. overlap of epicardial and endocardial surfaces). The atrial wall thickness
could not be extracted from the CT data reliably. Therefore, regional atrial wall
thickness was extracted from a set of high resolution MRI images and a statistical
regional wall thickness was determined and augmented the statistical shape model.
The output meshes also included an isolating layer at the septum. The electrophys-
iological structures in the myocardium were marked in the statistical shape model
using the fiber placement algorithm presented in Section 5.4.
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(a) (b)
Fig. 7.3. Volumetric statistical shape model with electrophysiological structures based on [216, 362] as
presented in [60]. Figure from [60].
The segmentation of cardiac MRI data is in some aspects more challenging than
the segmentation of CT data. Especially vessels in close proximity to the cardiac
chambers are often hard to separate from each other and from the myocardium.
Therefore, the hybrid method presented by Hanna et al. [48] to segment CT data
failed to segment MRI images. On the other hand, statistical shape models can
segment the endocardium reliably, but cannot account for anatomical variations in
PVs. Therefore, a segmentation workflow was developed at Philips Research in
collaboration with this thesis, which used a family of statistical shape models to
segment the left atrial endocardium from cardiac MRI data. Three mean models
were created and trained, which covered the vast majority of observed pulmonary
vein drainage patterns [363, 364]. Each image dataset was segmented three times,
once with each mean model. A support vector machine was then used to deter-
mine the most suitable segmentation from the results. This approach was used to
segment the image data for models 10 and 11 (Tab. 7.1).
Processing of Segmentations for the Simulation Use
As the second step in the workflow to create simulation-ready atrial models,
the endocardial surface models were transferred into a high-resolution structured
grid (Dx=0.33mm). Based upon literature values for the atrial wall thickness
(Sec. 2.1.1.4), the right ventricle and the endocardia of both atria were dilated.
This resulted in a volumetric four chamber model. If the original segmentation of
the endocardial wall did not include tissue labels for the cardiac vessels, the os-
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Fig. 7.4. Three different statistical shape models of the left atrium as presented in [363, 364]. Left: regular
model with four PVs, middle: the left PVs have a common trunk, right: model with extra right middle PV.
tia and stubs of the PVs and caval veins were labeled manually in the volumetric
model. Afterwards, atrial fiber orientation was semi-automatically introduced into
the atrial models, as described in Section 5.4. The semi-automatic segmentation
also introduced tissue labels for right atrium, left atrium, SN, CT, PM, BB (R/L),
II, R/L blood pool, Septum, TVR, MVR, middle posterior interatrial bridge, low
posterior interatrial bridge, CS bridge and low anterior interatrial bridge into the
atrial models. The resulting volumetric, heterogeneous, anisotropic atrial model
could be used for the simulation of the electrical activity in the patient-specific
atria.
If desired, the simulation-ready patient atrial models were triangulated into tetra-
hedron meshes using CGAL (see next section for more details). These models
could then be used with other simulation environments [365, 366], e.g. Chaste
(Cancer, Heart and Soft Tissue Environment, www.cs.ox.ac.uk/chaste) [367], or
for elastomechanical simulations (Chap. 14). An example for such a patient-
specific, heterogeneous, anisotropic atrial tetrahedron model can be publicly re-
trieved from the Anatomical Model Data Base (AMDB,
http://amdb.isd.kcl.ac.uk) [368].
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7.1.1 Late Gadolinium Enhancement MRI Models
The cardiac segmentation process was augmented with structural tissue data re-
trieved from LGE-MRI (Sec. 4.1). First, the endocardial surface in the LGE-
MRI needed to be registered with the endocardium segmented from the cardiac
morphology scan. Second, LGE-intensity was calculated as maximum intensity
projection of the image intensity within 3mm surrounding the endocardial sur-
face [270]. A direct transfer of the LGE-MRI intensity was not possible, as i) the
resolution of the LGE-MRI was too coarse (commonly approximately 4mm) and
ii) the LGE image contains quite a few artifacts and noise. As the atrial myocardial
wall cannot be extracted from the MRI data, the maximum atrial wall thickness of
3mm was used as radius for the interpolation. The procedure is described in more
detail in [270].
The LGE-intensity on the endocardial surface was transferred into the volumet-
ric atrial models in three steps. First, the intensity values were binarized. Values
above the threshold were projected along a gradient vector from the endocardium
to the epicardium into the atrial wall. Last, a morphological closing operator with
a structure element size of 3⇥3⇥3 voxel was applied to the model to close small
gaps. Those arose from the difference in endocardial surface to epicardial sur-
face ratio. The technical realization of the projection along the transmural gradient
was as follows. First, a circumsphere around each selected triangle of the endo-
cardial surface mesh was created. Then, each voxel in the volumetric atrial model
which lay on the border between the left atrial blood pool and the myocardium and
which was enclosed by the sphere was marked according to the binarized intensity
value [369].
This method can be used to recreate regions of ablation scars (post-ablation LGE-
MRI), fibrosis (pre-ablation LGE-MRI) and/or edema (post-ablation T2-weighted
MRI) in volumetric atrial models (Sec. 4.1). Scars created from RF ablations were
transferred for models 8, 9, 9c, 10 and 11 (Tab. 4.1 and Tab. 7.1). More details are
provided in Chapter 13.
7.1.2 Discussion
In this section, a workflow to create patient-specific simulation-ready atrial models
with minimal user interaction was presented. The workflow was optimized for
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MRI data. Within the euHeart project, MRI was the imaging modality of choice, as
it does not rely on ionizing radiation. Nevertheless, also a number of models were
segmented from CT data in collaboration with Dr.-Ing. Frank M. Weber [268].
The initial segmentation was thereby performed using software tools developed
by Philips Research Aachen and Hamburg. Other groups also provide solutions to
segment the cardiac chambers from CT [370], 4D CT [371], cone-beam CT [372],
and TEE [373]. The modular setup of the developed framework allows to also use
these tools instead of the Philips software.
The atrial anatomy requires segmentation approaches to cope with variability in
PV drainage pattern. In this section two approaches to account for this were pre-
sented and used to generate patient-specific atrial models. Another approach, pro-
posed by Zheng et al. [374], utilizes a left atrial model to segment ungated C-arm
CT data during EP interventions. Such approach could enable a model genera-
tion without previous imaging sessions, but may not provide functional data about
pathological tissue in the atria.
The introduced atrial fiber orientation and atrial region labels were not specific to
the individual patient, but based on rules. Although some of the prominent bundles
may be visible for an expert eye in high resolution CT data [12, 36], they are usu-
ally occluded in MRI and regular CT data and thus cannot be segmented for each
patient individually. The rule-based structures reflect the atrial excitation sequence
better than isotropic models, which was shown in Section 5.4.2. Coupling of the
anatomical model with electrical measurements from the atria, e.g. LAT maps,
could allow a personalization of the locations of the fast conducting bundles in the
future, as proposed in Section 9.1.1.
Similarly, the atrial wall cannot be imaged with MRI data yet. First results from
manual determination of atrial wall thickness from sparse high resolution MRI
slices were presented in [60]. Until reliable imaging techniques for the atrial wall
become available, statistical atlas data provides the best approximation to build
volumetric atrial models.
The multi-model approach introduced by Kutra et al. [363] also includes an au-
tomatic assessment of the quality of the segmentation result. In the future, the
analysis of the local segmentation error could provide the user with a reliability
score for the segmentation and could show where manual corrections are needed.
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Fig. 7.5. Example of a tetrahedron thorax model (model 4). The thorax was cut open along the coronal
plane and a right lateral axial plane. The atria were not cut for better impression of their location in the
thorax. Tissue classes are colored to highlight the organs. The node distances at organ borders is smaller
than within the organs (see inlay). Mean node distance in the atria is 0.83mm.
The transfer of regional structural information of the myocardium from LGE-MRI
still bears some uncertainties. As the atrial wall cannot be imaged with MRI tech-
niques yet, LGE intensity in the surrounding of the maximum atrial wall thickness
was analyzed. This might also include high LGE-MRI intensity arising from other
structures, e.g. the esophagus next to the left atrial posterior wall. A comparison of
LGE-MRI segmentation techniques revealed a high inter-expert variability in man-
ual LGE-MRI segmentation as well as a broad range of segmentation results using
a variety of segmentation techniques [274]. One of the major problems for these
issues lay in the imaging quality for the atrial wall and the LGE-MRI. Once these
problems are better resolved, the transfer of structural information from LGE-MRI
and T2w-MRI into the models will become more reliable without needing to adjust
the transfer method.
The method to transfer structural information from LGE-MRI introduces error
at the borders between healthy and pathological tissue due to the use of circum-
spheres around triangles in the endocardial surface mesh. The magnitude of the
error depended on the resolution of the endocardial surface mesh and was neg-
ligible small in the present datasets (0.66mm). The resolution of the surface
mesh can easily be increased by refining the mesh and thus, the error could be
suppressed further.
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7.2 Manual Segmentation of Thorax MRI Data
The forward-calculation of ECG signal from simulations of atrial excitation re-
quires a thorax model of the same patient. In this section a manual approach to
create thorax models from MRI data is presented. Whole thorax MRI data were
segmented manually using deformable triangle meshes [375]. Thereby, a sphere
was placed into the center of the organ. The radius of the sphere was chosen such
that it resembled the mean radius of the organ. The mesh surface was then dragged
locally to overlay the border of the specific organ. This method is independent of
the imaging modality and image quality, but the user has to identify the correct
border of the organ by eye. Organs with a non-spherical shape were segmented
using multiple meshes, which were merged afterwards. E.g. the liver could be seg-
mented using two meshes to cover the organ inside and parts of the bowel, and
a third mesh covered only parts of the bowel next to the liver. The two volumes
enclosed by the inside meshes were added and the volume of the third mesh was
subtracted afterwards, such that only the volume of the liver remained.
For some organs, e.g. the lungs, region growing [333] or level set methods were
also used for the segmentation process. The latter were realized in a software tool
provided by Hans Barschdorf, Philips Research Hamburg, Germany, for the eu-
Heart project. Using this software, organs were segmented by user-selected points
inside, outside and on the border of an organ. Common level set methods [258] im-
plemented in the Visualization Toolkit (VTK) and Insight Segmentation and Reg-
istration Toolkit (ITK) were then used to create a triangle surface mesh around the
organ from these points. In all thorax models lung, kidneys, liver and spleen were
segmented. Depending on the case, the remaining thorax volume was additionally
classified into fat, bone, muscle, blood in the aorta, bowel or bowel content.
The surface meshes were then used to label different organs and tissue types in
a voxel volume of the patient’s thorax. The voxel representation of the patient’s
thorax was merged with the segmented cardiac voxel data. From the lattice data, a
tetrahedron model of the thorax and heart of the patient was created using the Com-
putational Geometry Algorithms Library (CGAL, www.cgal.org)) [376]. CGAL
employs the 3D Delaunay triangulation [377] to create a tetrahedron model from
structured grid data. Borders between organs were triangulated as smooth surfaces
and thus contained more nodes compared to the inner volume of an organ or tissue
region. The atria were meshed finer than the rest of the organs. At the end, the atria
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included approximately as many nodes as the rest of the thorax (Tab 7.1). Fiber
orientation in the atria was transferred from the voxel model into the tetrahedron
model afterwards. All other organs were set to have isotropic conduction proper-
ties. Figure 7.5 provides an example for a tetrahedron thorax model constructed in
this manner. Table 7.1 provides more detail on the created models.
7.2.1 Discussion
In this section a workflow to create patient-specific thorax models from respec-
tive MRI data was presented. The manual segmentation using deformable surface
meshes was a time consuming process. The VTK/IKT tool provided by Philips
sped up the process significantly (5 - 15 minutes per organ). Nevertheless, the
process might be prone to inter-user variability in the segmentation outcome. An
automatic segmentation approach using statistical shape models, similar to the
approaches presented for the cardiac segmentation could overcome this limita-
tion. Although a number of segmentation approaches for organs other than the
heart are described in literature [378], no approach to segment the whole thorax is
present. For most soft-tissue structures desired for the forward calculation (lungs,
abdominal organs), no model-based segmentation pipeline fromMRI data is avail-
able [378]. The combination of multiple MRI sequences allows for a fast and auto-
matic generation of muscle-fat-lung models [379, 380] on the cost of longer MRI
acquisition sessions. This approach could in the future be used to create patient-
specific thorax models for ECG computations with least possible user interaction.
The utilized software suites are just two examples of segmentation software. Other
free tools, e.g. CardioViz3D [381, 382], Seg3D [383] or 3DSlicer [384], are also
based on VTK/ITK. Although some of these provide more functionality than the
tools used here, the present software could be better included into the technical
workflow, because the software was either developed in-house or in close collab-
oration with the IBT.
Not all thorax organs are needed for a reliable simulation of the atrial ECG [71].
In the segmented thorax models, organs which significantly influence the ECG
computation were included. Additionally, the kidneys and spleen were segmented,
as these organs were clearly delineated in the image data and segmentation could
be done in a short amount of time.
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Except for the atria, all organs in the thorax models were set to have isotropic
electrical properties. Fiber orientation in these organs cannot be retrieved from
image data in a reasonable time in the clinical setting. Rule-based approaches to
include fiber orientation in the skeletal muscles were shown to produce ECGs
worse than those computed with isotropic models [385]. Anisotropy in the thorax
was therefore neglected for the forward calculation.
For the future, further automation in methods to segment thorax MRI data are
desired to allow for a smooth model generation workflow, which could also be
introduced into clinical procedures.
7.3 Anatomical Models from Patient Data
Using the workflow and techniques presented above, 22 patient-specific atrial and
8 thorax models were created. Table 7.1 summarizes the properties of the anatom-
ical models. Figure 7.7 to 7.14 provide visualizations of the thorax images as well
as the thorax, heart and atria models of subjects 1–8. Figures 7.15 and 7.16 show
visualizations of the atrial models and the modeled atrial fiber orientation in all
cases.
Thorax MRI data of subjects 1, 2, 6 and 7 were segmented by Dr.-Ing. David
Keller as part of his PhD work [267]. For model 1 there is also a high resolution
dynamic ventricle model available [386, 387]. The detailed models of the atria
and the whole thorax models of these patients were created as part of the present
study. The geometrical models of the Visible Human data (20, 21) were created
previously as well [92, 353–356]. The geometry of the sheep atria were created at
the Auckland Bioengineering Institute, New Zealand, and provided by Dr. Jichao
Zhao and Prof. Dr. Bruce Smaill [96]. For all models, rule-based fiber orientation
was created as described in Section 5.4 as part of this thesis.
From the thorax models, the organ volumes of the lung, liver, spleen and kidneys
were calculated (Fig. 7.6(a)). The mean volumes were 3385 cm3 (lung), 1749 cm3
(liver), 278 cm3 (spleen) and 360 cm3 (kidneys). The lung volume showed con-
siderable inter-model variation of two to more than five liters. This was probably
caused by the strong differences in patient/volunteer height and weight (Tab. 4.1).
All values were within physiological range.
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Fig. 7.6. Volumes of organs and atrial myocardium in the models.
In the models, the right atrial myocardium had a greater volume and thus mass
compared to the left atrial myocardium (Fig 7.6(b)). In the right atrium, the most
dominant structures in terms of relative myocardial volume were the RAA and the
TVR (Fig 7.6(c)). In the left atrium, the PV volume showed a great intermodel
variation. This was caused by the different segmentation approaches for the PV
region. The CT was the largest fast specialized conducting bundle in both atria.
7.3.1 Use of Models and Model Cohorts
The models presented in the previous section were used for different simulation
studies and collaborations. This section briefly describes which models were used
for the different studies and also introduces three subgroups of models which were
used in some of the investigations.
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The Visible Human models (20, 21) and the Auckland sheep model (22) [96] were
used to evaluate the outcome of the semi-automatic placement of atrial fiber ori-
entation (Sec. 5.4.3, 5.4.4). Both Visible Human models were used to investigate
the impact of fast-conducting bundles on the sinus rhythm excitation in man [388].
The Visible Female model with rule-based fibers was also used in the studies pre-
sented in [366, 389] and for a comparison of the anisotropic sinus rhythm excita-
tion sequence in sheep atria compared to human atria [337]. For the hemodialysis
study (Chap. 15), model 4 was used. This model was also used to refine methods
to reconstruct the atrial excitation sequence from BSPM data [390, 391] and to
simulate atrial fibrillation (Chap. 11). Model 8 was used to develop conduction
velocity constraints for a solution of the inverse problem of ECG [287]. Models
17 and 18 were used to augment statistical shape models with fiber orientation
in the atria [339]. Model 19 was used to create a deformation model of the atria
(Sec. 14).
Model Cohorts
Three cohorts of models were created, which were used for different studies. Using
a cohort of models instead of just using one model, which is common practice in
atrial modeling (see Tab. 3.1), had the advantage that potential geometry-specific
errors were averaged in the final results. The variation in the results of individ-
ual models in the studies presented in Chapters 9 and 5.2 foster this approach.
Furthermore, a cohort of models allows the development and evaluation of model-
processing techniques, which can be later on applied to new, patient-specific mod-
els.
1. Whole Thorax Model
This model cohort comprised the atrial and thorax models of subjects 1–8 (Tab. 7.1).
These models are the most complete ones, as realistic simulation of the atrial exci-
tation can be performed and the results can be forward calculated to body surface
ECGs. This multi-scale simulation approach allows the investigation of e.g. patho-
logical changes in cell electrophysiology from cell to ECG. The model cohort was
used to evaluate the adaptation of the global conduction velocity in models to the
P-wave duration (Sec. 9.3) and to investigate the effects of variations in the inter-
atrial conduction on the ECG signals (Sec. 9.1.2). Furthermore, the models were
used to study the atrial repolarization sequence in the ECG (Chap. 10).
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2. AF Atria Models
The second cohort was made up of all models from AF patients (subjects 8–11).
For these individuals, also left atrial LAT maps (Tab. 4.1) were available. The
cohort was used to determine the individual region of first left atrial activation and
to personalize the atrial simulations accordingly (Sec. 9.1.1).
3. Anisotropic Atria Models
The largest cohort of models was comprised of models 1–11 and 13–19 and rep-
resented all patient-specific human atrial geometries. The cohort was used to eval-
uate the fiber orientation algorithm (Sec. 5.4) and the algorithm to create generic
ablation lesion patterns (Sec. 5.5).
7.3.2 Discussion
Using the segmentation and post-processing techniques presented in this chapter,
more than twenty models of human atria and eight models of patient and volunteer
thoraxes were created. The models were grouped into three model cohorts for the
further utilization in different studies. A number of the models were also supplied
to collaboration partners and used for different applications.
Atlases and statistical models play an increasing role in cardiac modeling [392].
Atlases are generated from image data of various sources, and are used to deter-
mine representations of the mean organ anatomy [393]. They can also be used
to investigate the variability of anatomical structures, e.g. local fiber orienta-
tion [329]. Data for cardiac atlases can be acquired in the clinic, or directly be ac-
cessed from web-based databases, e.g the Cardiac Atlas Project (CAP) [394]. The
anatomical databases usually provide quick access to a large number of annotated
data. The model cohorts presented here were used to rule out geometry-specific
effects in the outcome of multi-model simulation studies.
Publicly accessible datasets can enable the verification of modeling and simula-
tion workflows using reference datasets [395]. Similarly, reference models can be
used to cross-validate numerical methods [396]. For such purposes, an Anatomi-
cal Model Database (AMDB) [368] was set up as part of the euHeart and Virtual
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Physiological Human projects. The anisotropic atrial model 18 was made publicly
available on the AMDB.
Statistical shape models are currently widely used for image segmentation. In the
future, they might also support clinical therapy planning and medical training.
The present results helped to augment the statistical shape models with anatomical
features relevant for electrophysiological simulations. The augmented models may
in the future provide more confidence in the direct clinical use and medical training
if combined with methods for the fast simulation of the atrial excitation.
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Fig. 7.7. MRI, segmentation and 3D models of subject 1 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
Fig. 7.8. MRI, segmentation and 3D models of subject 2 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
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Fig. 7.9. MRI, segmentation and 3D models of subject 3 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
Fig. 7.10. MRI, segmentation and 3D models of subject 4 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
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Fig. 7.11. MRI, segmentation and 3D models of subject 5 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
Fig. 7.12. MRI, segmentation and 3D models of subject 6 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
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Fig. 7.13. MRI, segmentation and 3D models of subject 7 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
Fig. 7.14. MRI, segmentation and 3D models of subject 8 (Tab. 4.1). Circles mark electrodes used for
standard ECG. Arrows point at standard ECC electrodes on the left side and the back.
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Fig. 7.15. Posterior view of atria models 1–9 augmented with fiber architecture (Tab. 4.1).
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Fig. 7.16. Posterior view of atria models 10–19 augmented with fiber architecture (Tab. 4.1).
8Personalization of the Cellular Electrophysiology
In this section methods for the patient-group and patient-specific personalization
of models of the atrial electrophysiology are presented.
8.1 Patient-Group Models
Measuring cellular electrophysiological properties in-vivo is not yet feasible due
to technical, health and ethical constraints. The adaptation therefore focused on the
personalization of the electrophysiological models by choosing the most suitable
existing electrophysiological model for each patient. This patient-group specific
personalization is commonly done using models of AF-remodeled electrophysi-
ology for AF patients. This was also done in the course of this work (subjects
8 – 11, Tab. 4.1). In a next step, this personalization process could be refined
by choosing the appropriate model for the stage of AF (paroxysmal, persistent,
long term persistent, permanent). Regional adaptations could also cover the use
of different electrophysiological models with one patient geometry. E.g. a model
for the electrophysiology of fibroblasts [236, 294, 397] could be used for fibrotic
regions extracted from LGE-MRI (Sec. 7.1.1). The patient-group personalization
approach relies on the diagnosis of the patient’s disease and thus on the expertise
of the clinician.
8.2 Patient-Specific Adaptations
A patient-specific adaptation of the electrophysiological model was achieved by
setting the extracellular ion concentration parameters of the CRN model to mea-
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Fig. 8.1. Influence of altered extracellular ion concentrations to patient blood electrolyte concentrations.
Red: CRN model, blue: patient 8, green: patient 9, dashed: AF-remodeling. Figure adapted from [225].
sured values of blood electrolyte concentrations of the same patient [225]. Changes
in the concentration of electrolytes in the blood will wash in/out into the extracellu-
lar space of the cardiomyocytes [398, 399] and thus such personalization becomes
feasible. For subjects 8 and 9 (Tab. 4.1), blood electrolyte concentrations were
measured (Tab. 8.1). The CRN model was augmented to be able to also reproduce
the effects of altered extracellular potassium concentrations (Sec. 5.1.1) and sub-
sequently, patient-specific CRN models of the electrophysiology of AF patients 8
and 9 were created.
Figure 8.1 shows the impact of the altered extracellular ion concentrations on the
regular CRN model and the AF-remodeled CRN model for both patients. In all
configurations, the resting membrane potential was reduced by the electrolyte al-
terations and the conduction velocity was slowed [225]. Similar effects were ob-
served in patients undergoing hemodialysis therapy to compensate for lost renal
function (Sec. 15) [399]. Table 8.2 provides results from a quantitative analysis
of the changes in action potential morphology in the healthy CRN model in four
atrial regions described in [92]. The decrease in upstroke velocity dVm/dt was
the cause for the reduced conduction velocity observed in the tissue simulations
(Fig. 8.1(b)).
A further patient-specific adaptation of the model was performed by adjusting the
basic cycle length (BCL) in the simulations to the patient’s heart rate. The heart
rates were extracted either from BSPM measurements or from ECGs recorded
from the electroanatomical mapping systems (Tab. 4.1).
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Table 8.1. Values for extracellular / blood substance concentrations in the CRN model and AF patients 8
and 9. Creatinine and urea measurements were not used for the model personalization and are provided
only for completeness. CRN values from [72].
[K+]o [Na+]o creatinine urea
mmol/L mmol/L mmol/L mmol/L
CRN model 5.4 140 – –
subject 8 4.0 141 108 –
subject 9 4.1 137 66 6.9
8.3 Discussion
In this chapter methods for the adjustment of the general model of atrial electro-
physiology to the patient and the patient’s disease were introduced. The impact of
AF-remodeling outruled the effects of changes in extracellular ion concentrations
on the action potential morphology and thus on APD and ERP in two AF patients.
Nevertheless, the alterations in extracellular ion concentrations significantly re-
duced the excitation conduction velocity in the personalized models, caused by
the decrease in [K+]o (Sec. 15). For the conduction velocity, the effects of AF
remodeling and hypokalemia augmented each other and may provide a better sub-
strate for the initiation and maintenance of AF, as conduction velocity, APD and
ERP were reduced.
Electrical remodeling due to persistent AF [73] has a significant effect on the APD,
ERP and conduction velocity (Fig. 8.1, Sec. 5.2.2). The changes in electrophys-
iology in patients with paroxysmal AF will most certainly be less pronounced.
As the cellular experimental database is sparse with respect to paroxysmal AF,
the persistent AF-remodeled CRN model was used in this work to personalize the
electrophysiological model to all AF patients, neglecting the stage of disease pro-
gression. As soon as more data become available, further parameter sets or new
models for paroxysmal or permanent AF may allow for a personalization to the
stage of the disease (patient subgroup).
The personalization of the model to the measured blood electrolyte concentrations
poses a simple way for a patient-specific model adaptation, as blood samples are
regularly analyzed in clinical environments. Attention should be paid to a sam-
pling shortly before or after the situation which should be simulated, as electrolyte
concentrations may show short-term variations.
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Table 8.2. Impact of patient’s extracellular ion concentration on the CRN model for four right atrial re-
gions [92]. amp: amplitude.
region DdVm/dt DAPD90 Dpeak Damp
V/s ms mV mV
CAM -4.40 4.35 -1.23 6.03
CT -3.70 1.02 -1.09 6.13
AVR -5.00 -7.54 -1.36 5.94
APG -4.40 1.33 -1.21 6.03
The effects on the action potential and tissue properties were minimal, as all sim-
ulations were performed in sinus rhythm. At BCLs of sinus rhythm, the restitution
slopes of the tissue properties are flat (Fig. 8.1, Sec. 5.2.2) and therefore the model
behavior does not significantly change.
In the future, the adaptation of electrophysiological models could base on the
adaptation of model parameters and channel kinetics to a-priori knowledge of the
patient. Known genetic mutations in patients could be recreated in-vitro and the
experimental findings could be used to investigate consequences of the genetic
mutation on the atrial electrophysiology [400–402]. The presented methods pose
the first steps towards the creation of such patient-specific electrophysiological
models. Further experience with the electrophysiological model personalization
will speed up the engineering of new personalization methods in the future.
9Personalization of the Excitation Propagation
The atrial excitation propagation results from the atrial anatomy as well as global
and local electrical tissue properties (Fig. 6.1). Therefore, model personalization
must consider these properties. In this chapter, two methods for the personalization
of the sinus rhythm simulations in patient-specific atrial models are presented and
evaluated. First, a method to personalize the inter-atrial conduction routes from
intracardiac LAT maps and BSPM measurements is described. Second, a method
to adjust the monodomain tissue conductivity to fit the sinus rhythm simulation
to the measured P-wave duration is presented. The methods complemented each
other and were combined in a workflow for the personalization of the excitation
propagation in patient-specific atrial models (Fig. 9.1). The workflow produces a
patient-specific atrial excitation model and can provide a model-based prediction
of the LAT and conduction velocity direction and magnitude.
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Fig. 9.1.Workflow for patient-specific simulation of the atrial sinus rhythm and ECG / BSPM.
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Fig. 9.2. Expected points of early left atrial activation. 1: Short Bachmann bundle. 2: Long Bachmann
bundle. 3: Limbus of fossa ovalis. 4: Low anterior bridge. 5: High anterior bridge. 6: High posterior bridge.
7: Musculature of the coronary sinus.
9.1 Personalization of Interatrial Conduction Routes
The human atria are electrically isolated by the interatrial septum (Sec. 2.1.1.1).
Various muscular bridges cross the septum and provide electrical connections be-
tween the atria. The most common bridges are semi-automatically introduced into
the geometrical atria models along with the semi-automatic placement of atrial
fiber orientation (Sec. 5.4). Bachmann’s bundle is the most prominent interatrial
connection. In contrast to the other bridges, it extends into the right atrium and LA,
has well aligned fiber orientation and allows a fast excitation conduction. With the
fiber-placement method, Bachmann’s bundle, a low anterior bridge, two posterior
bridges and a bridge connecting the ostium of the coronary sinus to the LA were
modeled. Bachmann’s bundle was thereby electrically isolated from the LA in
about one fifth of its extent into the LA. In the simulations with these models, the
first LA activation usually occurred over BB.
9.1.1 Personalization Based on Local Activation Time Maps
Intracardially recorded LATmaps from the left atrium (Sec. 2.4.2) provide insights
into the LA activation sequence of the individual patient. The creation process of
LAT maps usually lasts several minutes and involves input from the clinician. The
data quality is therefore variable, making an automatic analysis of these maps
not usable at this point. In the course of this thesis, a manual approach for the
personalization of the interatrial conduction was developed.
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Table 9.1. Sites of early left atrial activation observed in the LAT maps and altered interatrial bridges.
Subject numbers correspond to patients in Tab. 4.1 and models in Tab. 7.1. Site numbers correspond to
Fig. 9.2.
subject early LA activation BB (CV) FO low anterior high anterior posterior CS
1 / 2 3 4 5 6 7
8 site 2, site 7 long (-50%) no yes no yes yes
9 size 3, site 6 no (–) yes yes no yes yes
10 site 1 / site 5 short ( –) no yes yes yes yes
11 site 1, site 3, site 4 short (-50%) yes yes no yes yes
Personalization Approach
First, the user analysed the LAT map of a patient visually. Based on this anal-
ysis, the user determined which bridges from the semi-automatic segmentation
approach should be included and which should be removed for the simulation.
Additionally, the length and the conduction velocity of BB could be varied. The
anaylsis of the LAT map was guided by the scheme shown in Figure 9.2. The
scheme shows seven locations for left atrial activation, which correspond to the
locations of the interatrial bridges. The user needs to determine in which of these
locations a left atrial activation was to be seen in the measured LAT map. The
corresponding bridges were set for the subsequent simulation, whereas all other
bridges were removed from the model.
If an inferior location and a BB location in the measured LAT map yielded an
activation, the conduction velocity in BB was reduced by -50%. This needed to be
done, as a fast conduction via BB will activate the left atrium so fast, that a further
inferior wavefront from the right atrium may not enter the left atrium, because the
left atrium is acitvated in the corresponding region already.
Personalization Results
The described course of actions was applied to four AF patient datasets (8–11,
Tab. 4.1, Tab. 7.1). The results of the LAT map analysis are listed in Table 9.1.
Simulation Results
Two simulations were performed for models 8 – 11. One simulation was conducted
with the standard configuration of interatrial bridges. A subsequent simulation was
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Fig. 9.3. a) Simulated and measured LATs in the left atrium of subject 8. Green stars indicate sites of early
activation in the simulations. Encircled numbers correspond to sites of early activation in the measured
LAT maps (Fig. 9.2). Arrows indicate major direction of propagation. Dotted lines mark the collision of
two wavefronts. b) Integrated BSPMs over the P-wave for an initial simulation with interatrial conduction
via BB and a simulation which had been adjusted to the earliest LA activation near the region of the FO.
On the right side the measured integrated BSPM is shown. BSPMs were generated by interpolation of the
integrated simulated or measured signals in the electrodes onto the body surface.
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conducted after adapting interatrial bridges specifically to each patient (Tab. 9.1).
Figures 9.3 – 9.6 show the simulated and measured LAT in the left atrium of the
patients. Complete activation time span cannot be determined accurately from the
LAT maps, as measurement errors at PVs and MV obscure the precise determina-
tion of the latest activation. Scale extremes were set for each simulation / measure-
ment such that the colors at sites of early activation and colors at late activation
near the LPVs correspond between the setups.
Simulations with the standard bridge configuration showed an early activation at
the left anterior side of the LA. Two wave fronts activated the posterior wall of
the LA. One wavefront came from the LA roof and the other from the right in-
ferior. The wavefronts merged in the low posterior LA wall. The latest region to
depolarize lay left inferior of the ostium of the LIPV.
In subject 8, the measured LAT map showed two sites of early activation depolar-
izing the anterior LA (sites 2, Fig. 9.3 middle row). Another wavefront arose from
the region of the low posterior septum (site 7, Fig. 9.3 middle row). The activa-
tion from site 2 (BB) was faster and did not allow a wide spread of the wavefront
arising from site 7. The posterior side showed three wavefronts (a, b, c, Fig. 9.3
middle row right). Wavefronts a and b merged between the RSPV and the low left
posterior LA (dashed line, Fig. 9.3(a) middle row). In the simulation with adapted
bridges, the LA was activated early at one site centered on the anterior LA. As
in the measurements, another wavefront swapped over the anterior LA from the
inferior septum (CS musculature). Three wavefronts activated the posterior LA.
Two of these merged between the RIPV and the region inferior to the LIPV.
For subject 8 the simulated transmembrane voltages were forward calculated to
retrieve BSPMs for both simulations. Figure 9.3(b) shows the simulated and mea-
sured time integrated BSPMs in this subject. The adjustment of the interatrial
bridges to the LAT map of the patient led to an upward shift of the isopotential
line. Additionally, the line was bent at the center of the thorax front in contrast to
the standard simulation. The BSPM of the adjusted simulation showed a better cor-
respondence to the measured BSPM pattern (RMSE adjusted bridges: 0.028mVs
vs. regular bridges: 0.040mVs).
In the measured LAT map of subject 9, first LA activation occurred inferior of
the RSPV at two adjacent sites (site 3 and site 6, Fig. 9.4 middle row). Three
wavefronts activated the posterior LA from the LA roof, the right PVs and the
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Fig. 9.4. Simulated and measured LATs in the left atrium of subject 9. Green stars indicate sites of early
activation in the simulations. Encircled numbers correspond to sites of early activation in the measured
LAT maps (Fig. 9.2). Arrows indicate major direction of propagation. Dotted lines mark the collision of
two wavefronts.
right inferior LA (a, b, c, Fig. 9.4 middle row right). The wavefronts collided left
of the RSPV and left of the RIPV. The latest activation was measured on a line
connecting the MV and the left PVs. The simulation with the adjusted interatrial
bridges recreated the sites of early LA activation (green stars, Fig. 9.4 bottom
row). Additionally, the adjusted simulation showed three activation wavefronts on
the posterior side and a similar line of latest activation as in the measurements
(Fig. 9.4 bottom row).
In the measured LAT map of subject 10, the LA was activated early right inferior
of the RSPV with a fast activation of the high septal region (site 1, Fig. 9.5 middle
row). The LAT map showed a number of artifacts on the posterior LA (areas of
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Fig. 9.5. Simulated and measured LATs in the left atrium of subject 10. Green stars indicate sites of early
activation in the simulations. Encircled numbers correspond to sites of early activation in the measured
LAT maps (Fig. 9.2). Arrows indicate major direction of propagation. Dotted lines mark the collision of
two wavefronts.
early activation in the free wall) (red regions, Fig. 9.5 middle row right). Never-
theless, three wavefronts could be observed which activated the posterior LA (a,
b, c, Fig. 9.5 middle row right). All wavefronts ran towards the left and left in-
ferior LA. In the adjusted simulation, an early activation of the high septum was
achieved over two superior anterior bridges (green stars, Fig. 9.5 bottom row). Two
early and one later wavefront activated the posterior LA towards the left and the
left inferior region similar to the activation pattern observed in the measurement
(Fig 9.5 bottom row).
In subject 11, the measured LAT map showed four sites near the atrial septum
activating a large area of the anterior LA nearly simultaneously (sites 1, 3, 4,
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Fig. 9.6. Simulated and measured LATs in the left atrium of subject 11. Green stars indicate sites of early
activation in the simulations. Encircled numbers correspond to sites of early activation in the measured
LAT maps (Fig. 9.2). Arrows indicate major direction of propagation. Dotted lines mark the collision of
two wavefronts.
Fig. 9.6 middle row). Two major wavefronts were observed on the posterior LA
(a, b, Fig. 9.6 middle row right). These merged on a line between the LIPV and
the RIPV. Wavefront a progressed towards the left inferior LA. Wavefront b acti-
vated the inferior LA from the right to the left side. In the adjusted simulation, the
introduction of the fossa ovalis bridge and slowing of conduction along BB, led
to simulated isochrones comparable to the measured activation sequence (Fig. 9.6,
bottom row).
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Fig. 9.7. a) P-wave morphologies identified by Holmqvist et al. for different interatrial conduction
routes [33, 117, 403]. b) P-wave morphologies of simulated VCG signals under different interatrial con-
duction routes and P-wave morphologies of simulated Einthoven ECG signals. Black curves represent the
mean of the simulated signals. The site numbers correspond to Figure 9.2.
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Fig. 9.8. Proposed differentiation method based on VCG and Einhoven ECG leads.
9.1.2 Impact of Interatrial Conduction on the ECG & VCG
The manual adjustment of the interatrial connections in the previous section led
to an altered left atrial depolarization sequence. This also caused a variation in the
computed BSPM pattern, as was to be expected. Holmqvist et al. investigated the
morphology of the P-wave in the three VCG leads in patients with different inter-
atrial conduction routes [33, 117, 403]. They distinguished between three types of
preferential interatrial conduction. Type 1 was LA activation in the region of the
fossa ovalis. Type 2 was activation via Bachmann’s bundle and type 3 was activa-
tion via the coronary sinus. Figure 9.7(a) shows the typical P-wave morphologies
in the three VCG leads. Lead X does not change between the types.
In this section, an extended method to distinguish interatrial conduction from ECG
signals is presented. Two approaches were taken. First, sinus rhythm with differ-
ent interatrial conduction pathways was simulated in eight models (model 8–11,
Sec. 7.3.1) to gain a better understanding of the relationship between interatrial
conduction and the P-wave morphology and to test the hypothesis of Holmqvist
et al.. Second, an extended method to distinguish the interatrial conduction route
from the ECG was extracted from the simulation results and applied to the simu-
lations and measured ECGs.
For the simulations, the fast-marching simulation approach introduced in Sec-
tion 5.7 was used. The time of complete atrial depolarization was normalized to
100ms for an easier comparison of the ECG signals afterwards. The results from
the sinus rhythm simulations were forward calculated to retrieve ECG signals and
BSPMs. BB was set to be electrically isolated from the LA in 60% of its LA ex-
tent, instead of regularly 20%, to pronounce the effect of different LA activation
locations. VCG signals were calculated from the standard 12 lead using the inverse
Dower method (Sec. 2.4.1.1).
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Table 9.2. Analysis of the simulation results. Grey shaded cell indicate correctly identified simulated inter-
atrial conduction.
Holmqvist et al. proposed
BB FO CS not clear BB FO CS not clear
simulated BB 7 0 1 0 7 1 0 0
simulated FO 3 0 5 0 2 5 0 1
simulated CS 0 0 7 1 0 0 8 0
Figure 9.7(b) shows the simulated VCG and Einthoven ECG signals for the eight
models and the averaged signal for each lead. The VCG signals of the Bachmann’s
bundle connection confirmed the findings from Holmqvist et al.. For conduction
via fossa ovalis, the simulated VCG signals were biphasic, whereas the proposed
scheme showed only monophasic signals (Fig. 9.7(b)). These correspond to the
first half of the simulated VCG signals. For conduction via the coronary sinus
musculature, leads Y and Z in the simulations and scheme correspond well, but
lead X showed low amplitudes and a multiphasic signal, from which the overall
shape was difficult to generalize. Einthoven ECG signals showed less variation
between the eight simulations than VCG signals did. Einthoven signals from fossa
ovalis and Bachmann bundle conduction could not be distinguished (all signals
monophasic positive in all leads), but conduction via the coronary sinus showed
significantly different signals in all leads (biphasic vs. monophasic) (Fig. 9.7(b)).
Based on the averaged simulation results, a method to differentiate between the
three major interatrial conduction routes was developed (Fig. 9.8). Einthoven
ECG and VCG signals which showed a great inter-model variance (e.g. lead X),
were not taken into consideration for the differentiation method. In the proposed
method, signals are distinguished as either being positive, but not necessarily hav-
ing only one maximum, or as having positive and negative signals parts.
The differentiation method was applied on the simulated ECG / VCG signals
(Tab. 9.2). The proposed method showed better results than the method proposed
by Holmqvist et al., especially with respect to FO conduction (Tab. 9.2). With both
methods, conduction via CS could be clearly identified. The method proposed by
Holmqvist et al. could not predict FO conduction correctly in any cases, whereas
the proposed method detected this in 5 of 8 simulations correctly. Conduction via
BB was correctly identified with both methods in 7 of 8 simulations.
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9.1.3 Discussion
In this section two methods to personalize interatrial conduction pathways from
LAT maps and ECG data were presented. Manual adjustment of the rule-based
interatrial bridges led to a better match of the simulated to the measured left atrial
activation sequence in four AF patients. The data indicated that the interatrial con-
duction is highly variable between individuals. The simulation results highlight the
importance to incorporate an isolating layer in the interatrial septum in the models,
to allow for distinct interatrial activation breakthroughs.
LAT maps were created by manually selecting the time of local activation in
catheter signals. Such approach is prone to user caused errors. In all LAT maps,
such errors in terms of very late and very early activation times were found. Such
area can be identified, as they show not gradual increase in activation time into
the surrounding tissue and thus no wave propagation. These errors need to the
removed prior to an adaptation of the interatrial conduction in the model to the
measurement data. Similarly, in the area of the atrial septum, the far field from
right atrial activation might be interpreted as left atrial excitation sequence. Spe-
cial caution needs to be taken during the LAT recording process to avoid such
misinterpretation. For future studies an automatic detection of LATs is desirable
to avoid such errors from the beginning. This would also enable an automatic de-
tection of sites of early activation and thus an automatic model personalization.
So far only locations of early left atrial activation were extracted from LAT map
data. In a next step also regions of slow conduction or conduction block could be
identified from the data and the model could be adapted accordingly. The mean left
atrial conduction velocity determined from the LAT measurements could be used
to tune the left atrial conduction velocity in the models prior to the personaliza-
tion of the global conduction velocity to the models (Sec. 9.2). This could provide
a more precise match of the simulations and measurements. Technical advances
of the EAMS allow for a registration of MRI morphology data to the catheter
measurements. This needs to be done prior to data recording to avoid misregis-
tration afterwards. LAT maps based on MRI morphology data will have a more
precise geometry and will thus provide more reliable conduction velocity data.
Additionally, a quantitative comparison between locally simulated and measured
activation times as well as a direct adaptation of local conduction velocity will be
possible. A combination of LAT recording and a pacing protocol covering mul-
9.1. PERSONALIZATION OF INTERATRIAL CONDUCTION ROUTES 177
tiple cycle length could also provide information about local conduction velocity
restitution [84], which could be directly incorporated into the model [223].
Using a cohort of eight atria and thorax models it was possible to investigate the
influence of the three major interatrial connections (BB, FO, CS) on the ECG.
Previous studies proposed a diagnosis of interatrial conduction based on VCG sig-
nals [33, 117, 403]. These studies showed only moderate sensitivity and specificity.
The simulated ECG and VCG signals indicated different typical VCG patterns for
the interatrial conduction via fossa ovalis. The VCG, although calculated from the
ECG signals and thus not containing more information than these, seems to reveal
important information about the interatrial conduction. The proposed differentia-
tion method based on VCG signals was enhanced to use signals from VCG lead
and ECG leads. This combination of signals yielded a clearer differentiation be-
tween the types of interatrial conduction. In a future study, the proposed differen-
tiation method could be applied to measured ECG signals from patients, in whom
the interatrial conduction pathways are known, to clinically validate the method-
ology.
The use of a cohort of anatomical models could rule out anatomy-specific effects in
the simulated ECG signals. The approach additionally provides information about
the variance of simulated ECG signals under the different conditions and may
thus provide a measure of confidence of the averaged signals. The limb ECG leads
showed a smaller variance in signals compared to the simulated VCG signals. This
was most likely caused by a variance in ECG electrode positions between models
(Fig. 7.7 – 7.14). Although limb lead positions also show a variance, the signals
in the area further away from the cardiac electrical sources show less variation
and thus the variance in electrode positions does not cause great variance in the
signals.
The measured LAT maps indicate a combination of interatrial conduction routes
rather than having only a single left atrial breakthrough site. This will cause a
distortion of the ECG / VCG signals. Nevertheless, the study from Holmqvist et
al. indicates a dominance of the preferential conduction routes in the ECG sig-
nals. Future simulation studies could investigate the ECG signals of simultaneous
conduction over multiple bridges using the presented simulation framework.
The fast-marching simulation approach allowed a high throughput of simulations
in a cohort of eight models. This procedure ruled-out results specific to an indi-
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vidual anatomy, which could lead to misinterpretation of the results. In the future,
the influence of the conduction velocity of BB or the influence of a variation in
sinus node location on the ECG could be investigated similarly to gain a further
in-depth understanding of the atrial excitation sequence and P-wave morphology.
Both proposed methods to personalize interatrial conduction routes could be cou-
pled to the automatic segmentation of the atria from MRI data (Sec. 7.1). Thereby,
the location of myocardial structures not visible in clinical images data such as
fast conducting bundles and interatrial conduction pathways could be retrieved
from LAT data. These could subsequently be used to adjust the location of these
structures in the anatomical segmentation model [60] for the individual patient.
9.2 Personalization of the Global Conduction Velocity
The adaptation of the conduction velocity in simulations using the bidomain or
monodomain model for the excitation spread cannot be performed straight for-
ward (Sec. 5.6). The local conduction velocity in such simulations depends on the
local tissue conductivity, fiber orientation, model geometry, wavefront curvature
and wavefront incidence angle. In this section, a two step approach is presented
to personalize the global monodomain conductivity in sinus rhythm simulations
on patient-specific geometries. First an initial simulation with literature values for
the conductivity is performed. Then a correction formulation is applied to the con-
ductivity to receive the patient-specific global conductivity for the sinus rhythm
simulation. Figure 9.9 depicts the workflow. In the end of the section, the results
of the personalization of the global conduction velocity are shown and resulting
ECG and BSPM signals are compared to the measurements.
Formulation for Tissue Conductivity Adjustment
The monodomain tissue conductivity can be described by a quadratic function of
the simulated excitation conduction velocity [351, 352]:
s = a ·CV 2+b ·CV + c. (9.1)
Figure 5.30 provides an example of this relationship. If two simulations with dif-
ferent conductivities are performed, a relation between the simulated conduction
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Fig. 9.9.Workflow to determine the patient-specific tissue conductivity.
velocities can be formed by
s2
s1
=
a ·CV 22 +b ·CV1+ c
a ·CV 21 +b ·CV1+ c
. (9.2)
Let simulation 1 be an initial simulation with literature values for the conductiv-
ity sinit and conduction velocity CVinit . For a second simulation, the conductivity
should be adjusted such that another, e.g. measured, conduction velocityCVmeas is
reproduced by the simulation. For the second simulation, the value of the unknown
conductivity sadapt is required. As the quadratic term in equation 9.1 dominates
the others [351] (Sec. 5.6), equation 9.2 can be reduced and approximated to a
relationship of the conductivities to the square of the conduction velocities.
sadapt
sinit
=
a ·CV 2meas+O(CVmeas)
a ·CV 2init +O(CVinit)
sadapt
sinit
⇡ CV
2
meas
CV 2sim,init
(9.3)
The conduction velocity can be rewritten as the ratio of the longest possible path
in the model s and the time for complete atrial depolarization TcAD. In the case of
the initial simulation, the latter is the time TcAD,init where the last model element
depolarizes. For the measured conduction velocity, this corresponds to the P-wave
duration PWd.
sadapt
sinit
⇡
  s
PWd
 2⇣
s
TcAD,init
⌘2 (9.4)
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Fig. 9.10. a) Measured PWd and simulated TcAD in subjects 1–8. b) Absolute difference between measured
and simulated time of complete atrial depolarization. Adjustment of the conductivity using equation 9.5
led to a precise match of PWd. Outliers are the two simulations with greatest offset to the measured PWd
in the initial simulations.
As the size of the atrial model corresponds to the size of the atria of the patient
from whom the ECG was taken, the equation can be reduced and rearranged to
receive a formula for the adapted tissue conductivity
sadapt ⇡ sinit⇥
✓
TcAD,init
PWd
◆2
. (9.5)
This approach to adapt the monodomain tissue conductivity does not influence the
anisotropy ratio between the longitudinal and transversal conductivity, as both are
scaled by the same factor.
Simulations with Personalized Global Conduction Velocity
The formula was applied in sinus rhythm simulations using eleven patient mod-
els (model 1–11, Tab. 7.1) and the respective ECG measurements. The measured
and simulated PWds are summarized in Fig. 9.10. A precise match of the time of
complete atrial depolarization to the PWd was achieved with a single adaptation
step. The mean absolute difference between the simulated and measured PWd was
2.8ms.
Comparison of Simulated and Measured ECG Signals
The method presented in this section aimed at adapting the global conduction ve-
locity to fit the simulated and measured PWd, and not the P-wave morphology. It
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Fig. 9.11.Measured and simulated time-integrated BSPM during the P-wave.
is nevertheless interesting to see a comparison of these. Figures 9.11 shows the
measured and simulated integral BSPMs for subjects 1 – 8. Figures 9.12 and 9.13
show a comparison of the simulated and measured ECG signals. The length of
the signals are the same, as this was the aim of the personalization process. The
BSPMs corresponded well overall (RMSE 0.267± 0.097mVs). A precise match
of BSPM patterns was not achieved. The mean of the median correlation coeffi-
cients between the personalized simulated ECG signals and the measured signals
was 0.577± 0.206. The polarity and phase of the limb lead ECG signals were re-
produced in the majority of the cases, whereas VCG signals showed a stronger
deviation from the measurements.
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Fig. 9.12. Measured (red) and simulated (blue) P-wave signals in various ECG leads. X-axis limits corre-
spond to the individual P-wave duration, which was matched before (Tab. 4.1). Y-axis is the ECG signal in
mV. Figures continues in Fig. 9.13.
9.2.1 Discussion
In this section a fast method to adjust the global conduction velocity in patient-
specific anatomical models to the measured PWd was presented. The approach
only required one additional simulation prior to the personalized simulation. Lit-
erature values for the tissue conductivity were adjusted using a quadratic term
derived from the relationship between monodomain tissue conductivity and con-
duction velocity. In simulations in which the conductivity adjustment factor was
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Fig. 9.13. Continuation of Figure 9.12.
considerably large, the time increment of the Euler scheme needed to be adjusted
to allow for numerical stability of the model (e.g. 10µs instead of 20µs). This
prolonged the duration of the simulation.
Heterogeneous conduction velocities in the models were adjusted by the same
factor. The atria contain different fast conducting bundles and slow conducting
zones. It is not clear whether these structures show the similar inter-individual
variation of conduction velocity as regular left and right atrial myocardium [84].
Nevertheless, the adjustment of all model conduction velocities in the same way
led to a precise match of the simulated and measured P-wave duration. Adaptation
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of regional variations in conduction velocity, e.g. based on LAT maps (Sec. 9.1.1)
could further provide a better match of integral BSPMs and ECG signals. Similar
approaches have been presented recently based on signals recorded with circular
mapping catheters [223].
The correlation coefficients of the simulated and measured ECG signals were
rather low. This was caused by electrode signals near the isopotential line of the
BSPM. Slight variations of the isopotential line inverted the polarity of signals
in adjacent electrodes and led to negative correlation coefficients, although the
general pattern and ECG limb lead signals looked well. To minimize this artifact,
the median correlation coefficient (CC) of all ECG channels for each patient was
determined instead of the mean CC.
The use of a cohort of model and patient datasets allowed a validation of the gen-
eral methodology and enabled a simple statistical analysis of the variation of the
results of the method under different prerequisites. Using singular anatomies al-
ways bears the potential of anatomy-specific errors, which cannot be identified
from within the system. Such errors could be ruled out in the mean solution as
a cohort of models was used. In the future, the cohort with adapted conduction
velocities may provide a useful tool for the investigation of pathological and ther-
apeutical impacts on the atrial excitation sequence. Similar approaches become
more common in the Physiome environment, e.g. for the cross-validation of sim-
ulation environments [396]. An initial use of the model cohort is presented in
Chapter 10.
To the knowledge of the author, the present study is first to quantitatively compare
simulated and measured ECG signals from the same individuals. Previous studies
may have shown better correspondence of measured and simulated signals [230],
but in these studies the atria model, the thorax model and the ECG data were de-
rived from three different individuals. The predictive power of such adapted sim-
ulations is therefore limited. In the future, the adjusted global conduction velocity
could be used as an initial estimate for ECG imaging (ECGI) methods [287]. Addi-
tionally, ECGI could provide information about atrial conduction pathways which
could be fed into the model personalization process. Analysis of the atrial activa-
tion sequence derived from the adjusted models can provide non-invasive insights
into the patient’s conduction velocity. These results are shown and discussed in the
next Section.
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Fig. 9.14. Time of first and final activation of the left and right atrium in eleven models with personalized
global conduction velocity.
9.3 Analysis of Conduction Velocity in Personalized Simulations
Simulations with personalized global conduction velocity allowed an insight into
the bi-atrial depolarization sequence of the individual patient without the need of
invasive measurements. In this section, local conduction velocities in personal-
ized simulations and respective measured LAT maps are analyzed and compared.
Local conduction velocity was calculated from the LATs generated from the PWd-
adapted simulations for subjects 1–7 and from adapted simulations and measured
left atrial LATs in subjects 8–11. Conduction velocity was calculated as described
in Section 4.4.
Analysis of Simulated Local Activation Times
In average, LA activation started 19.9±5.5ms after the sinus node impulse. Right
atrial activation was completed after 101.7±33.0ms. LA activation was completed
88.5±17.0ms after first LA activation respectively 108.4±21.0ms after the sinus
node impulse. Figure 9.14 shows box plots of the distributions of the first and final
activation of both atria in the 11 models.
Analysis of Simulated Conduction Velocity
Conduction velocities simulated with standard values for the tissue conductivity
varied between 0.60m/s and 0.79m/s. The adjusted conduction velocity showed
a greater range between 0.56m/s and 0.98m/s. Table 9.3 summarizes the conduc-
tion velocities in the 11 models. Conduction velocities in the adjusted simulations
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Table 9.3.Mean conduction velocities in the models of eleven individuals (data from right and left atrium).
Boxplots of the conduction velocity distribution in each adjusted simulation are shown in Fig. 9.15.
Subject CVinit CVad justed
m/s m/s
1 0.67± 0.15 0.62± 0.14
2 0.69± 0.17 0.86± 0.21
3 0.76± 0.16 0.82± 0.17
4 0.63± 0.12 0.70± 0.14
5 0.79± 0.15 0.64± 0.12
6 0.63± 0.16 0.61± 0.15
7 0.78± 0.16 0.89± 0.18
8 0.60± 0.12 0.56± 0.11
9 0.58± 0.12 0.98± 0.19
10 0.67± 0.13 0.80± 0.16
11 0.66± 0.13 0.69± 0.14
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Fig. 9.15. Estimated conduction velocities in the models of eleven individuals. The global conduction
velocity was adapted such that the measured PWd was met by the simulation. Mean conduction velocity
values are listed in Tab. 9.3.
showed a significant variance. Figure 9.15 provides box-plots of this intra-model
variation of conduction velocity. The conduction velocity magnitudes were dis-
tributed Gaussian like around the mean conduction velocity in the simulations.
Comparison of Measured and Simulated Conduction Velocity
For subjects 8–11, also the conduction velocities in the LAT maps (Sec. 9.1.1)
were analyzed. Conduction velocities showed a great variance within each LAT
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Table 9.4. Simulated and measured conduction velocities in the left atrium of four AF patients. Boxplots
of the conduction velocity distribution are shown in Fig. 9.17.
Subject CVLA,ad justed CVLA,meas
m/s m/s
8 0.52± 0.11 0.78± 0.46
9 0.97± 0.20 0.77± 0.50
10 0.82± 0.16 0.64± 0.45
11 0.70± 0.13 0.84± 0.51
map (Fig. 9.16). The mean values of the conduction velocity determined from the
activation times are listed in Table 9.4. Histogram plots of the conduction veloc-
ity magnitude revealed a single sided exponential distribution for the measured
conduction velocities. The mean measured conduction velocities correspond only
to a limited extent to the mean simulated conduction velocities, which showed
a Gaussian distribution. Nevertheless, mean simulated conduction velocities lay
within one standard deviation of the measured mean conduction velocities. Box-
plots of the measured and simulated conduction velocities highlight the great vari-
ance of the measured conduction velocities (Fig 9.17). Simulated and measured
conduction velocities in subject 11 fit well, whereas median simulated conduction
velocities in the other subjects only lay within the 25th to 75th percentiles of the
measured conduction velocities.
9.3.1 Discussion
In this section, LATs and local conduction velocities from eleven models and re-
spective measurements were analyzed. This revealed some interesting findings.
First, conduction velocity in simulations with literature values for the tissue con-
ductivity fit into the range of measured atrial conduction velocities (Tab. 2.2). This
shows, that for atrial models, for which no ECG data is available, the literature
values for the tissue conductivity provide a good estimate of the atrial conduc-
tion velocity. Subjects 8 and 9 showed the lowest mean conduction velocity in the
literature value simulations. In these subjects, the CRN model was adjusted to re-
flect electrical persistent-AF remodeling and the extracellular ion concentrations
in the model were adjusted to respective measurements (Sec. 8.2). This accounts
for the slow conduction velocity in these simulations. Similar low conduction ve-
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Fig. 9.16. Local conduction velocity magnitude and direction derived from left atrial LAT maps of patients
8–11 (Tab. 4.1). The conduction velocity magnitude is shown on the endocardial surface extracted from the
EAMS. The excitation direction is shown as black arrows overlayed on the endocardial surface.
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Fig. 9.17. Estimated and measured conduction velocities in the left atrial models of four AF patients. Mean
conduction velocity values are listed in Tab. 9.4.
locities are commonly observed in patients with atrial flutter and atrial fibrillation
(Tab. 2.2).
Second, simulated conduction velocities showed variations within each simula-
tion. These variations were caused by differences in extent and size of fast con-
duction pathways, variable local fiber orientation and wavefront incidence angle
as well as differences in local surface curvature. E.g. in region where fibers were
well aligned, conduction velocity was higher than in regions with frequent change
in fiber orientation, although the tissue conductivity was the same in both regions.
Similar variation in conduction velocity was also observed in the measurement
data. This shows that an adaptation of the global conduction velocity in the simu-
lations adjusts the global activation time on the one hand. On the other hand, the
adjusted simulations might provide an insight into abnormal regional conduction
velocities.
Third, conduction velocity calculations from measured LAT maps were prone to
errors. For one, errors in location activation time (Sec. 9.2.1) led to very high local
conduction velocities. Furthermore, in areas where activation time was constant,
e.g. in PVs were measurement data were missing, conduction velocity was deter-
mined to be zero. The majority of these artifacts were canceled out prior to the
conduction velocity computation by removing the according LAT / coordinates
pairs from the calculation. Nevertheless, some erroneous measurement values re-
mained present in the data. Secondly, the geometry of the LAT maps might be
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distorted. Besides the rough outer shape of the LAT maps, in some cases the pa-
rameters for a correct 3D localization of the surface were not set in the EAMS
(field-scaling, e.g. subject 9). This flattens the geometry between the anterior and
posterior side which results in larger conduction velocities at the left atrial roof,
as this area is squeezed. For future LAT map acquisitions, the EAMS geometry
should be merged with CT or MRI morphological segmentations of the atria and a
high density of sampling points should be used. Furthermore, an automated detec-
tion of local tissue activation would remove user-introduced errors. If these steps
are taken, a direct parameterization of the model with measured local conduction
velocities could be performed. This would create a tool for the model-based anal-
ysis of local tissue structure and the planning of RFA interventions.


Part IV
Applications
Essentially, all models are wrong, but some models are useful.
George E.P. Box

10
Study of Atrial Repolarization in the ECG
The ECG signal of the atrial repolarization sequence is usually obscured by the
signal of the ventricular depolarization (QRS complex). In patients with AV-block,
the atrial repolarization signal can be recorded in the ECG (Ta-wave, Sec. 2.4.1).
Computational modeling provides a tool to get a clearer look at the atrial repolar-
ization sequence in the ECG and thus gain a deeper understanding of the repolar-
ization sequence in healthy and diseased individuals. In this chapter, results of the
simulation of the atrial depolarization and repolarization sequence in a cohort of
models are presented.
10.1 Simulation Setup
Sinus rhythm activity (BCL=800ms) was simulated in eight atrial models and then
forward computed in thorax models of the same individuals to retrieve ECG and
BSPM signals (models 1–8, Tab. 7.1). For the simulations, the heterogeneous elec-
trophysiological model of Courtemanche et al. described in Section 5.2 was used.
Cell coupling in the atria was calculated using the monodomain equation. Sim-
ulated transmembrane voltages were forward computed on finite element thorax
models as described in Section 3.4.
To validate the simulation outcome, ECG data from four AV-block patients were
recorded at the Department of Cardiology, Lund University, Lund, Sweden. The
patients were awaiting implantation of permanent cardiac pacemakers and had no
history of other heart disease and were not taking anti-arrhythmic drugs [404].
ECG signals over at least 10 seconds were recorded with a standard 12-lead ECG
system. The signals were high-pass and low-pass filtered afterwards and then a
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Fig. 10.1. Representative example of atrial ECG signal and BSPM in a healthy model with and without
electrophysiological heterogeneities. Figure adapted from [295].
signal averaging was performed [154]. P-wave and Ta-wave onset and offset were
marked manually by the clinical experts. The data was provided by Professor Pyotr
Platonov and colleagues (Department of Cardiology and Center for Integrative
Electrocardiology, Lund University, Sweden).
10.2 Results
10.2.1 Homogeneous and Heterogeneous Electrophysiology
In a first set of simulations (2x8), the influence of the modeled electrophysiological
heterogeneities on the BSPM and ECG were investigated. In the homogeneous
simulations, the Ta-wave started right after the P-wave reached the isopotential line
again. This indicates that the repolarization starts after both atria were completely
activated. From the standard leads, Einthoven II had the strongest signal during
the Ta-wave. The BSPM of the Ta-wave was precisely the inverted pattern of the
P-wave (Fig. 10.1).
The P-wave signal and BSPM during the P-wave was not altered by the introduc-
tion of the heterogeneities, which was expected, as mostly repolarizing currents
were altered. In the heterogeneous simulations, the dipolar pattern of the BSPM
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Fig. 10.2.Measured and simulated atrial ECG signals.
during the Ta-wave was twisted clockwise on the thorax front. The signal polar-
ity in the standard ECG leads was inverted during the Ta-wave compared to the
P-wave. The signals of Einthoven II and III showed a similar morphology and am-
plitude. The signal of Einthoven I had a significantly smaller amplitude compared
to the other leads and also compared to the homogeneous simulations. The P-wave
ending and Ta-wave beginning overlapped each other. This led to an offset from
the isopotential line at the end of the P-wave. The amplitude of the Ta-wave in the
signal of Einthoven II was smaller in the heterogeneous simulations compared to
the homogeneous simulations (-0.047±0.025mV vs. -0.062±0.035mV), but the
time of the maximum amplitude was not altered (125±50ms vs. 123±50ms).
ECG signals from the four AV-block patients showed inverted polarity of the Ta-
wave compared to the P-wave in the vast majority of the signals. The P-wave
and the Ta-wave signal were strongest in Einthoven II lead in three out of four pa-
tients. The simulated ECG signals had a morphology similar to the measured ECG
signals (Fig. 10.2), although models and ECG measurements were taken from dif-
ferent individuals. P-wave and Ta-wave duration were longer in the measurements
than in the simulations. For the simulations the monodomain tissue conductiv-
ity was chosen such that conduction velocity was similar to those used in stan-
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Table 10.1. Impact of heterogeneities and electrical remodeling in the CRN model on the 3D excitation
sequence and ECG. Corrected PTa (PTac) calculated as proposed by [150]. PWd: P-wave duration, TaWd:
Ta-wave duration, RSb: begin of the repolarization sequence, RSe: time when last cell starts repolarization.
Model / Heart Rate PWd PTa PTac TaWd RSb RSe
Measurement (bpm) (ms) (ms) (ms) (ms) (ms) (ms)
healthy 75 101±13 393±20 441±20 293±18 75±11 254±16
[150] 75 435 483 316
[152] 386 420 276
[151] 70 124±16 449±55 512±60 323±56
[404] 86±15 129±17 451±53 519±57
persistent AF 75 109±14 229±15 277±15 121±5 67±3 151±17
paroxysmal AF [404] 73±17 126±15 408±47 441±68
dard atrial models. Simulated Ta-wave duration and PTa interval, which is the
sum of P-wave and Ta-wave duration and reflects the temporal summation of all
atrial electrical events [150], fit well into the duration ranges reported in literature
(Tab. 10.1).
10.2.2 Influence of Persistent AF Remodeling
Under persistent AF-remodeled conditions, the P-wave duration remained nearly
unchanged in all eight models. The Ta-wave was significantly shorter than in the
healthy case and its amplitude was larger (-0.074±0.048mV vs. -0.062±0.035mV).
Besides the drastic shortening of the Ta-wave, the morphology was comparable to
the healthy Ta-wave, e.g. Einthoven II and III signals were similar and Einthoven
I had a near-zero amplitude. The observed overlap of the P-wave and Ta-wave was
negated and strongly pronounced in the remodeling simulations (for an example
see Fig. 10.5).
This strong overlap of P-wave and Ta-wave was caused by the early onset of the
repolarization, which occurred while the atria were still depolarizing (Fig. 10.6,
RSb<PWd in Tab. 10.1). Additionally, the intra-model APD variation was siginif-
icantly reduced compared to the healthy case (Fig. 10.6(b)).
The BSPM during the Ta-wave showed a dipolar pattern between the upper chest
and the bowel, centered at the median axis (Fig. 10.5). The area of negative po-
tential spread out over the entire frontal hip in most simulations. P-wave pattern
remained unchanged compared to the healthy simulations.
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Fig. 10.3. BSPM of integrated P-wave and Ta-wave of models 1-4.
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Fig. 10.4. BSPM of integrated P-wave and Ta-wave of models 5-8.
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Fig. 10.5.Representative example of atrial ECG signal and BSPM in a healthy model and a model reflecting
persistent AF electrical remodeling. Figure adapted from [295].
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Fig. 10.6. a) Representative distribution of depolarization and repolarization time in a bi-atrial simulation
(model 5). b) Representative histogram plots of the distribution of APD and repolarisation time (model
2). The variation in APD (width of histogram curve) is significantly reduced compared to the healthy
simulations (Fig. 5.8).
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10.3 Discussion
In this chapter simulations of the atrial depolarization and repolarization sequence
and the corresponding ECG signals under healthy and persistent AF-remodeled
conditions were presented. For this purpose a cohort of eight atria and thorax
models were used. Modeling studies commonly use only one atrial model cou-
pled with a generic thorax model or a thorax model from a different individ-
ual [218, 230]. This approach may introduce model-specific uncertainties in the
results. The workflow described in Section 7 allowed for the creation of a co-
hort of volunteer-/patient-specific models in a reasonable time and thus enabled
the multi-model simulation study. The variation in simulated ECG fiducial times
(Tab. 10.1) of up to ±13% highlights that the use of only one model could have
resulted in misleading simulation outcome.
The polarity and morphology of the simulated P-waves and Ta-waves were in
agreement with the measurement data from four AV-block patients and to the find-
ings reported in literature [151, 152, 404]: The polarity of the Ta-wave was in-
verted compared to the P-waves in the standard leads and the signal in Einthoven
II had the largest amplitude for both the P-wave and Ta-wave. Lead Einthoven II
covered the greatest potential variance during the P-wave and was thus aligned
with the dipolar pattern of the BSPM. The BSPM pattern over the P-wave agreed
with previously published measurement data [144]. The BSPM pattern over the
Ta-wave indicated that a bipolar ECG lead between the suprasternal notch and the
right hip, or unipolar electrodes on the right side of the chest could record Ta-wave
signals with a larger amplitude than the regular 12 lead ECG in AV-block patients.
The simulated P-wave duration was shorter than the P-wave duration reported in
the Ta-wave ECG studies (Tab. 10.1). For the simulations, conduction velocities
were adapted to reflect velocities used in established models [91]. A decrease of
the model conduction velocity will prolong the P-wave and thus provide a better
match to the measurement data. This is likely to also resolve the difference in
PTa duration. The simulated Ta-wave durations fitted into the range of measured
values.
In the measurement data, Ta-wave duration decreased with faster heart rates
(323± 56ms (BCL 714ms) [151], 316ms (BCL 800ms) [150], 276ms (BCL
856ms) [152]). Debbas et al. reported a linear relationship between the Ta-wave
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Fig. 10.7. Relationship of TaWd to PP interval. Black circles indicate data from Debbas et al. [150], green
squares with error bars show data from Holmqvist et al. [151] and blue crosses mark the new simulation
data. The red curve represents the linear fit of Debbas et al. [150] to the respective measurement data. The
blue curve is a square root fit to the data from Debbas et al. and the simulation data.
duration and the pacing interval [150] which fits to previous findings from Hayashi
et al. [152]. The non-linear restitution curves of APD and conduction velocity
(Sec. 5.2) indicate a more complex relationship between the two measures. E.g. a
square root equation in the form of
TaWd =
⇣p
(PP a)⇤b
⌘
+ c (10.1)
with the unknown coefficients a, b and c was fitted to the measurement data from
Debbas et al. and the simulation results using a least squares optimization. These
coefficients were determined to be a= 331.1ms, b= 6.676ms and c= 158.4ms.
The RMSE between the fit and the data was 20.87ms compared to an RMSE of the
original linear fit of 21.15ms. Figure 10.7 shows the data and the fits. The major
difference between both assumptions can be observed at very high (>150 bpm)
and regular sinus rhythm heart rates (<75 bpm). A shorter repolarization duration
at high frequencies, as predicted by using equation 10.1, might contribute to the
development or maintenance of AF.
In the heterogeneous simulations, a zero-offset at the end of the P-wave was ob-
served due to a temporal overlap of the atrial depolarization and repolarization
204 CHAPTER 10. STUDY OF ATRIAL REPOLARIZATION IN THE ECG
sequence, which concurs with in-vivo findings [150]. The homogeneous simula-
tions were not able to reproduce this behavior.
Holmqvist et al. reported a decreased Ta-wave duration in patients suffering from
paroxysmal AF [404]. The simulations under persistent AF-remodeled conditions
showed a more pronounced shortening of the Ta-wave duration. As AF is a pro-
gressing disease [99], these findings accompany each other. The simulations pro-
vided the insight, that the shortened Ta-wave duration was caused by a combina-
tion of i) a more dense repolarization sequence (shorter APD in all regions) and ii)
early repolarization while the depolarization was still ongoing.
The presented methodology to simulate the atrial repolarization sequence in the
ECG using a cohort of anatomical models and the heterogeneous CRN model
could be used for further investigations of the atrial repolarization sequence under
healthy and pathological conditions in the future. E.g. the relationship between PP
and TWd could be further explored and the influence of a reduced cell coupling
(gap junctional remodeling) on the repolarization sequence could be investigated.
The knowledge gained from the simulations could be used to better understand the
onset and maintenance of atrial arrhythmias due to repolarization disturbances.
11
Simulation of Atrial Fibrillation
Atrial models have been used to investigate the mechanisms leading to atrial ar-
rhythmias and atrial fibrillation for a long time [2]. The vast majority of the utilized
models were 3D surface or shell models with a rather small number of computa-
tional nodes. Additionally, most often the models were tuned to artificial condi-
tions to initiate wave-breaks, reentries and rotors (very slow conduction velocity,
shorter refractory period, sudden regional variations in electrophysiology etc.). Ini-
tiating atrial fibrillation by imitating the pathophysiological initiation process, e.g.
by ectopic firing in the pulmonary veins [100], is becoming more popular since the
models are better understood (Tab. 11.1). Surface models have a reduced demand
in computational power and allow longer simulations. With the constant increase
in available computational power, also the simulation of AF in atrial models with
a finite wall thickness is becoming feasible. Beforehand, such simulations could
only be performed using rule-based simulation approaches (e.g. [257]). These are
usually unsuitable, as the discretization artifacts coming along with this approach
play a significant role at high excitation frequencies and might produce false re-
sults.
Table 11.1. Initiation of AF in 3D atrial models. ES: ectopic stimulus.
study year EP model AF-init comments
Gong et al. [206] 2007 CRN ES-train (10) at PVs
Plank et al. [94] 2008 CRN ES at RIPV LA only
Reumann et al. [187] 2008 CRN 2x overlapping ES at PVs
Deng et al. [405] 2010 CRN ES and cross-field
Tobon et al. [93] 2010 Nygren ES in 6 different locations
Uldry et al. [406, 407] 2010 Luo-Rudy
Lu et al. [217] 2011 Nygren ES at RSPV and IVC
Aslanidi et al. [218] 2011 CRN ES between CT and PM
Zhao et al. [96] 2012 Fenton-Karma ES at PVs
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Fiber orientation plays an important role in the maintenance of AF. Especially
in regions with high anisotropy, e.g. fibrotic tissue, the underlying fiber orienta-
tion contributes significantly to the development and maintenance of the arrhyth-
mia [94, 96]. Fiber architecture is organized in complex, multi-layer patterns in
the human atria (Sec. 2.1.1.3). This structure cannot be reproduced by 3D sur-
face models. Furthermore, Allessie and co-workers recently presented evidence
for transmural reentry [408] caused by endo-epicardial dissociation [409–411].
Such phenomena may not be reproduced in shell models. In this chapter, an ex-
ample of the simulation of atrial fibrillation in a volumetric atrial model under
pathophysiological initiation conditions is presented.
11.1 Simulation Setup
The model of subject 4 (Tab. 7.1) was chosen for this simulation for no particu-
lar reason, except for the availability of a thorax model from the same individual.
At the time of the study, the data of subject 8, an AF patient, was not processed
yet, otherwise this model would have been chosen. The model contained com-
plete rule-based fiber orientation (Sec. 5.4) and heterogeneous electrophysiologi-
cal properties based on the CRN model (Sec. 5.2). Furthermore the CRN model
was adjusted to reflect persistent-AF electrical remodeling (Sec. 3.2.2). The mon-
odomain anisotropy ratio was set to 10:1 (CV anisotropy 3:1) in accordance with
previous volumetric modeling studies [94, 96]. Such anisotropy ratio is thought
to reflect fibrotic atrial myocardium. The longitudinal tissue conductivity was re-
duced to 40% of the regular value [216]. A similar approach has been chosen
before in other AF simulation studies [412]. The resulting reduction of conduc-
tion velocity was approximately 65%. Simulations were carried out on a Mac OS
X 10.6 computer with 8 x 2.8GHz Intel Xeon processors and 32 GB RAM us-
ing a C++ simulation framework based on PETSc [413]. The problem was dis-
cretized using finite elements and solved using the forward Euler approach with a
time step of 20 µs. Prior to the simulations, the nodes in the model were initial-
ized with 10 beats of single cell pre-calculation at regular sinus rhythm frequency
75 bpm (BCL=800ms). Ten seconds of atrial activity were simulated and subse-
quently forward-calculated every millisecond to the body surface ECG. Compu-
tation took approximately five days for the simulation of the atrial excitation and
another seven days for the ECG computation.
11.2. RESULTS 207
Table 11.2. Regular and sequence of ectopic stimuli during the simulation.
stimulus time site tissue under stimulus excitation outcome
0 0.000 sinus node excitable tissue sinus rhythm excitation
1 0.227 junction
RSPV/LA
partly refractory tissue reentry (center moves from origin to left
anterior LA)
2 2.027 junction
RSPV/LA
partly refractory tissue reentry (center meanders around stimu-
lus location)
3 3.827 junction
RSPV/LA
partly refractory tissue reentry (same location as 2, then moves
into RSPV, center moves out of PV after
1.1s)
4 5.627 junction
RSPV/LA
depolarized tissue none
5 7.427 junction
RSPV/LA
excitable tissue none
6 9.227 junction
RSPV/LA
refractory tissue figure of eight reentry / two rotors (one
in RSPV, one at junction of RSPV and
LA
At first, regular excitation was initiated at the site of the sinus node in the superior
right atrium. Then, ectopic activity was initiated next to the RSPV with a BCL of
1.8 s. The location of the stimulus was chosen based on the excitation pattern and
the anatomical structures. The location of the ectopic activity lay on the border of
the PV and the left atrium. Furthermore, two wavefronts collided in this region dur-
ing sinus rhythm activation providing a repolarization wavefront, which allowed
excitation propagation in only one direction. The time of the first ectopic activity
was determined as the time where the underlying tissue repolarized to -75mV. The
ectopic stimulus was spherical with a radius of 3mm.
11.2 Results
Right atrial activation was dominated during regular excitation and during the ar-
rhythmia phase by fast conduction along the major muscular bundles (BB, CT,
PM). The first ectopic beat initiated a stable rotor in the left atrium, which moved
from the initiation location towards the anterior left side of the left atrium. The
other ectopic stimuli party caused a second rotor. These rotors meandered around
the location of the ectopic activity until the rotor center moved out of the PV tissue.
No ectopic stimulus initiated a third rotor. Stimuli 4 and 5 did not cause a rotor at
all, but stimulus 6 resulted in a figure of eight reentry. Table 11.2 summarizes the
findings. Figure 11.1 shows the transmembrane voltage distribution at the time of
and after each ectopic stimulus.
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Fig. 11.1. Example of ectopic foci triggering atrial fibrillation. After one sinus node activation, ectopic
activity was stimulated at the RSPV (BCL 1800ms, e.g. 242 ms). Multiple rotors developed. The most
stable and largest rotor was created from the first ectopic beat and manifested at the anterior left atrial roof.
The left atrial rotor therefore drove the right atrial activation.
11.2. RESULTS 209
1 2 3 4 5 6 7 8 9
−0.1
−0.05
0
0.05
0.1
time (s)
Ei
nt
ho
ve
n 
II 
si
gn
al
 (m
V)
(a)
0 5 10 15 20 25 30 35 40 45 50
0
0.5
1
1.5
x 10−5
Frequency (Hz)
|FF
T(I
I)|
(b)
Fig. 11.2. a) Computed Einthoven II ECG signal from the AF simulation. Vertical red lines indicate times
of ectopic stimuli at the RSPV. b) Power density spectrum of the fast Fourier transform of the ECG signal.
During the arrhythmia phase additional reentries developed spontaneously in the
right atrium temporarily. One reentry (2.5 - 3.0 s) moved around the border of the
CT and the PMs. Another one developed along the inferior end of the CT (6.3 -
8.1 s). Further stationary rotors developed and diminished at the anterior junction
of pectinate muscles and the TVR, where fiber orientation changes abruptly.
The forward-calculated Einthoven II ECG signal is shown in Figure 11.2 along
with the power-density spectrum calculated from the fast Fourier transform of
the signal. The frequency with the maximal amplitude was 7.14Hz, which cor-
responds to 428 bpm or a cycle length of 140ms. The amplitude of the signal was
reduced after the second ectopic stimulus and further reduced after stimuli 4 and
6.
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11.3 Discussion
In this chapter, an example of the initiation of atrial fibrillation by single ectopic
activity in a volumetric 3D biatrial model was presented. The reduction in tis-
sue conductivity was greater than the conductivity reduction commonly used to
model electrical remodeling (sremod = 0.7 ⇥ shealthy e.g. [73]). With tissue con-
ductivity reduced to 70% it was not possible to induce reentry in the model. The
conduction velocity was similar to the conduction velocity observed in AF patient
8 (Fig. 9.17). The dominant frequency observed in the body surface ECG was in
the range of clinically observed frequencies during persistent AF [414].
Notably, rotor centers of stable rotors manifested at borders of adjacent tissue re-
gions (LAA–LA, TVR–RA, CT–PM). In these areas an abrupt change of fiber ori-
entation and cellular electrophysiology was present. These findings coincide with
findings from simulations studies, which induced AFmore easily in heterogeneous
models [68, 69]. The use of gradients to ensure a smooth transition of electrophys-
iological properties between neighboring regions counteracted the manifestation
of rotor centers in the present study.
The simulation took a considerable amount of time. The present approach does
therefore not allow for a systematic investigation of the influence of different
model parameters. The use of unstructured grid models would reduce the com-
putational load, as bath nodes may not need to be included into the computation.
The use of simplified excitation propagation models which can still reproduce dif-
fusion and repolarization [262–264] as well as the use of phenomenological elec-
trophysiology models [240] would further speed up the simulations in the future,
once all relevant model parameters are understood and a reduction of the models
becomes feasible.
The cells in the model were initialized at a regular sinus rhythm frequency. Ini-
tialization with higher pacing rates could yield an easier initiation of reentries, as
the ERP and conduction velocity will be reduced (Sec. 5.2). Similar approaches
are also undertaken by other groups (BCL=230ms [218], BCL=280ms [406],
BCL=375ms [94]). Also other stimulus location could be investigated, e.g. other
PVs [94, 187], the caval veins [217], between the CT and PM [218] and at various
locations across the atria [93, 415].
11.3. DISCUSSION 211
Besides fiber orientation, also a method to introduce sheets of myocardial tissue
was introduced in Section 5.4. Up-to-now, conduction properties were set isorota-
tional along and across fiber orientation. Using the information about local sheet
orientation enableds the use of variations in conduction properties within a sheet
and between sheets. This could e.g. be used to further investigate transmural dis-
sociation and reentries as proposed in the literature [408–411].
In the future, heterogeneous tissue properties reflecting regions of increased fi-
brosis could be introduced based on LGE-MRI measurements from AF patients
(Sec. 13.2.3). This could favor wavebreaks and produce more stable arrhyth-
mia. Also, all prerequisites are set to model the atrial deformation during AF
(Chap. 14). This could provide new insights into mechanisms leading to throm-
bus development during AF.
The performance of the AF simulation framework can be increased in various as-
pects. A decrease in computation time in conjunction with the existing anisotropic
heterogeneous atrial models will allow a systematic investigation of anatomical
and electrophysiological parameters with respect to the initiation and maintenance
of AF in the future. This will provide new insights into the mechanisms lead-
ing to AF.

12
Investigation of Conduction Block in Ablation Lesion
Gaps
Radio-frequency ablation of atrial fibrillation shows only moderate long-term suc-
cess rates after the first RFA intervention [1]. Most often gaps between ablation le-
sions develop over time and reverse the initial termination of the arrhythmia. Gaps
in circumferential PVI can occur nearly anywhere, but are slightly more commonly
present at the LPVs compared to the RPVs [111]. The isthmus area between the
LIPV and the mitral valve was shown to be especially prone to gaps [111]. Dur-
ing the initial lesion formation process, ablation lesions are wider compared to the
chronic state of the lesions, as explained in Section 2.3. Initially, necrotic, edema
and inflammatory regions are caused by the application of the radio-frequency
current. Over a period of several weeks, the damaged non-necrotic tissue partly
regenerates and partly forms scar tissue. Ablation lesions, which are initially elec-
trically isolating can form electrical pathways during this healing period. Addi-
tionally, differences in cell electrophysiology caused by RFA, e.g. shorter APD
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Fig. 12.1. Setup of simulation environment to investigate lesion gap conduction under different electro-
physiological and tissue conditions. L is the variable lesion gap width. White circles indicate the position
of voltage sensors. Dashed grey lines indicate longitudinal fiber direction. Yellow tissue indicates the stim-
ulation zone.
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Table 12.1. Simulations settings for the investigation of lesion gap conduction.
tissue EP model fiber orientation w.r.t. to gap direction
A1 RA physiological longitudinal
A2 LA physiological longitudinal
A3 PV physiological longitudinal
A4 RA physiological transversal
A5 LA physiological transversal
A6 PV physiological transversal
B1 RA physiological isotropic
B2 LA physiological isotropic
B3 PV physiological isotropic
B4 RA AF-remodeled isotropic
B5 LA AF-remodeled isotropic
B6 PV AF-remodeled isotropic
near the edge of a lesion [126], may play a role in the recurrence of AF. In this
chapter, a simulation study investigating the conduction behavior of lesion gaps
under different anatomical and electrophysiological conditions is presented. The
effects of fiber orientation underlying the lesion gap, the atrial region (Sec. 5.2)
and electrical remodeling due to AF (Sec. 3.2.2) were investigated.
12.1 Simulation Setup
A geometrical model representing a plain patch of atrial tissue with an ideal-
ized ablation scar (zero conductivity, sharp edges) was created. Four sensors were
placed in the atrial tissue at which the action potential was recorded. The setup
is shown schematically in Figure 12.1. The width of the lesion gap was within
the range of ablation lesion width (Sec. 2.3.3). The model was constructed on a
structured voxel grid with a resolution of 0.05mm. The problem was discretized
using finite differences and solved using a semi-implicit Euler scheme [416] with
a timestep of 20 µs. Voxels were initialized with 50 beats of single-cell pre-
calculation before the tissue simulation was started. Monodomain tissue conduc-
tivity was set to 0.176 S/m in fiber direction and 0.062 S/m perpendicular to fiber
direction. This resulted in conduction velocities of 1200mm/s along fiber orienta-
tion and 680mm/s transversal to fiber orientation at sinus rhythm (75 bpm) in right
atrial tissue. The tissue patch was stimulated at one side with 240 pA/pF for 1ms.
The value was determined as twice the rheobase of the right atrial tissue patch
setup.
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Atrial electrophysiology was simulated using the CRN model for right atrial, left
atrial and pulmonary vein tissue (Sec. 5.2) in regular and persistent-AF remod-
eled state (Sec. 3.2.2). Reduced tissue conductivity from electrical remodeling [73]
was not considered to isolate the effect of altered cell electrophysiology. Simula-
tions were performed with 14 different pacing cycle lengths ranging from 50ms
to 1000ms. For each setup, gaps of varying width in the ablation lesion were in-
troduced. 25 gap widths were investigated (0.05–2.0mm) for 12 different anatom-
ical situations (Tab. 12.1). Overall 2520 simulations were performed. Afterwards,
the transmembrane voltage signals of the sensors were evaluated to determine the
cross-gap conduction and the conduction velocity in the gap. Voxel activation was
thereby determined as the time when the transmembrane voltage during the action
potential upstroke increased above -20mV. The threshold was chosen in a way that
changes in transmembrane voltage caused purely by diffusion did not lead to an
activation detection.
12.2 Results
Comparison of the behavior of different atrial tissue types revealed that right and
left atrial tissue were slightly less prone for cross-gap conduction compared to
pulmonary vein tissue (Fig. 12.2(a)). Fiber orientation had a greater influence on
the gap conduction. Gaps with transversal fiber orientation showed a cross-gap
conduction at gaps of width of 0.55–0.6mm compared to 0.35–0.4mm with lon-
gitudinal fiber orientation. Electrical activity with pacing cycle length (PCL) below
400ms showed a better gap isolation in all cases. Fiber orientation also influenced
the wave-front curvature of the wave exiting the lesion gap (Fig. 12.3).
Electrical remodeling of the cell electrophysiology increased gap isolation width
by approximately 0.1mm (Fig. 12.2(b)). Additionally, the edge of the PCL de-
pendent isolation variation was shifted towards shorter PCLs under the influence
of electrical remodeling (200ms vs. 400ms) due to shorter APD and ERP in re-
modeled tissue (Sec. 5.2). The differences between tissue types with respect to the
lesion gap conduction remained present under electrical remodeling. Ablation le-
sion width and thus the length of the gap corridor did not alter the results. Pacing
at cycle lengths shorter than the tissue ERP did not result in an excitation wave, but
diffusion raised the membrane potential slightly in the proximity to the stimulus
location.
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Fig. 12.2. Dependency of conduction over a gap in an ablation lesion on fiber orientation (a) as well as on
electrophysiological tissue properties (b). The area under each curve indicates configurations which results
in conduction block across the lesion gap. The area above each curve represents configurations which
results in cross-gap conduction. Red: right atrium, green: left atrium, blue: PVs. a) Solid: longitudinal,
dashed: tranversal fiber orientation. b) Solid: healthy, dashed: persistent AF remodeling.
In cases where the excitation wave did not reach the tissue behind the incomplete
lesion, the tissue within the lesion gap was always activated: The excitation block
occurred at the outlet of the lesion (Fig. 12.1, left). In cases where the lesion gap
was wide enough to allow an activation of the tissue behind the lesion, the con-
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Fig. 12.3. Example of the effects of fiber orientation in the tissue patch (pulmonary vein tissue, 1000ms
BCL, 1mm gap). Shown are transmembrane voltages at different time instances during the tissue patch ac-
tivation. Wave-front curvature after exiting the gap differs significantly between the two cases. Please note
the different time instances between the two cases caused by different conduction velocity in longitudinal
and transversal fiber direction.
duction velocity over the lesion gap was slowed down in narrow lesion gaps. The
main findings are summarized in Table 12.2.
12.3 Discussion
In this chapter an analysis of the effects of various factors on the conduction across
gaps in ablation lesions was presented. The results might serve as one explanation
for the recurrence of AF after RFA therapy and thus for the moderate long-term
success rates in contrast to short term success [1].
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Table 12.2. Main findings of the simulation study. Red parameters increased the maximum gap width at
which conduction block was observed, thus more gaps were conducting. Green parameters decreased the
maximum gap with at which conduction block was observed, thus the setup was less vulnerable for lesion
gap conduction. EP: electrophysiology.
region-dependent block pulmonary vein
right atrium
left atrium
fiber-dependent block longitudinal (high conductivity)
transversal (low conductivity)
EP-dependent block physiological / normal
electrical remodeling
rate-dependent block sinus rhythm
arrhythmia
At the time of RFA therapy, the atrial myocardium is in an AF-remodeled state.
Thereby, the cell electrophysiology, tissue conductivity and excitation frequency
differ from the physiological values. After conversion of the arrhythmia to a reg-
ular rhythm, a process of reverse remodeling is most likely to happen. Thereby,
tissue and cell parameters will return to physiological values again. The simula-
tion results indicate that lesion gaps which were electrically isolating during the
RFA intervention (electrical remodeling, fast activation from arrhythmia) can be-
come conductive under healthy conditions (normal electrophysiology, slow acit-
vation) independent from structural changes of the ablation lesions. This could be
an explanation for the recurrence of AF after RFA procedures.
Ranjan and colleagues [110] proposed a recovery of gap conduction based purely
on an increase in tissue conductivity during the reverse remodeling process. This
could be caused by a recovery of gap junction coupling and / or by healing of
inflammatory tissue. In the monodomain model, transversal fiber orientation is re-
alized as a reduced tissue conductivity. The transversal, low conductivity setup
showed in the present simulations also a better gap conduction block, which sup-
ports the hypothesis from Ranjan et al..
Thomas et al. [417] showed an effect, that with isthmus cross sectional areas be-
low 0.7mm2 (0.5mm⇥1.4mm) there is no conduction across lesion gaps at BCL
shorter than 400ms. Gaps having 0.9mm2 (0.9mm⇥1.0mm) cross sectional area
allowed conduction at all tested BCLs. The measurements were done at the area
of Crista Terminalis, a fast conducting muscle bundle in the right atrium with well
aligned fiber orientation. The present findings agree with these measurements, as
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Fig. 12.4. Simulation of a non-conducting sharp edged outlet and of a conducting funnel shaped outlet.
Left atrial electrophysiology, transversal fiber orientation, 1000ms BCL, 0.2mm gap.
for all BCLs that allowed conduction, the 0.9mm gap was always conducting in
case of longitudinal fibers.
Pérez and co-workers [418] measured lesion gap conduction in more complex gap
geometries and with different fiber directions in a rabbit right ventricle. They pro-
posed that conduction through gaps in RF lesions is associated with gap geometry
and cross-sectional area and that complex geometry of gaps could lead to unidirec-
tional blocks and/or rate-dependent blocks. The findings of the simulation study
agree with these measurements. In particular rate-dependent and fiber-dependent
block were observed. On the other hand, activation always spread within the lesion
gap and block occurred at the outlet of the lesion. This is most likely to be caused
by a source-sink mismatch at this site, such that the large amount of cells behind
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Fig. 12.5. Reentry in a model with an incomplete ablation lesion in left atrial myocardium (Dx=0.33mm,
smallest width of funnel gap 0.2mm, electrically remodeled electrophysiology and tissue conductiv-
ity [73]). The lesion contained a large gap at the right side and a small, funnel shaped gap at the left.
The latter gap caused single sided conduction and thus acts like a diode (35 & 137ms). In this chronic state
the border zone diminished and makro-reentry was observed between the two gaps (137ms ff).
the gap cannot be activated from a small amount of cells at the gap outlet. Simula-
tion of other outlet geometries which slowly equal out the source-sink mismatch,
e.g. geometrically seen a funnel, confirmed this hypothesis (Fig. 12.4), although a
systematical analysis of e.g. the opening angle was not performed. Both findings
rather point to a significance of the outlet size and geometry than to a significance
of the complete gap geometry. The funnel shaped outlet led to a gap conduction in
one direction only (diode like behavior), which may cause makro-reentry circuits
if another conductive gap in the lesion was present (Fig. 12.5). The reentry path-
way was closed when a border zone was set around the ablation lesions (Fig. 12.6).
This reflects the case acutely after RFA therapy (Sec. 2.3).
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Fig. 12.6. Reentry in a model with an incomplete ablation lesion in left atrial myocardium (same setup as
in Fig. 12.5). In the acute phase after ablation, the lesion was surrounded by a low-conductivity border zone
of 0.1mm width (sborder = 0.01⇥smyocardium). The border zone blocked conduction in both ways through
the funnel gap (170ms). In the chronic state the border zone diminished and makro-reentry was observed
between the two gaps (137ms ff).
The fiber orientation dependent wave-front curvatures observed after the wave ex-
ited the lesion gap (Fig. 12.3) confirmed findings from a combined simulation and
measurement study [419]. The findings of slowed conduction across narrow but
conductive lesion gaps also agreed with the findings from this study by Cabo et
al. [419].
In the present study, conduction across lesion gaps was achieved for rather small
lesion width compared to the Ranjan study which observed conduction block in
gaps between 1.5 to 4mm [110]. This could be caused by differences in simulation
setup (monodomain vs. bidomain, 3D patch vs. 2D sheet) and by differences in
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tissue conductivity. Nevertheless, the principle findings agree between the present
study and the study undertaken by Ranjan et al..
Wood et al. [126] observed a shorter APD near edges of acute ablation lesions,
which diminished after three weeks. A shorter APD is also present in electrically
remodeled tissue as used in the present simulations. It is likely that the ablation-
induced APD shortening might lead to the conduction-block across small lesion
gaps, as observed under the influence of electrical remodeling. The post-ablation
recovery of APD in proximity to ablation lesions might also contribute to the re-
currence of gap conduction and thus possibly AF. The present study also revealed
an increased risk for gap conduction in the proximity to the pulmonary veins,
which are almost always target of ablation. This finding suggest that wide area
PVI might be less sensitive for conduction across the ablation lesions compared to
narrow PVI.
The results from the present study hint that long-term recovery of ablation lesion
gap conductivity and thus possible recurrence of AF, could be explained by the si-
multaneous reverse remodeling of tissue conductivity, cell electrophysiology and
excitation frequency. The setup allows further in-depth investigations of anatom-
ical and electrophysiological factors leading to gap conduction in the future, e.g.
tissue conductivity variations.
13
Model-Based Evaluation of Ablation Therapy
Patient-specific atrial models may enable personalized model-based therapy eval-
uation and planning in a clinical environment. Such approach requires fast compu-
tational methods to not unnecessarily lengthen the clinical procedure. On the other
hand, image data is commonly acquired at least one day prior to a major clinical
intervention providing time for performing simulations over night. In this section
a clinical application of patient-specific atrial models is described. The goal was to
evaluate the outcome of radio-frequency ablation (RFA) interventions using atrial
models as support to the image data. Two scenarios were considered for this. First,
the success of pulmonary vein isolation (PVI) in two AF patients (models 8 & 9,
Tab. 7.1) was evaluated from image data acquired acutely after the intervention (<
24 h after RFA). Second, the chronic development of RFA lesions after PVI was
investigated in three AF patients (models 9c, 10 & 11 Tab. 7.1) based on image
data acquired at least 3 month post ablation.
13.1 Simulation Setup
First, volumetric, anisotropic atrial models were generated for each case as de-
scribed in Section 7.1. Afterwards, structural information about the RFA lesions
were extracted from late Gadolinium enhancement (LGE) MRI (Sec. 7.1.1). The
LGE intensity is variable between patients and scans. The relative LGE-MRI in-
tensity threshold to determine scar regions was therefore varied between 0 and
100%. For each threshold a bi-atrial model with scar tissue in regions where
LGE-intensity was above the threshold was created. Next, sinus rhythm excita-
tion was simulated in each model utilizing the monodomain (acute RFA lesions)
and the anisotropic fast-marching level set approach (Sec. 5.7, (acute and chronic
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lesions)). Monodomain simulations were run for thresholds provided by expert
clinicians from King’s College London, UK. The computational load did not per-
mit a complete sensitivity analysis using the monodomain approach. Analysis of
the sensitivity of PV isolation on LGE-MRI threshold was done using the fast-
marching approach. For each simulation the isolation and activation of tissue
within each PV sleeve was analyzed for each threshold value. Two ratios were
determined.
Ria,threshold =
inactive PV sleeve myocardium
regular PV sleeve myocardium
(13.1)
Rs,threshold =
PV sleeve scar tissue
regular PV sleeve myocardium
(13.2)
If the complete sleeve tissue of a PV was set to be scar tissue at a certain threshold
(e.g. 0%), Rs will be 1.0 and Ria will be 1.0. If a PV was successfully isolated from
the left atrial body, Ria will be 1.0, but Rs will be smaller than 1.0 for thresholds >
0%. The difference between both ratios described the relative portion of PV sleeve
tissue which was not ablated, but isolated.
Ri,threshold =
inactivate PV sleeve myocardium PV sleeve scar tissue
regular PV sleeve myocardium
(13.3)
PVI was considered successful for Ria ! 1.0 with Rs ! min. Additionally, the
change in left atrial activation sequence caused by the scar tissue was assessed
visually.
13.2 Results
13.2.1 Acute LGE-MRI and Virtual Ablation
In the left atrial model of subject 8, the weakest isolation from the left atrial body
occurred in the LSPV, whereas the LIPV showed large portions of ablation scar
already at high threshold values. The right PVs showed circumferential isolation
from threshold below 62%. At 61.2%, the excitation pattern in the left atrium
revealed two gaps in the lesion around the RIPV (Fig. 13.1(a)). Two additional
ablation lesions were set in-silico at the spots of conduction break-through (virtual
ablation, Fig. 13.1(a), encircled). These isolated the RIPV electrically from the left
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Fig. 13.1. Monodomain simulation of atrial excitation on models with RFA scar based on LGE-MRI ac-
quired <24 h (acutely) post-ablation. Arrows indicate activation wavefronts. Dashed encircled are addi-
tional lesions placed virtually (subject 8) or caused by an increase in LGE-MRI threshold (subject 9). In
both cases, this led to an isolation of the RIPV.
atrium. The overall left atrial excitation sequence was not altered at these LGE-
MRI threshold values.
In subject 9, the RIPV was the weakest isolated PV. Simulation of the sinus rhythm
at a threshold of 61.2% revealed a lesion gap at the posterior side of the RIPV. An
increase of the threshold by 0.3% closed this gap such that all PVs were isolated
from the left atrial body (Fig. 13.1(b)). In contrast to the ablation lesions of subject
8, tissue acutely affected from RFA was distributed more equally over the left
atrium in subject 9. This led to a significantly reduced portion of active left atrial
myocardium in the simulations. Small corridors between both pairs of PVs and
along the mitral valve annulus allowed a regular sinus rhythm left atrial activation
sequence.
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Fig. 13.2. Results of sensitivity analysis of acute LGE-MRI threshold and PV isolation. Solid curves:
relative amount of inactivate PV sleeve tissue Ri, dashed curves: relative amount of scar in PV sleeves Rs.
The difference between both curves marks non-scar isolated amount of PV sleeve tissue. PV are considered
to be isolated at the threshold value at which both curves of the PV split.
Table 13.1. Overview of LGE-MRI acquisition, clinical findings and simulation observations.
subject LGE-MRI acquisition clinical observations in-silico findings
8 24h post-ablation successful PVI all PVs reconnect nearly at same thresh-
old
9 24h post-ablation successful PVI all PVs reconnect nearly at same thresh-
old
3 month post-ablation successful PVI all PVs reconnect nearly at similar
thresholds
10 pre-redo-ablation all PVs reconnected RIPV most prone to reconnection
11 pre-redo-ablation RSPV reconnected RIPV most prone to reconnection
The sensitivity analysis showed in both cases that all PVs were isolated from the
left atrium in a very narrow range of threshold values (Fig. 13.2), thus not provid-
ing a reliable indicator for the reconnection probability of the PVs. From a clinical
perspective, PVI was successful in both patients (no AF recurrence three month
post-ablation). This could correlate to the sensitivity analysis findings, as no single
PV was significantly more prone to reconnection as the others.
13.2.2 Chronic LGE-MRI / Redo procedures
Three AF patients underwent LGE-MRI after at least 3 month post-ablation. Sub-
ject 9 had a successful first RFA procedure, but subject 10 and 11 needed to un-
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Fig. 13.3. a) Activation of the four pulmonary veins depending on the threshold of LGE-MRI for the
transfer of scars into the model of patient 9c. Dashed lines: scar tissue, solid lines: tissue which is not
activated during sinus rhythm. Differences between the two curves of each PV denotes tissue, which is
isolated from regular activation. 0% threshold means that all regions which have a LGE-MRI value are
considered to be scar tissue. 100% means that no region is considered to be scar. b) Endocardial shell with
LGE-MRI intensity distribution and simulated activation times using different LGE-MRI thresholds. The
dashed circle denotes the PV most likely to reconnect to the left atrial myocardium.
dergo a second RFA intervention (redo-procedure, Tab. 13.1). LGE-MRI was ac-
quired prior to the redo-procedures.
In subject 9c the right PVs showed a significant portion of scar tissue at high
threshold values. The RSPV was the first to be partly isolated from the left atrial
body. Complete PV isolation was achieved in all PVs at similar threshold values
(Fig. 13.3(a)). This corresponds to the findings from the acute post-ablation sen-
sitivity analysis of the same subject (Fig. 13.2(b)). The LIPV was the PV to be
isolated from the left atrium at the lowest threshold and thus had potentially the
weakest isolation (Fig. 13.3(b)).
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Fig. 13.4. a) Activation of the four pulmonary veins depending on the threshold of LGE-MRI for the
transfer of scars into the model of patient 10. Dashed lines: scar tissue, solid lines: tissue which is not
activated during sinus rhythm. Differences between the two curves of each PV denotes tissue, which is
isolated from regular activation. 0% threshold means that all regions which have a LGE-MRI value are
considered to be scar tissue. 100% means that no region is considered to be scar. b) Endocardial shell with
LGE-MRI intensity distribution and simulated activation times using different LGE-MRI thresholds. The
dashed circle denotes the PV most likely to reconnect to the left atrial myocardium.
In subject 11, the sensitivity analysis revealed that the RIPV has the weakest iso-
lation (Fig. 13.4(a)). The portion of scar tissue in each PV was in this case nearly
linearly proportional to the LGE-MRI threshold value. Electroanatomical mapping
during the second RFA procedure in this patient revealed that all PVs were recon-
nected (Tab. 13.1). This would correspond to LGE-MRI thresholds above 23%, as
shown by the sensitivity analysis.
In subject 12, the simulations showed that the RIPV was most likely to reconnect
to the left atrium, although the threshold values for all PVs were closer together
than in subject 11 (Fig. 13.4(a)). Intracardiac measurements during the redo proce-
13.2. RESULTS 229
0 10 20 30 40
0
20
40
60
80
100
LGE−MRI intensity threshold (%)
re
la
tiv
e 
PV
 s
le
ev
e 
vo
lu
m
e 
(%
)
 
 
RIPV
RSPV
LPV
(a)
 









  
 







(b)
Fig. 13.5. a) Activation of the three pulmonary veins depending on the threshold of LGE-MRI for the
transfer of scars into the model of patient 11. Dashed lines: scar tissue, solid lines: tissue which is not
activated during sinus rhythm. Differences between the two curves of each PV denotes tissue, which is
isolated from regular activation. 0% threshold means that all regions which have a LGE-MRI value are
considered to be scar tissue. 100% means that no region is considered to be scar. b) Endocardial shell with
LGE-MRI intensity distribution and simulated activation times using different LGE-MRI thresholds. The
dashed circle denotes the PV most likely to reconnect to the left atrial myocardium.
dure revealed that the RSPV was reconnected to the left atrium (Tab. 13.1). In the
simulations, the region around both right PVs showed small LGE-MRI intensities
(Fig. 13.4(b)).
13.2.3 Fibrosis from pre-ablation LGE-MRI
For subject 9, the intensity of LGE-MRI prior to the first RFA procedure was also
mapped onto a 3D shell of the left atrium (Tab. 4.1). Strong LGE-MRI intensity
in images acquired prior to an RFA procedure might reveal pre-existing scars.
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Table 13.2. Tissue properties for three degrees of fibrosis transferred from pre-ablation LGE-MRI.
fibrosis LGE-MRI CV stissue
degree threshold longitudinal anisotropy longitudinal anisotropy
none 100% 100% 1.9:1 100% 3.75:1
mild 56% 80% 4:1 64% 16:1
moderate 60% 60% 8:1 36% 64:1
severe 64% 40% 12:1 16% 144:1
Additionally, there’s strong evidence that such approach can also identify regions
of tissue fibrosis [272, 274].
Using the same approach as to mark RFA scar tissue in volumetric left atrial mod-
els (Sec. 7.1.1), fibrotic regions were marked in the model (Fig. 13.6 top 2 rows).
Three thresholds were considered to mark three degrees of fibrosis (Tab. 13.2). Tis-
sue properties were altered such that myocardial dissociation increased and con-
duction velocity decreased with stronger fibrosis. Tissue conductivity for healthy
myocardium was determined through personalization of the interatrial connections
and the global conduction velocity to match the PWd as described in Chapter 9.
The remodeling CRN model with extracellular ion concentration adapted to the
patients blood electrolyte concentrations (Chap. 8) was used to simulate atrial elec-
trophysiology.
Inclusion of fibrosis into the model led to a slowing of the wavefront propagation
in the fibrotic regions compared to the regular simulation (Fig. 9.4). Furthermore,
excitation did not propagate into the RSPV, which sleeve tissue was made up of
severe fibrosis. The left atrial activation sequence was altered on the anterior left
atrium. Late activation occurred near the left atrial roof and the LAA (Fig. 13.6,
encircled). A line of severe conduction slowing could be observed between the
right and left PVs on the posterior side (Fig. 13.6, dashed line). Both effects could
also be seen in the measured LAT map from the same patient, although the degree
of conduction slowing was less. Figure 13.6 provides a comparison of the fibrotic
model and the simulation outcome as well as the measured LAT map.
13.3 Discussion
In this chapter results from LGE-MRI based model augmentation in six cases were
presented. LGE-MRI data collected shortly after an ablation procedure (within the
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Fig. 13.6. LGE-MRI intensity based fibrosis model in subject 9. Fibrotic regions can be seen in the second
row as grey zones. The darker the grey the more severe the fibrosis. Fibrosis regions might in part be an
explanation for late activation on spots on the anterior left atrium (encircled in magenta) and conduction
block on the left atrial roof (dashed lines). The phenomena could not be reproduced with the regular model
(Fig. 9.4).
first 24 h) showed large signal intensity in regions of scar, edema and inflammatory
tissue. In order to reliably image scar formation after RFA in the left atrium, LGE-
MRI data needs to be recorded at least 3 month after the ablation procedure [138].
Such was done for subject 9c, 10 and 11.
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The transfer of scar tissue into the models based on LGE-MRI intensity showed
great variability, especially using LGE-MRI data acquired acutely after RFA.
Thereby, virtually placed additional ablation lesions resulted the same simula-
tion outcome as slight variations in LGE-MRI intensity threshold. To provide a
quantitative analysis of PV reconnection probability, sensitivity analyses of the
PV isolation with varying LGE threshold were performed.
For the sensitivity analysis the fast-marching approach was used to simulate sinus
rhythm activation. This approach had the draw-back that small gaps in ablation
lesions were conductive, in contrast to monodomain simulations and experimental
findings (Chap. 12). For subjects 10 and 11 a reduced number of monodomain sim-
ulations with thresholds around the crucial PV isolation thresholds were performed
to validate the simplified simulation approach. The outcome of the monodomain
simulations is shown in Figures 13.4(a) and 13.5(a) with stars and diamonds. For
subject 12, a good correspondence could be observed, whereas in subject 11 re-
sults of the superior PVs differed. In the monodomain solution the superior PVs
were isolated at higher values and thus less prone to reconnection.
LGE-MR images are difficult to segment [274]. This is caused by low LGE-MRI
resolution, contrast-agent accumulation in anatomical structures next to the atria
(e.g. the esophagus or great vessels) and missing information about the regional
wall thickness in the left atrium. LGE-MRI intensity was extracted from the im-
age as the integrated intensity in a 3mm range around the left atrial endocardial
surface (Sec. 7.1.1) [270]. This range is at the upper end of reported left atrial wall
thickness (Sec. 2.1.1.4), to capture all LGE-signal within the atrial wall. The low
image resolution and significant variations in manual scar segmentation between
experts [274] did not permit a reliable direct transfer of scar tissue from LGE-MRI
into the model at the moment.
Tissue conductivity was set to zero in scar regions. Similar approach is commonly
done in ablation modeling studies [93, 185, 187, 420]. Ablation lesions might be
more complex in their microscructure (Sec. 2.3). The modeling approach could be
enhanced by adding border zones of slow conduction and isotropic tissue proper-
ties in scar and surrounding regions to model acute lesions and the lesion healing
over time. In this presented cases, this was not necessary, as the outcome of chronic
scar formation was regarded [138].
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Minor problems with the isolation of the LSPV were observed. The automatic
image segmentation approach only provided the left atrial endocardial surface,
which was dilated afterwards. This caused a connection between the LSPV and
the LAA epicardial surface in some of the models. Therefore, the LSPV may be
activated from the LAA, although it was isolated at its orifice from the left atrial
body, thus distort the sensitivity analysis results. This was observed in subject 10.
Segmentation techniques using volumetric statistical shape models could prevent
such errors in future studies [60, 361].
The results of the sensitivity analysis of subjects 10 and 11 did not correspond to
the equivalent clinical findings. This might be caused by various reasons. (i) The
applied fast-marching level set method to simulation atrial excitation is not able to
reproduce diffusion processes and wavefront curvature effects yet and thus allows
excitation through any kind of small gaps. (ii) The model-based analysis of the im-
age data relies on the segmentation of LGE-MRI data, which was shown to be an
unreliable task yet [274]. It might therefore be necessary to tune LGE-MR image
acquisition, morphological image acquisition (wall thickness) and to use fast sim-
ulation methods with diffusion [262] to receive reliable results from the sensitivity
analysis. Nevertheless, the presented framework has the potential to support diag-
nosis of AF patients awaiting redo-procedures. The simulations provide a visual
impression of the excitation pathways in the left atrium and eventual propagation
into reconnected pulmonary veins and can thus help to plan RFA interventions.
LGE-MRI data acquired prior to an EP intervention might be able to reveal regions
of fibrotic tissue in the atria [269, 272]. Based on such data, fibrotic left atrial
myocardium was introduced into the model of subject 9. This simulation study
was quite speculative and was meant to serve as a proof of concept.
Three degrees of fibrosis were set depending on the LGE-MRI intensity. The con-
duction velocity magnitude and anisotropy were varied with the LGE intensity.
The values for anisotropy were quite strong, to pronounce the effects of the fi-
brotic regions. Plank et al. [94] modeled severe fibrosis with a tissue conductivity
ratio of 12:1. Zhao et al. [96] on the other hand assumed regular atrial conductiv-
ity anisotropy as 10:1 and Tobon et al. set remodeled atrial conductivity ratio to
4:1 [412]. Measured conduction velocity anisotropy ratios in healthy atrial tissue
range from 8.5:1 (70:1 for tissue conductivity) in human pectinate muscles [79],
6.55 (43:1) [421] in healthy canine Bachmann bundle to 5.5 (30:1) [422] in healthy
canine right atrial free wall. The assumed values for mild and moderate fibrosis lay
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within this range. In future studies more degrees of fibrosis or a continuous transfer
function between degree of fibrosis depending on the LGE-MRI intensity could be
used.
In the fibrosis model only atrial myocyte cells were considered. Other cell types,
primarily fibroblasts, might be present in fibrotic regions. Fibrosis could therefore
also be modeled as a mixture of myocytes and fibroblasts [236, 397]. Modeling
studies investigating the electrotonic coupling between such cell types and other
microstructural tissue heterogeneities [423] provided explanations for the genesis
of CFAEs and other signal fractionation. Microfibrosis can also be modeled by the
introduction of conduction barriers between adjacent computational nodes [424].
In the present case, the modeling approach needed to be more macroscopic, as the
aim was to investigate the influence of fibrotic patches on the biatrial excitation
sequence. The other approaches require a finer model resolution, which was not
sensible for the present aim.
Fibrosis in the model led to a slowing of the global and local excitation wave
spread. This resulted in zones of slowed conduction or near conduction block.
These could serve as an explanation for similar zones in the measured LAT map.
Nevertheless, the thresholds for the transfer of fibrosis from LGE-MRI to the
model were chosen based on an educated guess and thus the findings are to be
taken cautiously. A quantitative measure for the determination of the threshold
would provide more confidence in the in-silico findings.
The established modeling and simulation framework was able to provide new in-
sights into the impact of ablation scars and fibrosis on the left atrial activation.
Once a more quantitative imaging and segmentation of LGE-MRI data is avail-
able, the framework might be used to predict long-term success of RFA therapy
and for the planning of redo procedure. It thereby might help to understand reen-
try pathways and to localize gaps in ablations lesions prior to the EP intervention.
Modeling of local fibrosis based on LGE-MRI might help to guide ablation pro-
cedures and could contribute to the understanding of abnormal electrical signals
observed in the left atrium during the EP procedure.
14
Influence of Ablation Lesions on the Cardiac Function
Radio-frequency ablation is performed in AF patients to restore cardiac function
by isolating arrhythmic triggers and substrate from the left atrial myocardium
(sec. 2.3). The main goal is to reduce the risk of clot formation and thus for is-
chemic stroke. Additionally, the quality of life of the patient should increase. It
is well known that in general the success of an RFA procedure (AF termination)
increases with the amount of scar tissue created. On the other hand, it is not clear
how the ablation scars influence the cardiac pump function. The effect is hard to
study in clinical trials as the ablation scars change their material properties over
time, but simultaneously reverse remodeling of the atria and ventricles after RFA
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Fig. 14.1. Four chamber tetrahedron model of subject 19 (Tab. 4.1 & 7.1).
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Fig. 14.2. Fiber orientation in the four compartment model of subject 19. The y value of the fiber orientation
vector is color coded using an HSV color map. Perspectives as in Figure 14.1.
therapy might overlap the effect of the introduced ablation scars. Computational
models bear the potential of examining the effects separately. In this section, a
study is presented which investigates the influence of various ablation lesion pat-
terns on the left atrial and left ventricular stroke volume.
In-silico studies examining the atria-ventricular relationship during the mechanical
cardiac cycle comprise several requirements. Among these are:
• Coupled geometrical atrial and ventricular model with fiber orientation.
• Electrophysiological and cell coupling model for the atria and for the ventricles.
• Tension development and elastomechanical model of the atrial and ventricular
myocardium.
• Elastomechanical model of ablation scars.
• Measurement data of the cardiac activity for model validation, preferably from
the same subject as the geometry was derived from.
As the ventricles have been subject of electrophysiological and elastomechanical
modeling for a long time, the prerequisites with respect to the ventricles are given
in many research institutions. In contrast, volumetric atrial models with fiber ori-
entation are given in only very few groups (Tab. 3.1) and models of tension de-
velopment and elastomechanics of the atria have not been developed yet. In this
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thesis, solutions for the majority of the prerequisites concerning the atria were
presented which now allow for combined atria-ventricular electrophysiology and
eleastomechanical simulations.
In this chapter, the impact of different ablation lesion patterns on the cardiac de-
formation is investigated. The simulation study was done in collaboration with
Dipl.-Phys. Thomas Fritz, who was responsible for the biomechanical simulation
framework. The fundamentals of the elastomechanical simulation of cardiac tissue
are therefore not described in detail in this thesis.
14.1 Simulation Setup
A whole heart model was derived from a healthy volunteer (subject 19, Tab. 4.1
& 7.1). Ventricular fiber orientation was approximated according to the rules de-
scribed by Streeter et al. [167]. Atrial fiber orientation was modeled as described
in Section 5.4. Figure 14.2 depicts the fiber orientation in the whole heart model.
Electrophysiology and tension development were simulated on a voxel grid (Dx =
0.33mm). Cardiac deformation was computed in a tetrahedron model of the four
cardiac compartments within an elastic shell representing the pericardium [425].
The four chambers were not directly connected to the pericardium but could
slide against each other. The model contained approximately 25.000 elements.
Model fixation was derived from multi-slice cine-MRI from subjects 10, 11 and
19 (Tab. 4.1). In this data, the orifices of the caval veins and PVs as well as the
apex did not move significantly and were thus assumed to be stationary. The model
was fixated around the openings of the caval veins, around the orifices of the four
PVs and at the apex. The AV plane was not fixated. Figure 14.1 shows the four
compartment tetrahedral model used for the biomechanical simulations.
The ventricular electrophysiology was simulated with the electrophysiological
model from ten Tusscher et al. [426]. The ventricles were activated endocardially
with a realistic stimulation profile [427] and excitation propagation was computed
with the monodomain model. More detail on the simulation of the ventricular elec-
trophysiology can be found in [386]. Atrial electrophysiology was simulated us-
ing the gradual heterogeneous CRN model (Sec. 5.2). Tension development in the
ventricles was simulated using the HTD model [308, 311] and in the atria with the
aHTD model (Sec. 5.3).
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Fig. 14.3. Stress-strain relationship in atrial myocardium and atrial scar tissue as modeled in this study.
Ventricular and atrial elastomechanical properties were modeled using the model
of Guccione et al. [428, 429]. The model was originally developed for ventricular
myocardium. In the absence of respective measurement data for the atrial my-
ocardium, it was assumed that the atria and ventricles behave similar. The model
describes anisotropic hyperelastic and incompressible myocardial tissue. No infor-
mation about the elastomechanical properties of RFA scars were found. However
Takahashi et al. [430] suggest that RFA scars behave like myocardial infarction
tissue in the long run. In a chronic state such tissue has a 6–8 fold higher stiff-
ness than regular tissue [431]. In some simulations, the stiffness was increased by
a factor of 10 [432, 433]. For the present study, the stiffness parameter C in the
Guccione model was also increased by a factor of 10:
Cscar = 10 ·Cregular. (14.1)
In an uniaxial stretch experiment, this altered the stress-strain relationship as
shown in Figure 14.3.
Generic ablation lesion patterns were set in the left atrial model as introduced in
Section 5.5. A subset of lesion patterns was chosen (no lesion, B, D, F). The other
lesion patterns did not differ significantly from these patterns and would thus not
provide additional insights.
Two sets of independent simulations were run. For one, the impact of ablation
lesions on the active atrial deformation was investigated. Therefore, atrial depolar-
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Table 14.1. Simulated and measured left atrial volume over the complete cardiac cycle.
model [434] [435] [18] [19]
Maximum Volume (ml) 66.4 97±27 90 (60–120) – –
Unloaded Volume (ml) 52.0 – – – 62±22
Minimum Volume (ml) 38.7 44±13 30 (35–40) 41.86 –
Stroke Volume (ml) 27.7 53±21 – – –
Ejection Fraction (%) 41.7 54±12 – – –
ization and repolarization and subsequently tension development and deformation
were simulated for the regular model and five ablation lesion patterns. In a second
set of simulations, the influence of ablation lesions on the passive atrial deforma-
tion was examined. Ventricular contraction following ventricular excitation was
simulated six times with different ablation lesion patterns in the left atrium. In
each simulation the left atrial and left ventricular volume curve were recorded.
14.2 Results
Simulation of the regular cardiac excitation in the atria started in the right atrium
between the SVC and the RAA. The activation spread downwards the right atrium
and coupled into the left atrium anterior via BB. The wavefront rolled over the roof
of the left atrium and merged with a second wavefront coming from the inferior
right atrium between the inferior PVs (Fig. 14.6, top row arrows). The tension
development sequence followed the electrical activation is therefore not shown.
The maximum force was greatest in the CT and showed a gradient from right to left
and superior to inferior within the right atrium. The PVs and the atrio-ventricular
rings showed the smallest tension development.
The deformation caused by the tension development (Fig. 14.4 led to a decrease
in left atrial volume as shown in Figure 14.7(a). Ventricular contraction caused
an increase in left atrial volume as shown in Figure 14.7(c). The extrema of the
atrial volume are listed in Table 14.1. These lay within the range of experimental
findings, although the left atrial volumes were at the lower end of measured ranges.
Introduction of ablation lesions did not alter the right atrial activation and tension
development. Pattern B, D, F isolated the PVs from the electrical activation. Thus
no force was developed in the PVs and the surrounding area in these patterns.
Pattern D changed the direction of the activation wavefront in the left atrial region
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Fig. 14.4. Cardiac deformation during atrial contraction and relaxation. The active tension is color coded
in the atria.
between the PVs. Pattern F electrically isolated a major portion of the left atrium
(PVs and region in between). In this area force development was suppressed. There
was no significant difference in tension development between lesions B and D.
Figure 14.6 shows the electrical activation and maximum local tension for the
regular case and the five ablation lesion models.
Introduction of ablation reduced the decrease in atrial volume during the atrial
contraction and relaxation (Fig. 14.7(a)). Pattern F showed the greatest effect on
the left atrial volume and had the smallest change from unloaded atrial volume.
The atrial volume during ventricular contraction was affected only slightly by the
ablation lesions (Fig. 14.7(c)). Ventricular volume during atrial and ventricular
contraction was not significantly affected by the ablation lesions (Fig. 14.7(b)
& 14.7(d)). Table 14.2 lists the maximum and minimum atrial volume in the
healthy case and in the five ablation lesion cases over the cardiac cycle. The stroke
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Fig. 14.5. Cardiac deformation during ventricular contraction. The L2 norm of the wall stress is color coded
in the atria.
volume and ejection fraction were decreased in the ablation lesion models. Sole
PVI (pattern B) had the least decrease of stroke volume and pattern F the greatest.
14.3 Discussion
In this section a combined electrophysiological and elastomechanical simulation
study investigating the influences of standard ablation lesion patterns on the car-
diac function was presented. To the knowledge of the author, this is the first study
to simulate active atrial deformation. Previous computational studies of atrial elas-
tomechanics concentrated on the left atrial deformation during ventricular contrac-
tion [318, 319] or during external deformation [317]. Further studies investigated
the effects of stretch-sensitive channels on the initiation of AF in static atrial mod-
els [323–325].
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Fig. 14.6. Local activation time and maximum force in model 19 with different generic ablation lesion
patterns during sinus rhythm.
Passive elastomechanical properties of the atria were approximated by a model
of the ventricular elastomechanical properties due to the absence of a comparable
model for the atria. This model was very recently adapted to reproduce the atrial
elastomechanics [436] based on measured stress-strain curves from [317]. Simu-
14.3. DISCUSSION 243
0 0.2 0.4 0.6
35
40
45
50
55
time (s)
le
ft 
at
ria
l v
ol
um
e 
(m
l)
(a) Atrial Conctraction
0 0.2 0.4 0.6
157
158
159
160
161
162
time (s)
le
ft 
ve
nt
ric
ul
ar
 v
ol
um
e 
(m
l)
(b) Atrial Conctraction
0 0.05 0.1 0.15 0.2 0.25
50
55
60
65
70
time (s)
le
ft 
at
ria
l v
ol
um
e 
(m
l)
(c) Ventricular Conctraction
0 0.05 0.1 0.15 0.2 0.25
80
100
120
140
160
time (s)
le
ft 
ve
nt
ric
ul
ar
 v
ol
um
e 
(m
l)
(d) Ventricular Conctraction




Fig. 14.7. Left atrial and left ventricular volumes during atrial and ventricular contraction. Lesion patterns
described in Tab. 5.9 and Fig. 5.27.
lations using the same four chamber model did not reveal strong changes in the
deformation sequence compared to the present simulations. Nevertheless, future
studies should use the adapted model instead of the ventricular model. If simu-
lations do not need to account for anisotropic elastomechanical properties in the
atria, the Mooney-Rivlin model [437], which was also recently adapted to atrial
properties [436], could be used.
The atrial wall thickness of model 19 was at the upper end of measured values of
the wall thickness (Sec. 2.1.1.4). This did not significantly influence the electrical
activation sequence, but led to an increased absolute stiffness during the elastome-
chanical simulations. In the simulations, the stiffness of the atria in the Guccione
model was therefore adjusted qualitatively to allow for a regular contraction and
deformation of the atrial chambers as observed in the cine-MRI (Fig. 14.8).
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Table 14.2. Influence of different ablation patterns on the left atrial volume.
no lesion B D F [430]
Maximum Volume (ml) 66.4 64.6 63.8 63.6 –
Minimum Volume (ml) 38.7 40.6 41.9 45.1 –
Stroke Volume (ml) 27.7 24.1 21.9 18.5 5.75
Ejection Fraction (%) 41.7 37.2 34.4 29.0 18±11
The elastomechanical properties of scar tissue were described by the Guccione
model as well. This model describes the myocardium as an incompressible,
anisotropic, hyperelastic material. Ablation scars either have isotropic tissue prop-
erties or fiber orientation in this region is chaotic [119], which can microscopically
be described as isotropic tissue [130] (Sec. 2.3.1). It is not expected that modeling
the scars as isotropic tissue, e.g. by using the Mooney-Rivlin model, will change
the simulation results substantially, as the high stiffness of the scars does not per-
mit a deformation of these anyway.
The stiffness of ablation scars was derived from the stiffness of ventricular chronic
myocardial infarction tissue due to the lack of better experimental data. The stiff-
ness of myocardial infarction tissue changes over the course of time after the
infarction [431]. The tendency is that the scar becomes more stiff over time.
A similar behavior could be assumed for ablation scars as well. Ablated tissue
shows variations in tissue perfusion in LGE-MRI during the first three month post-
ablation [138]. The simulation framework used for the present study could also be
used to investigate the changing impact of ablation scars on the cardiac function
over time.
During ventricular contraction, the atrial wall stress was strongly increased in ele-
ments near the fixation nodes around the orifices of the PVs and caval veins. The
fixated structures were nearly motion-free in the cine-MRI available. Nevertheless,
a little motion could be observed in these structures. It could therefore be useful
to not apply strict boundary conditions in these structures, but allow for a reduced
elastic deformation. This could be realized by attaching onsets of vessel tissue to
the structures and fixating these at the end. This would also correspond better to
the anatomical situation. Strong wall stress in the regions of the PVs could also be
a factor influencing ectopic activitiy in this region through stretch-activated chan-
nels.
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Fig. 14.8.Cardiac motion observed in the cine-MRI of subject 19 as well as in the corresponding four cham-
ber model. Figure based on visualizations provided by Dipl.-Phys. Thomas Fritz, Institute of Biomedical
Engineering, Karlsruhe Institute of Technology (KIT).
Maximum tension decreased from right to left and from superior to inferior. Weak-
est tension development was found in the PVs and valve rings. A strong contrac-
tion in these structures seems to be unrealistic, as it would work against the cardiac
skeleton. These findings coincided with the single cell simulation results presented
in Section 5.3. Right atrial contraction was significantly pronounced compared to
the left atrium. This was caused by various factors. For one, tension development
was stronger in the right atrium. Second, fiber orientation was well aligned along
the CT and PMs in the right atrium. In the left atrium, two sheets of different fiber
direction overlap another and thus may hinder contraction. Third, the left atrium
was fixated at the PVs. The PVs and the left atrial wall in between lay within a
plane. Therefore this part of the left atrial wall could not displace to a great extent.
In the cine-MRI from the same patient, the right atrium also showed a stronger
contraction than the left atrium.
The simulated left atrial volume time course as well as the ejection fraction and
stroke volume fit into the range of measured values for these data (Tab. 14.1). The
model was thereby at the lower end of the measured values. This was due to a
small unloaded left atrial volume. The left atrial volume was determined without
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the volume in the PVs. The definition of the extent of the left atrial volume towards
the mitral valve might also show inter-study variability. The left atrial volume
curve also showed a similar behavior as measured curves [438, 439] except for
the temporary volume decrease during ventricular contraction (Fig. 14.7(c), 150–
300ms). During this time period the ventricular contraction did not pull the valve
plane towards the apex.
The main finding from the study was that ablation lesions in the left atrium reduce
left atrial stroke volume and therefore may hinder left ventricular filling. Thereby
the reduction went hand in hand with the amount of ablation scar set. Takahashi et
al. also observed a reduced left atrial ejection fraction after ablation in-vivo [430].
No physiological data for comparison were available in these patients, as they were
in AF prior to the ablation therapy. In the study a substantially greater portion
of the left atrium was ablated in average, which could explain the low ejection
fraction, similar to the results from the present study in which a greater amount of
ablation lesions accounted for the ejection fraction reduction.
No relationship between the scar location and the comparment volumes could be
observed. However, sole circumferential PVI resulted in the least decrease of atrial
function. From the perspective of curing a patient from AF, usually more ablation
scar results in a better long-term outcome of the ablation procedure. The simula-
tion results indicate that extensive left atrial ablation may also reduce the quality
of life of the patient in terms of cardiac function. Additionally, left atrial regions
isolated from regular electrical activation did not show great deformation neither
during atrial contraction nor during ventricular contraction. This may lead to an
increased risk of blood clot formation in these regions post-ablation.
Atrial and ventricular activity were simulated independently from another. This
approach was valid for regular sinus rhythm simulations, as atrial and ventricu-
lar contraction and deformation are happening sequentially under these circum-
stances. If faster sinus rhythm or atrial arrhythmia are to be simulated, combined
whole heart simulation will most likely produce more reliable results. This ap-
proach would also allow for the investigation of atrio-ventricular diseases such
as the Wolf-Parkinson-White syndrome. Whole heart simulations require signifi-
cantly more computational resources (memory and time). It should therefore care-
fully be evaluated if separate simulations may be suitable for the given problem as
well.
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For the ventricles, only the contraction phase and not the relaxation phase was
simulated. This was due to numerical problems during the relaxation phase. Ab-
lation lesion patterns were not expected to have a significantly different influence
on the atrial volume during this phase.
In a next step, atrial contraction and left atrial volume could be analyzed un-
der the influence of AF-remodeling. A suitable tension development model is
given in Section 5.3. For the elastomechanical properties, tissue anistropy should
be increased, as observed during structural remodeling. Similarly, conductivity
anisotropy should be increased and conduction velocity should be reduced in such
simulations (Sec. 3.2.2).
In the present study, the electro-mechanical coupling [440] was simulated using
the aHDT model (Sec. 5.3). Conversely, also the mechano-electrical feedback
could be incorporated into the simulations [320]. The mechano-electrical feed-
back loop was shown to have significant impact on the initiation and perpetuation
of AF [321, 322]. Computational modeling bears the potential to provide new in-
sights in the processes underlying the initiation of AF by e.g. left atrial overload,
dilatation or hypertension. Initial efforts in this area have been undertaken by Kui-
jpers et al. [323–325]. In these studies the atria were modeled as fixed structures.
Therefore stretch-sensitive channels were artificially stimulated and only the im-
pact on the electrophysiology could be observed. The modeling framework pre-
sented in this chapter opens up the possibility to investigate the more complex
relationships between atrial motion under pathological constraints and atrial elec-
trophysiology and vice-versa.
In this chapter an approach to model active and passive atrial deformation under
physiological and post ablation therapy conditions was presented. The four cham-
ber simulations revealed a reduction of left atrial ejection fraction with increasing
portion of ablation lesions in the left atrium. The modeling framework enables
a better understanding of post-therapy complications and may assess the risk of
blood clot formation if coupled to computational fluid dynamics (CFD) software.
In the future, simulations of atrial elastomechanics may allow for an improved
planning of ablation lesions for the individual AF patient.

15
Impact of Hemodialysis on the Atrial Electrophysiology
Patients with end-stage renal disease (ESRD) have a greater prevalence for de-
veloping atrial fibrillation (AF) than the healthy population [441]. AF is also more
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Fig. 15.1. Overview of the methodology used for the multi-scale modeling study. The goal was to under-
stand the influence of hemodialysis therapy on the atrial electrophysiology on cellular and ECG level (red
dashed arrows). Therefore a set of blood electrolyte conditions based on measurements from hemodialysis
and ESRD patients (blue dotted arrows) was used to parameterize 1D and 3D simulations in atrial tissue
(gree solid arrows).
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Table 15.1. Measured plasma ion concentration before (pre) and after (post) hemodialysis (HD) ses-
sions. Values given as mean ± standard deviation in mM. Data from the first six dialysate compositions
from [446].
Dialysate [K+]o [Ca2+]o
K+ Ca2+ pre-HD post-HD pre-HD post-HD
2.0 1.25 5.0 ± 0.4 3.3 ± 0.2 1.17 ± 0.11 1.24 ± 0.12
2.0 1.50 5.0 ± 0.5 3.4 ± 0.2 1.16 ± 0.11 1.37 ± 0.06
2.0 1.75 5.2 ± 0.6 3.5 ± 0.3 1.18 ± 0.09 1.52 ± 0.07
3.0 1.25 5.1 ± 0.6 3.7 ± 0.3 1.17 ± 0.12 1.19 ± 0.05
3.0 1.50 5.1 ± 0.6 3.9 ± 0.4 1.16 ± 0.10 1.25 ± 0.12
3.0 1.75 5.1 ± 0.4 3.9 ± 0.3 1.21 ± 0.12 1.37 ± 0.07
[398] 4.9 ± 0.5 3.9 ± 0.4 1.18 ± 0.09 1.30 ± 0.07
common in patients undergoing hemodialysis therapy to compensate for renal fail-
ure [442, 443]. Additionally, during hemodialysis the probability for the occur-
rence of supraventricular extrasystoles is increased. In hemodialysis patients with
AF morbidity and mortality are increased as a consequence [442, 444].
To better understand the relationship between hemodialysis therapy and AF devel-
opment, a multi-scale simulation study was conducted [399, 445] and is presented
in this chapter. A previous single-cell simulation study indicated that changes
in blood electrolyte concentrations alter the atrial electrophysiology in a pro-
arrhythmic manner [398]. The study lacked tissue and organ simulations. The
multi-scale modeling approach promised to reveal a chain of evidence for pro-
arrhythmic alterations of atrial electrophysiology due to hemodialysis therapy. It
can thereby bridge the gap between cellular changes and macroscopic observa-
tions in the ECG (Fig. 15.1). The investigations focused on parameters which play
a role for the initiation and maintenance of AF, e.g. conduction velocity, effective
refractory period and wavelength.
15.1 Simulation Setup
Measurement data were retrieved from two studies [398, 446]. In the first study [446],
16 patients underwent six hemodialysis (HD) sessions each. In each session the
composition of the dialysate bath was changed. Table 15.1 lists the dialysate bath
compositions. Blood plasma samples were taken from each patient before and
right after the HD session and potassium and calcium concentrations were deter-
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Table 15.2. Extracellular ion concentration setups for the whole atria sensitivity analysis simulations. Val-
ues are in mM.
Setup [K+]o [Ca2+]o [Na+]o
CRN model 5.4 1.8 140.0
1 hyperkalemia 5.2 – –
2 hypokalemia 3.3 – –
3 hypocalcaemia – 1.16 –
4 hypercalcaemia – 1.52 –
5 hyponatremia – – 135.0
6 hypernatremia – – 145.0
7 pre-HD 4.9 1.18 139.8
8 end-HD 3.9 1.30 141.6
mined (Tab. 15.1). In the second study [398], plasma electrolytes before and after
HD therapy from 20 ESRD patients undergoing hemodialysis therapy with a stan-
dard dialysate bath for less than six months (mean 4±2) were measured (Tab. 15.1,
bottom row).
A hemodialysis session usually lasts two to five hours and patients with renal fail-
ure need to attend for therapy at two to four days a week. As the change in blood
electrolyte concentrations progresses along with the therapy session duration, ion
concentrations in the extracellular space of the myocardium are washed in /out ac-
cording to the change in blood electrolytes. For the simulations, the CRNmodel of
atrial electrophysiology was used. The model was adjusted to recreate the effects
of variations in extracellular ion concentrations (Sec. 5.1.1).
Three simulation scenarios were considered. First, a 1D beam of coupled compu-
tational nodes was used to determine the change in upstroke duration and upstroke
velocity between pre-HD and post-HD conditions. The upstroke duration APup
was determined as the time between the beginning of the upstroke and its maxi-
mum. The upstroke velocity dVm/dt was calculated as the positive maximum of
the derivative of the transmembrane voltage over time during the upstroke.
The electrolyte configuration at the end of a hemodialysis session was composed
of changes in all ion concentrations. To better understand the contribution of each
ion, a sensitivity analysis of the influence of potassium, calcium and sodium on
the electrophysiology was performed in the 1D beam setup as second scenario.
Thereby, APD, ERP, conduction velocity and wavelength were determined as de-
scribed in Section 5.2. The sensitivity analysis was done for each of the four
right atrial regions (RA, CT, RAA, TVR). Five simulations with varying concen-
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trations of each ion were performed for each atrial region. Maximum and mini-
mum values of potassium and calcium were determined with a confidence interval
from the measurements (Tab. 15.1). Maxima of sodium concentration were taken
from [398].
Third, eight whole atria sinus rhythm simulations were conducted under minimum
and maximum single ion concentrations as well as under pre-HD and end-HD
conditions (Tab. 15.2) to determine the impact of the changes in cellular electro-
physiology on the global repolarization sequence and the P-wave. For the simula-
tions model 4 (Tab. 7.1) was used. Fiber orientation was set in the CT, PMs and
BB, as described in [169]. All other regions had isotropic tissue properties. Het-
erogeneities in atrial electrophysiology were set as in [92]. The BCL was set to
844ms in accordance to the heart rate observed in the ESRD patients [398].
15.2 Results
15.2.1 Action Potential Upstroke
Table 15.3 summarizes the change in the upstroke of the action potential in right
atrial regions during a hemodialysis session. The upstroke duration was pro-
longed in all atrial regions after hemodialysis. Common atrial myocardium (CAM)
showed the largest prolongation, AVR the smallest. This also caused a decrease in
upstroke velocity. The decrease was in a similar magnitude in all tissues. The rest-
ing membrane voltage was hyperpolarized in all regions by -5.6± 0.1mV at BCLs
longer or equal to 475ms (heart rates below 125 bpm). The general action potential
morphology was preserved in all regions.
15.2.2 Extracellular Ion Concentrations
Table 15.4 summarizes the results from the sensitivity analysis in the 1D tissue
beam setup and Figure 15.2 shows results for a sinus rhythm BCL. An increase
in extracellular sodium increased APD, conduction velocity, ERP and thus wave-
length in all right atrial cell types. An increase in extracellular calcium concentra-
tion caused a decrease in APD, ERP and wavelength in all cell types but did not
alter the conduction velocity significantly. An increase in extracellular potassium
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Table 15.3. Maximum upstroke velocity dVm/dtmax (mV/ms) and upstroke duration APup (ms) at 844ms
BCL for different atrial tissues.
Tissue pre-HD end-HD difference
absolute relative
CAM APup 4.94 5.67 +0.73 +14.7%
dVm/dtmax 119.3 115.4 -3.9 -3.3%
CT APup 4.94 5.56 +0.62 +12.6%
dVm/dtmax 117.8 115.0 -2.8 -2.4%
TVR APup 5.42 5.88 +0.46 +8.5%
dVm/dtmax 120.2 115.8 -4.4 -3.7%
RAA APup 5.28 5.99 +0.71 +13.4%
dVm/dtmax 119.1 115.2 -3.9 -3.3%
Table 15.4. Results of sensitivity analysis.% indicates a positive dependency on the rise in extracellular
ion concentration; " a strong positive dependency;& a negative dependency. ' means nearly no change
and ./ indicates contradicting or a more complex dependency-pattern. See text for more information.
Res Tissue [Na+]o " [K+]o # [Ca2+]o " end-HD
APD90 CAM % ./ & %
TVR % ./ & &
RAA % ./ & '
CT % ./ & '
CV CAM % # ' &
TVR % # ' &
RAA % # ' &
CT % # ' &
ERP CAM % & & &
TVR % & & &
RAA % & & &
CT % & & &
WL CAM % # & &
TVR % # & &
RAA % # & &
CT % # & &
increased the conduction velocity and wavelength substantially and also increased
ERP. The change in APD did not directly depend on the change in extracellular
potassium. APD increased for [K+]o decreasing below a concentration of 4.5mM.
APD decreased for decreased [K+]o above 5.75mM. APD did not change signifi-
cantly for potassium concentrations between 4.5–5.75mM. ERP was most sensi-
tive to changes in extracellular potassium concentration.
The end-HD condition was a combination of hypokalemia, hypercalcaemia and
hypernatremia (Tab. 15.1). Conduction velocity was decreased in all cell types by
approximately -50mm/s compared to the pre-HD case. This was mainly caused
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Fig. 15.2. Results of the sensitivity analysis for a BCL of 868ms (69 bpm) for right atrial cell types (solid
green: CT, dashed red: CAM, dotted black: APG, dash-dotted blue: AVR). Vertical lines indicate the bounds
of pre-HD and end-HD concentrations as reported in [398]. The restitution behavior for the regular CRN
model (RA) is depicted in Fig. 15.3.
by the hypokalemia, which also caused the decrease of ERP (Tab. 15.4). APD was
increased in regular atrial myocardium, but decreased in the tricuspid valve ring
and did not change in the appendage or the crista terminalis. The wavelength as an
indicator for the development and maintenance of reentry circuits was decreased
in all cell types after HD therapy (Fig. 15.4). TVR cells had a wavelength af-
ter hemodialysis 25% shorter than the wavelength before hemodialysis in regular
atrial myocardium.
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Fig. 15.3. Restitution curves for the CRN model (RA) for different concentrations of potassium, calcium
and sodium (n= 1 . . .5). Green curves result from highest concentrations, cyan curves from smallest con-
centrations. Grey arrows indicate the impact of an increase in extracellular ion concentration on the resti-
tution behavior.
15.2.3 Atrial Activation Sequence and P-wave
The time of complete depolarization of both atria was longer under end-HD con-
ditions compared to pre-HD conditions (158 vs. 145ms). Local APD was longer
under end-HD conditions (Fig. 15.5) and also had a greater dispersion DAPD (109
vs. 62 ms, +76%).
Hyperkalemia, hypo-/hypercalcaemia and hypo-/hypernatremia did not alter the
Einthoven ECG signals. As an example the Einthoven II signal under hypoercal-
caemia conditions is shown in Figure 15.5. The offset from the pre-HD signal was
smaller in the other settings. End-HD conditions and hypokalemia led to a pro-
256 CHAPTER 15. IMPACT OF HEMODIALYSIS ON THE ATRIAL ELECTROPHYSIOLOGY





     










Fig. 15.4.Wavelength restitution curves before (solid curves) and just after hemodialysis (dashed curves).
Hemodialysis decreased the wavelength. This allows reentries to develop and maintain in a smaller geo-
metric area. Blue: CT, red: CAM, green: RAA, yellow: TVR. Figure adapted from [399].
longation of the P-wave (+13 and +24ms) and a more negative amplitude of the
Ta-wave. The effect was stronger under hypokalemia influence (Fig. 15.5). The
pronounced Ta-wave amplitude under end-HD conditions correlates to the larger
dispersion of APD, and thus repolarization, in the simulations.
15.3 Discussion
Using a multi-scale modeling approach, the effects of hemodialysis therapy on
the atrial electrophysiology have been investigated to close the knowledge gap
between cellular experimental findings and macroscopic observations.
Electrophysiological tissue properties were determined in a beam of atrial cells.
Such coupled-cell environment usually has quantitatively different properties com-
pared to single cell preparations (Sec. 5.2). The results for changes in transmem-
brane resting voltage and upstroke duration correspond to previous single cell sim-
ulations [398]. Maximum upstroke velocity was decreased in the multi-cell setup,
whereas it was increased in the single-cell study. The general effects of changes in
potassium, calcium and sodium on APD and ERP were comparable between both
studies. The multi-cell simulation setup allowed the determination of the influence
of electrolyte changes on the conduction velocity and thus also on the minimal
wavelength required for a reentry circuit (WL = CV ⇥ ERP). Conduction velocity
was decreased slightly by a decrease in [Na+]o, but was not significantly altered
by changes in [Ca2+]o. Decreasing [K+]o led to a substantial decrease in conduc-
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Fig. 15.5. Local APD90 distribution under pre-HD and end-HD conditions. Einthoven II ECG signals under
pre-HD, end-HD, hypokalemia and hypercalcaemia conditions.
tion velocity. The typical morphology of the restitution curves (Fig. 15.4) was not
altered significantly by the changes in extracellular ion concentrations, whereas
the absolute values differed.
In the sensitivity analysis, [K+]o introduced the largest relative change. The range
was determined by the measured electrolyte concentrations (Tab. 15.1). It is rea-
sonable to assume that broader ranges for [Ca2+]o and [Na+]o would not alter the
general findings, as the slopes of the [Ca2+]o and [Na+]o-dependent curves were
flatter than the slope of the corresponding [K+]o-dependent curves (Fig. 15.2).
The reported global slowing of conduction velocity [398] could be traced backed
to the decrease of plasma potassium concentration at the end of the hemodialysis
session. All right atrial cell types were affected in a similar manner and the most
significant influence on the electrophysiology was a change in conduction velocity
due to a change of [K+]o. ERP was decreased after hemodialysis therapy due to
a combination of decreased potassium and increased calcium concentrations in
the extracellular space. The changes of ERP and conduction velocity potentiate
another in the wavelength, which was reduced at the end of hemodialysis therapy
(Fig. 15.4). This indicates a pro-arrhythmic substrate which favors AF onset and
maintenance, as reentries or rotors may establish in a smaller geometrical region
or shorter pathway. This could serve as an explanation for the reported higher
incidence of AF in hemodialysis patients.
The 3D bi-atrial simulations revealed an increased dispersion of APD and thus
repolarization at the end of a hemodialysis session. Again, decreased extracellular
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potassium concentration could be identified as a cause for this. Changes in calcium
and sodium did not play a significant role. These results agree with findings from
Pandit et al. [447] that hyperkalemia causes an increased organization of chaotic
activation patterns and vice-versa that hypokalemia promotes chaotic activation.
The simulated P-wave was longer under end-HD conditions (+13ms). The total
P-wave duration and the increase due to hemodialysis are in agreement with ex-
perimental findings (131±11ms pre-HD vs. 140±12ms end-HD) [398]. The P-
wave prolongation was the result of the decreased conduction velocity in all atrial
regions after hemodialysis.
The values for extracellular ion concentrations given in the original CRNmodel [72]
differ from the measured pre-HD ion concentrations. Sodium concentration in the
CRN model corresponds to the measurements (140 vs. 139.8mM). The potas-
sium concentrations is assumed to be higher in the original model formulation
compared to the presented measurements (5.4 vs. 4.9–5.2mM). The CRN model
calcium concentration is significantly higher than the measured values (1.8 vs.
1.16–1.21mM). The difference is most likely caused by different experimental
environments. The CRN model is based on in-vitro experiments, which in some
cases require a different cell milieu than present in-vivo.
The variation in model parameters was justified by the assumption that extra-
cellular ion concentrations correspond directly to plasma electrolyte concentra-
tions. This is a reasonable assumption, as hemodialysis therapy lasts several hours
and changes in plasma concentrations will wash in/out into the myocardium and
thereby minimize gradients between concentrations in both compartments. It re-
mains to be proven experimentally that these concentrations correlate. The model
parameterization based on blood electrolyte measurements could also allow for a
personalization of the electrophysiological model in other settings (Sec. 8.2).
Hemodialysis decreases the blood volume overload and thus reduces atrial stretch
and sympathetic activation. Severi et al. discussed that the observed prolonga-
tion of the P-wave after hemodialysis is most definitely caused by direct effects
on the atrial electrophysiology. In contrast, acutely reduced atrial dilatation, as ex-
pected during the hemodialysis, increases the atrial conduction velocity (mechano-
electrical feedback) [322]. This could partially account for the simulated P-wave
prolongation, which was at the upper end of the measured prolongations.
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Similar to the atrial dilatation, also an increased incidence of atrial fibrosis can be
observed in hemodialysis patients. This is most likely caused by frequent changes
in fluid and pressure overload. In the model, both effects were neglected, although
they will influence the conduction velocity and thus P-wave duration. The conduc-
tion velocity slowing from dilatation and fibrosis will be the same at the beginning
of an hemodialysis session and afterwards, as both are chronic alterations of the
atrial tissue. The relative effects shown in this study therefore remain valid.
Seemann et al. [92] and Chandler et al. [239, 448] presented computational mod-
els of the electrophysiology of human sinus nodal cells. These models could be
examined with the same work flow as the heterogeneous CRN model. This could
in future studies provide insights into the influence of hemodialysis on cell auto-
maticity and ectopic triggers, which are more frequent during hemodialysis.
The study results indicate that hemodialysis therapy itself could be a cause for the
increased prevalence of AF in ESRD and hemodialysis patients. Very recent find-
ings from Buiten et al. [449] support this hypothesis. They were able to show that
AF episodes occur more frequently on week-days at which hemodialysis patients
undergo therapy sessions.
In the future, patient-specific atrial models might enable a model-based patient-
specific hemodialysis therapy control. This could be realized as an automatic con-
trol system attached to the hemodialysis hardware using ECG and blood elec-
trolyte measurements as input. The controller could then continuously regulate the
ion concentrations in the dialysate to prevent severe changes to the myocardial
electrophysiology based on real-time simulations using the current parameters.
Similar techniques have been shown to be useful in e.g. supporting temperature
monitoring during open heart surgery [362, 450, 451]. A prerequisite for this is the
reduction of the anatomical and electrophysiology model (e.g. [240] complexity
and a significant speed-up of the computation, e.g. by using simplified excitation
models (Sec. 5.7).

16
Conclusion
In this thesis solutions for personalized multi-scale atrial modeling were presented.
These span from single cell electrophysiology modeling to ECG computation.
They enabled model applications in basic and clinical research (Fig. 16.1).
For one, a method to introduce local atrial fiber orientation in patient-specific mod-
els allowed more realistic simulation of the atrial excitation sequence than before.
The fiber models introduced in this thesis already found wide use in the mod-
eling community and hopefully lead to more reliable in-silico studies in basic
research and eventually also in clinical practice. Fiber architecture was compli-
mented with a new model of heterogeneous atrial electrophysiology. The model
provided insights into the atrial repolarization sequence and the corresponding
signal in the ECG. The results support the hypothesis of the existence of action
potential duration gradients in the atria. For the first time, the multi-scale simula-
tion methodology was validated against in-vitro cell experiments and in-vivomea-
sured P and Ta-wave from AV-block patients. Fiber orientation and heterogeneous
electrophysiology enabled the initiation of atrial fibrillation in a patient-specific
anatomical model without the need of unrealistic initiation protocols. This opens
up a wide field of applications to understand initiation and perpetuation mecha-
nisms of atrial fibrillation in different atrial regions. In the future, investigations of
fiber- and region-related pathologies such as myocardial fibrosis can be assessed
for the individual patient using these methods.
Next, a model of the heterogeneous atrial tension development was created. To-
gether with the model of the atrial fiber architecture this enabled for the first time
the biomechanical simulation of the passive and active atrial deformation during
the cardiac cycle in a patient-specific whole heart model. A subsequent analysis
of the effect of common ablation lesion patterns on the cardiac function revealed
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Fig. 16.1. Classification of the atrial modeling methods and simulation results presented in this thesis into
a matrix of modeling scale and field of application. Additionally, the model personalization techniques
introduced in this thesis are listed. Colors correspond to the field of model usage (see Fig. 1.1).
a significant decrease in atrial stroke volume after ablation which correlated to the
amount of scar tissue introduced. With this methodology, ablation lesions could
be optimized prior to an intervention in-silico, to securely eliminate atrial fibril-
lation while ensuring the best possible cardiac function afterwards. This could
significantly improve the long-term quality of life of the patient. A coupling of
the biomechanical simulations to fluid dynamic simulations may also permit the
evaluation of the risk of blood clotting during atrial fibrillation and in pathologi-
cal regions in the atria. This would help to understand processes which cannot be
observed in-vivo and may contribute to the identification of new treatment oppor-
tunities.
Thirdly, an improved scheme to detect the preferential interatrial conduction route
from standard ECG measurements was developed with the aid of a newly devel-
oped fast simulation framework. This allowed for high-throughput whole organ
simulations in a cohort of anatomical models. This new approach of in-silico in-
vestigation provided more confidence in the simulation results and also showed
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if significant interindividual differences were to be expected when translating the
method to clinical data. In the future, the framework could be used to gain a deeper
understanding of abnormal atrial excitation and may be used to create new ECG
acquisition and signal analysis techniques.
The multi-scale modeling approach also provided an explanation for a prolonged
P-wave duration after hemodialysis therapy in renal disease patients. Changes in
blood plasma potassium and calcium were linked to changes in cell kinetics which
subsequently caused a slowing of atrial excitation and a prolongation of the P-
wave. The effected cells also show an increased vulnerability to the development
of atrial arrhythmia caused by the therapy. This provides a new point of view on the
fact that renal disease patients have an increased incidence of AF. The simulations
hint that not solely the disease, but also the therapy might be the reason for the
arrhythmia. In the future, model-based patient monitoring during hemodialysis
therapy could adjust the dialysis solutions to the individual patient’s situation, such
that the risk of arrhythmia initiation is minimized.
Besides the development of basic atrial modeling techniques, a framework to per-
sonalize and integrate anatomical, electrophysiological and excitation propagation
models was created. Statistical shape models were used to segment the variable
atrial anatomy. From the segmentation, simulation-ready models were created and
augmented with functional tissue information using LGE-MRI. Electrophysiolog-
ical models were personalized based on blood plasma ion concentrations. The
global atrial conduction velocity was adjusted to match the patients’ P-wave dura-
tion and interatrial conduction routes were adjusted to match local activation time
maps of the left atrium. Besides the potential application in a clinical workflow,
the framework was used to establish three cohorts of atrial and thorax models.
These can be used in multi-model simulation studies, which may provide a better
confidence in the simulation results as anatomy specific results can be ruled out.
Last, radio-frequency ablation scars were assessed on multiple modeling scales.
Microscopic simulations revealed a selective conduction of gaps in ablation le-
sions dependent on local fiber orientation, tissue electrophysiology and excitation
rate. The results aided the understanding of late recurrence of AF after an ab-
lation procedure. On the whole organ scale, a framework to evaluate the risk of
pulmonary vein reconnection after ablation therapy was developed and applied to
data from three AF patients. These simulations provided insights into electrical
pathways which reconnect the pulmonary veins to the left atrium and could guide
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the placement of additional ablation points. The framework can be used to plan
redo-procedures for patients in whom the previous ablation intervention was not
successful.
Overall, many advancements in cellular, tissue and whole atria modeling have
been described in this thesis. Techniques to personalize atrial models in a smooth
pipeline were presented. This allows a more realistic, more reliable and patient-
specific simulation of the atrial activity. The enormous potential of the multi-scale
modeling approach was shown in various applications, which already aided the in-
depth understanding of pathologies and therapy outcome. Altogether, this opens a
wide field of usage of personalized multi-scale atrial models for basic research and
clinical applications. This will hopefully aid the more complete understanding of
atrial diseases and respective therapy mechanisms. In the near future, model-based
therapy evaluation and planing could shorten clinical treatment times and increase
the therapy success for reduced treatment duration, therapy costs and, last but not
least, the burden on the individual patient.
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First, advanced models of the cellular atrial electrophysiology 
and regional fiber orientation are introduced. Second, novel 
methods to create patient-specific anatomical and excitation 
propagation models of the atria are described. Third, poten-
tial applications of personalized models in basic research and 
clinical practice are presented.
The advances described enable the generation of reliable per-
sonalized atrial models from medical image and electrical data. 
The results mark an important step towards the patient-specific 
model-based AF diagnosis, understanding and treatment.
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